Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
SODIUM PERBORATE TETRAHYDRATE, 97% | 10486-00-7 | BNaO3 · 4H2O | 153.86 | |
Sodium perborate monohydrate | 10332-33-9 | NaBO3.H2O | 99.81 | perboric; perboricacid,sodiumsalt,; sodiumborate,monohydrate; SODIUM PERBORATE MONOHYDRATE; Perboric acid sodium salt monohydrate; Perboric acid (HBO(O2)), sodium salt, monohydrate; DISODIUMPERBORATEMONOHYDRATE; Natriumperborat |
SODIUM PENTANOATE 96+% | 6106-41-8 | C5H9NaO2 | 124.11 | |
SODIUM PENTACYANOAMMINE FERROATE | 80789-79-3 | C5H17N7O5Na2Fe | 357.07 | |
Sodium p-cumenesulfonate | 15763-76-5 | C9H12O3SNa | ||
sodium palmitate | 408-35-5 | C16H31NaO2 | 278.412 | |
Sodium p-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]benzenesulfonate | 4156-21-2 | C9H6Cl2N4O3SNa | ||
Sodium p-[(4,6-diamino-m-tolyl)azo]benzenesulfonate | 6300-61-4 | C13H14N4O3SNa | 329.33000 | |
sodium O,O-diisopropyl dithiophosphate | 27205-99-8 | C6H14NaO2PS2 | 236.267691 | sodium O,O-diisopropyl dithiophosphate; Phosphorodithioic acid, O,O-bis(1-methylethyl) ester, sodium salt; Natrium-O,O-diisopropyldithiophosphat; phosphorodithioic acid, o,o-diisopropyl ester, sodium salt; Sodium diisopropyl phosphorodithioate; sodium dii |
Sodium O,O-diethylthiophosphate | 5852-63-1 | C4H10NaO3PS | 192.148931;g/mol | sodium;diethoxy-oxido-sulfanylidene-$l^{5}-phosphane;SodiumO,O-diethylthiophosphate;5852-63-1;2465-65-8(Parent);C4H10NaO3PS |
SODIUM N-UNDECYL SULPHATE | 1072-24-8 | C11H23NaO4S | 274.35 | SODIUM N-UNDECYL SULFATE; SODIUM N-UNDECYL SULPHATE; UNDECYL SODIUM SULFATE; sodium undecyl sulphate; Natriumundecylsulfat; Sodium 1-undecyl sulfate, 99%(dry wt.), water <2%; Sulfuric acid sodium=undecyl ester salt; Sulfuric acid undecyl=sodium salt |
Sodium Nitroprusside | 14402-89-2 | C5FeN6O.2Na | 261.92 | |
Sodium Nitrate-15N | 31432-45-8 | [15N]NaO3 | 85.98810 | |
Sodium nifurstylenate | 54992-23-3 | C13H8NNaO5 | 281.20 | 4-[2-(5-nitro-2-furyl)vinyl]benzoic acid sodium salt; sodium nifurstylenate; SODIUM NIFURSTYRENATE; 4-[2-(5-Nitro-2-furanyl)ethenyl]benzoic acid sodium; 4-[2-(5-Nitro-2-furanyl)ethenyl]benzoic acid sodium salt; Nifurstyrenate sodium; Nifurstyrenic acid so |
Sodium N,N-Diethyldithiocarbamate (25% solution in water) | 148-18-5 | C5H10NNaS2 | 171.2630 | Sodium N,N-Diethyldithiocarbamate (25% solution in water) |
Sodium ionophore VI | 80403-59-4 | C34H62O12 | 662.85 | Bis[(12-crown-4)methyl] dodecylmethylmalonate, Dodecylmethylmalonic acid bis[(12-crown-4)methyl ester] |
Sodium ionophore IV | 172883-29-3 | C27H46O5 | 450.65 | |
Sodium Indanylcarbinicillin | 26605-69-6 | C26H25N2NaO6S | 516.54 | (2S,5R,6R)-6-[[3-[(2,3-Dihydro-1H-inden-5-yl)oxy]-1,3-dioxo-2-phenylpropyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Sodium Salt; (2S,5R,6R)-6-[[3-[(2,3-dihydro-1H-inden-5-yl)oxy]-1,3-dioxo-2-phenylpropyl]amino]-3,3-di |
Sodium hypophosphite monohydrate | 10039-56-2 | NaH2PO2.H2O | 105.99 | SODIUM PHOSPHINATE MONOHYDRATE; SODIUM HYPOPHOSPHITE-1-HYDRATE; SODIUM HYPOPHOSPHITE MONOHYDRATE; fosfornansodny; Phosphinicacid,sodiumsalt,monohydrate; Sodiumhypophosphite,monohydra; sodiumphosphinatehydrate; SODIUM HYPOPHOSPHITE-1-HYDRATE R. G., REAG. P |
SODIUM HYPOPHOSPHITE MONOHYDRATE | 13933-52-3 | H4NaO3P | 105.99 | SODIUM PHOSPHINATE MONOHYDRATE; SODIUM HYPOPHOSPHITE-1-HYDRATE; sodium hydrogen phosphonate; Phosphonic acid, monosodium salt |
Sodium hypophosphite hydrate | 123333-67-5 | NaH2PO2.H2O | 105.99 | SODIUM PHOSPHINATE MONOHYDRATE; SODIUM HYPOPHOSPHITE HYDRATE; SODIUM HYPOPHOSPHITE-1-HYDRATE; sodium hypohosphite for food; Hodium hypophosphite hydrate |
SODIUM HYPOBROMITE | 13824-96-9 | BrNaO | 118.89 | |
SODIUM HYDROXYMETHYL GLYCINATE | 70161-44-3 | C3H6NNaO3 | 127.07400 | |
Sodium Gluconate | 527-07-1 | C6H11NaO7 | 218.14 | Sodium gluconate |
a-D-Glucoheptonic acid sodium salt dihydrate | 13007-85-7 | C7H13O8Na | 248.16 | Glucoheptonic acid sodium salt; Sodium glucoheptonate dihydrate; Sodium(2R,3R,4S,5R,6R)-2,3,4,5,6,7-hexahydroxyheptanoate; SODIUM GLUCEPTATE; sodiumheptonate; D-glycero-D-gulo-Heptonsaeure,Natrium-Salz; D-glycero-D-gulo-heptonic acid,sodium-salt |
Sodium Fumarate | 7704-73-6 | C4H3NaO4 | 138.05400 | |
Sodium formononetin-3(acute)-sulfonate | 949021-68-5 | C16H11NaO7S | 370.31 | Sul-F |
Sodium citrate,anhydrous | 68-04-2 | C6H5Na3O7 | 258.07 | 1,2,3-Propanetricarboxylicacid,2-hydroxy,trisodiumsalt; 1,2,3-propanetricarboxylicacid2hydroxy-trisodiumsalt; 2,3-propanetricarboxylicacid,2-hydroxy-trisodiumsalt; citnatin; citreme; citrosodina; citrosodine; citrosodna |
Sodium citrate, tribasic | 6858-44-2 | C6H7Na3O8 | 276.08 | sodiumcitratepentahydrate; TRI-SODIUM CITRATE 5, 5-HYDRATE; CITRIC ACID TRISODIUM SALT HYDRATE; Sodium citrate tribasic hydrate; Citric acid trisodium salt, Trisodium citrate hydrate |
Sodium cholesteryl sulfate | 2864-50-8 | C27H45NaO4S | 488.703 | SCS; Cholesteryl sodium sulfate; Cholesterol 3-sulfate sodium salt |
Sodium Cholate | 361-09-1 | C24H39NaO5 | 430.561 | Cholic Acid Sodium Salt |
sodium chlorodifluoroacetate | 1895-39-2 | 1% | 152.46 | DIFLUOROCHLOROACETIC ACID SODIUM SALT; CHLORODIFLUOROACETIC ACID, NA; CHLORODIFLUOROACETIC ACID SODIUM; CHLORODIFLUOROACETIC ACID SODIUM SALT; SODIUM CHLORODIFLUOROACETATE; chlorodifluoro-aceticacisodiumsalt |
SODIUM CHLORIDE (37CL) | 20510-56-9 | ClNa | 60.46 | SODIUM CHLORIDE (37CL) |
Sodium Chloride | 7647-14-5 | NaCl | 58.44 | |
Sodium Channel inhibitor 1 | 1198117-23-5 | C24H19F4N3O3 | 473.42 | Sodium Channel inhibitor 1; CHEMBL2164368; 7-FLUORO-3-OXO-2-(2-(PYRIDIN-2-YL)ETHYL)-N-(4-(TRIFLUOROMETHOXY)BENZYL)ISOINDOLINE-1-CARBOXAMIDE; SCHEMBL3900840 |
SODIUM CETYL STEARYL SULFATE | 59186-41-3 | C34H70Na2O8S2 | 717.02 | SODIUM CETYL STEARYL SULFATE; SODIUM CETEARYL SULFATE; Sulfuric acid, monooctadecyl ester, sodium salt, mixt. with sodium hexadecyl sulfate; SODIUMCETEARYLSULPHATE |
Sodium cellulose xanthate | 9051-13-2 | |||
SODIUM CARBONATE STABILIZED SULFON-ATED POLYSTYRENE SODIUM SALT | 9080-79-9 | (C8H8O3S)x.xNa | 0 | aep1; Benzenesulfonicacid,ethenyl-,homopolymer,sodiumsalt; Ethenylbenzenesulfonicacid,sodiumsalt,homopolymer; flexan500; oligoz; poly(styrenesulfonicacidsodiumsalt)(lowm.wt.); sodiumcarbonatestabilizedsulfonatedpolystyrenesodiumsalt; versatl400 |
Sodium Carbonate | 497-19-8 | CNa2O3 | 105.988 | Carbonic Acid Disodium Salt |
SODIUM CARBOMER | 73298-57-4 | |||
Sodium Caprylate | 1984-06-1 | C8H15NaO2 | 166.196 | Sodium octanoate |
sodium camphorsulphonate | 21791-94-6 | C10H15NaO4S | 254.28 | D-Camphor-10-Sulfonicacid,so; D-(+)-CAMPHOR-10-SULFONIC ACID SODIUM SALT; D-CAMPHOR-10-SULFONIC ACID SODIUM SALT; sodium 2-oxobornane-10-sulphonate; P-Camphor-10-SulfonicAcidSodiumSalt; SODIUM(+)-10-CAMOPHORSULFONATE; Sodium (+)-10-camphorsulfonate; D-cam |
SNAP-8719 HCl | 255893-38-0 | C22H29ClF3N3O2 | 459.94 | (R)-8-(1-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)propan-2-yl)-8-azaspiro[4.5]decane-7,9-dione hydrochloride; SNAP-8719; SNAP 8719; SNAP8719 |
Sodium 2-(2-dodecyloxyethoxy)ethyl sulphate | 3088-31-1 | C16H33NaO6S | 376.48 | Sodium lauryl di(oxyethyl) sulfate; sodium 2-(2-dodecyloxyethoxy)ethyl sulphate; Sodium laurathe sulfate; Ethanol, 2-2-(dodecyloxy)ethoxy-, hydrogen sulfate, sodium salt; Diethylene glycol monolauryl ether sodium sulfate.; SODIUMLAURYLDIGLYCOLETHERSULPHAT |
SNAP-8 | 868844-74-0 | C41H70N16O16S | 1075.16 | |
SNAP 94847 hydrochloride | 487051-12-7 | C29H32F2N2O2.HCl | 515.03 | N-[3-[1-[[4-(3,4-Difluorophenoxy)phenyl]methyl]-4-piperidinyl]-4-methylphenyl]-2-methylpropanamide hydrochloride |
SNAP 94847 hydrochloride | 1781934-47-1 | C29H32F2N2O2·HCl | 515.03 | N-[3-[1-[[4-(3,4-Difluorophenoxy)phenyl]methyl]-4-piperidinyl]-4-methylphenyl]-2-methylpropanamide hydrochloride |
SNAP 5089 | 157066-77-8 | C36H40N4O5.HCl | 645.19 | 5-[[[3-(4,4-Diphenyl-1-piperidinyl)propyl]amino]carbonyl]-1,4-dihydro-2,6-dimethyl-4-(4-nitrophenyl)-3-pyridinecarboxylic acid methyl ester hydrochloride |
SNAP 398299 | 903878-06-8 | C27H24F3N3O2 | 479.49 | 1,3-Dihydro-1-[3-[2-(1-pyrrolidinyl)ethoxy]phenyl]-3-[[3-(trifluoromethyl)phenyl]imino]-2H-indol-2-one; 1-[3-(2-pyrrolidin-1-ylethoxy)phenyl]-3-[3-(trifluoromethyl)phenyl]iminoindol-2-one |
SN-23862 | 142439-61-0 | C11H12Cl2N4O5 | 351.14 | SN23862; SN 23862 |
SN 2 | 823218-99-1 | C17H21NO | 255.35 | 5-mesityl-3-oxa-4-azatricyclo[5.2.1.0~2,6~]dec-4-ene |
SN 003 | 197801-88-0 | C19H25N5O2 | 355.43 | N-(4-Methoxy-2-methylphenyl)-1-[1-(methoxymethyl)propyl]-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine; 1-(1-methoxybutan-2-yl)-N-(4-methoxy-2-methylphenyl)-6-methyltriazolo[4,5-c]pyridin-4-amine |
Sliver bis(trifluoromethane sulfonimide) | 189114-61-2 | C2AgF6NO4S2 | 388.01 | silver; bis(trifluoromethylsulfonyl)azanide; Silvertriflimide; Silverbis(trifluoromethanesulfonyl)imide; Silverbis(trifluoromethylsulfonyl)amide; Silverbis(trifluoromethanesulfonyl)amide |
Smectite clay minerals | 12199-37-0 | 0 | SMECTITE; VAN GEL B; VAN GEL C; VAN GEL ES; VAN GEL O; Smectite-group minerals; Alminosillicic acid,magnesium sillicate; magnesium aluminosilicate (smectite) | |
SMDC818909 | 1147823-21-9 | C14H13N5O | 267.29 | 3-amino-N-(2-methyl-1H-indol-5-yl)pyrazine-2-carboxamide |
SMBA 1 | 906440-37-7 | C20H13NO3 | 315.32 | 2-[(2-Nitro-9H-fluorene-9-ylidene)methyl]phenol |
SMANT hydrochloride | 1177600-74-6 | C16H23BrN2O.HCl | 375.73 | N-(4-Bromophenyl)-3,5-dimethyl-1-piperidinepropanamide hydrochloride |
Smad3 Inhibitor, SIS3 | 1009104-85-1 | C28H27N3O3 | 453.542 | 1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one |
SM-21 maleate | 155059-42-0 | C18H24ClNO3.C4H4O4 | 453.92 | (±)-Tropanyl 2-(4-chlorophenoxy)butanoate maleate |
SM-164 | 957135-43-2 | C62H84N14O6 | 1121.42 | |
SM 324405 | 677773-91-0 | C19H23N5O4 | 385.42 | Methyl 3-[(6-amino-2-butoxy-7,8-dihydro-8-oxo-9H-purin-9-yl)methyl]benzeneacetate |
SM 16 | 614749-78-9 | C25H26N4O3 | 430.5 | SM-16; SM16; 4-[4-(1,3-Benzodioxol-5-yl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-2-yl]bicyclo[2.2.2]octane-1-carboxamide |
Slv319 | 362519-49-1 | C23H20Cl2N4O2S | 487.399 | 3-(4-Chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N'-methyl-4-phenyl-1H-pyrazole-1-carboximidamide; CHEMBL158784 |
SLV 320 | 251945-92-3 | C18H20N4O | 308.38 | Derenofylline; trans-4-[(2-Phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexanol |
SLR080811 HCl | 1449768-36-8 | C21H32ClN5O | 369.50 | |
SLR080811 | 1449765-65-4 | C21H31N5O | 406.00 | SLR080811; SLR080811; SLR 080811; (R)-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide hydrochloride |
SLP7111228 hydrochloride | 1449768-48-2 | C22H33N5O·HCl | 419.99 | (2S)-2-[[3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-pyrrolidinecarboximidamide hydrochloride |
SLP120701 HCl | 1449768-46-0 | C20H30ClN5O | 391.94 | (S)-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)azetidine-1-carboximidamide hydrochloride; SLP120701; SLP-120701; SLP120701 |
SLM 6031434 hydrochloride | 1897379-34-8 | C22H30F3N5O2·HCl | 489.96 | (2S)-2-[3-[4-(Octyloxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-1-pyrrolidinecarboximidamide hydrochloride |
SLM 6031434 | 1897379-33-7 | C22H30F3N5O2 | 453.5 | (2S)-2-[3-[4-Octoxy-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide |
S-Licarbazepine | 104746-04-5 | C15H14N2O2 | 254.29 | (10S)-10,11-Dihydro-10-hydroxy-5H-Dibenz[b,f]azepine-5-carboxamide; S-(+)-10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide; (S)-Licarbazepine; BIA 2-194; CGP 13751; Erelib; Eslicarbazepine; Pazzul; Stedesa; |
SLF | 195513-96-3 | C30H40N2O6 | 524.7 | Synthetic Ligand of FKBP; [(1R)-1-(3-aminophenyl)-3-(3,4-dimethoxyphenyl)propyl] (2S)-1-(3,3-dimethyl-2-oxopentanoyl)piperidine-2-carboxylate |
SLC5111312 hydrochloride | 1870811-01-0 | C22H27N5O3·HCl | 445.94 | (2S,3S)-3-hydroxy-2-[3-[6-(pentyloxy)-2-naphthalenyl]-1,2,4-oxadiazol-5-yl]-1-pyrrolidinecarboximidamide monohydrochloride |
SLC-0111 | 178606-66-1 | C13H12FN3O3S | 309.31 | 4-(3-(4-fluorophenyl)ureido)benzenesulfonamide; SLC-0111; SLC0111; SLC 0111; MST-104; MST-104; MST-104; NSC-213841; NSC213841; NSC 213841; U-104; U104; U 104. |
SL327 | 305350-87-2 | C16H12F3N3S | 335.348 | SL 327; SL-327. |
SL0101 | 77307-50-7 | C25H24O12 | 516.455 | SL-0101; SL 0101. |
SL 651498 | 205881-86-3 | C23H20FN3O2 | 389.42 | SL-651498; 6-fluoro-9-methyl-2-phenyl-4-(pyrrolidine-1-carbonyl)pyrido[3,4-b]indol-1-one |
Skullcapflavone II | 55084-08-7 | C19H18O8 | 374.4 | Scullcapflavone II; Neobaicalein; 5,2'-Dihydroxy-6,7,8,6'-tetramethoxyflavone |
Skullcapflavone I | 41060-16-6 | C17H14O6 | 314.3 | 5,2'-Dihydroxy-7,8-dimethoxyflavone;5-Hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxy-4H-1-benzopyran-4-one;Panicolin;Skullcapflavon I;2',5-Dihydroxy-7,8-dimethoxyflavone |
SKQ1 | 934826-68-3 | C36H42BrO2P | 617.61 | (10-(4,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decyl)triphenylphosphonium bromide; SKQ1; PDTP; Plastoquinonyl decyltriphenyl phosphonium bromide;Visomitin |
Skp2 Inhibitor C1 | 432001-69-9 | C18H13BrN2O4S2 | 465.34 | SKPin C1 |
SKLB610 | 1125780-41-7 | C21H16F3N3O3 | 415.372 | SKLB 610; SKLB-610. |
SKLB-23bb | 1815580-06-3 | C21H24N4O4 | 396.44 | HDAC6-IN-1; N-hydroxy-4-[2-methoxy-5-[methyl-(2-methylquinazolin-4-yl)amino]phenoxy]butanamide |
SKLB-1028 | 1350544-93-2 | C24H29N9 | 443.56 | 9-isopropyl-N2-(4-(4-methylpiperazin-1-yl)phenyl)-N8-(pyridin-3-yl)-9H-purine-2,8-diamine |
SKLB1002 | 1225451-84-2 | C13H12N4O2S2 | 320.39 | SKLB1002; SKLB 1002; SKLB-1002. |
SKL 2001 | 909089-13-0 | C14H14N4O3 | 286.29 | SKL-2001; N-(3-(1H-imidazol-1-yl)propyl)-5-(furan-2-yl)isoxazole-3-carboxamide; 5-(furan-2-yl)-N-(3-imidazol-1-ylpropyl)-1,2-oxazole-3-carboxamide |
SKF-82958 hydrobromide | 80751-65-1 | C19H21BrClNO2 | 410.73 | (±)-SKF-82958 hydrobromide;6-Chloro-2,3,4,5-tetrahydro-1-phenyl-3-(2-propenyl)-1H-3-benzazepine-7,8-diol;Chloro-APB hydrobromide;(±)-6-Chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide;6-Chloro-N-allyl-SKF-38393 hydrob |
Sinapine thiocyanate | 7431-77-8 | C16H24NO5.CNS | 368.45 | ethanaminium, 2-\\3-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2-propenyl\oxy\-n,n,n-trimethyl-, thiocyanate (9ci); 2-((3-(4-Hydroxy-2,5-diMethoxyphenyl)acryloyl)oxy)-N,N,N-triMethylethanaMiniuM thiocyanate |
Sitoindoside I | 18749-71-8 | C51H90O7 | 815.3 | Stigmast-5-en-3-beta-6'-palmitoylglu copyranoside; Stigmast-5-en-3beta-O-(6-O-hexadecanoyl-beta-D-glucopyranoside); beta -Sitosterol glucoside 6'-O-monopalmitate |
Sitofibrate | 55902-94-8 | C39H59ClO3 | 611.345 | [(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]2-(4-chlorophenoxy)-2-methylpropanoate; Sitofibrate; 55902-94-8; CHEMBL2105767 |
Sitaxsentan | 184036-34-8 | C18H15ClN2O6S2 | 454.90 | N-(4-chloro-3-methyl-1,2-oxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide Sitaxentan Sitaxsentan Thelin 184036-34-8 UNII-J9QH779MEM CHEMBL282724 3-Thiophenesulfonamide, N-(4-chloro-3-methyl-5-isoxazolyl)-2-((6-methyl- |
Sitaxentan sodium | 210421-74-2 | C18H14ClN2O6S2.Na | 476.89 | TBC-11251 |
SITAMAQUINE,N,N-DIETHYL-N'-(6-METHOXY-4-METHYL-QUINOLIN-8-YL)-HEXANE-1,6-DIAMINE | 57695-04-2 | C21H33 N3 O | 0 | SITAMAQUINE,N,N-DIETHYL-N'-(6-METHOXY-4-METHYL-QUINOLIN-8-YL)-HEXANE-1,6-DIAMINE; WR 6026; 6-METHOXY-8-(6-DIETHYLAMINOHEXYLAMINO)-4-METHYLQUINOLINE; N,N-Diethyl-N'-(6-methoxy-4-methylquinolin-8-yl)-1,6-hexanediamine; N-[6-(Diethylamino)hexyl]-4-methyl-6-m |
Sitamaquine tosylate | 1019640-33-5 | C21H33N3O.C7H8O3S | 515.71 | WR6026 tosylate; WR-6026 tosylate |
Sitagliptin-N-sulfate | 940002-57-3 | C16H15F6N5O4S | 487.38 | |
Sitagliptin-d4 | 1426173-93-4 | C16H11F6N5OD4 | 411.35 | (R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine D4 |
Sitagliptin Triazole Impurity HCl | 762240-92-6 | C6H7F3N4. HCl | 228.60 | 5,6,7,8-Tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine Monohydrochloride; 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride |
Sitagliptin Styrylacetyl Analog | 1675201-14-5 | C16H12F6N4O | 390.29 | 1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one; 3-Desamino-3,4-dehydro Sitagliptin |
Sitagliptin Phosphate | 654671-78-0 | C16H18F6N5O5P | 505.31 | Januvia; MK-0431 phosphate; MK 0431 phosphate; MK0431 phosphate |
Sitagliptin phosphate | 790712-60-6 | C16H15F6N5O.H3O4P | 505.314 | (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one phosphoric acid |
Sitagliptin N-Phoshate Impurity | 1351498-25-3 | C16H16F6N5O4P | 487.29 | Sitagliptin Impurity 33; (R)-(4-oxo-4-(3-(trifluoromethyl); Phosphoramidic acid, N-[3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]- |
N-Boc-Sitagliptin | 486460-23-5 | C21H23F6N5O3 | 507.44 | N-[(1R)-3-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]carbamic Acid 1,1-Dimethylethyl Ester; [(1R)-3-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1- |
Sitagliptin Monophosphate Monohydrate | 654671-77-9 | C16H15F6N5O·H3PO4·H2O | 523.32 | (2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine Dihydrogen Phosphate Monohydrate; 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2 |
Sitagliptin impurity F | 1608491-98-0 | C22H24F6N4O2 | 490.44 | |
Sitagliptin Impurity E Phosphate (Sitagliptin S-Isomer Phosphate) | 823817-58-9 | C16H15F6N5O. H3PO4 | 407.32 98.00 | 7-[(3S)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine Phosphate; (S)-Sitagliptin Phosphate; ent-Sitagliptin Phosphate |
Sitagliptin impurity D | 1379666-94-0 | C18H17F6N5O2 | 449.36 | 7-[(3R)-3-[(N-Acetyl)Amino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine; N-Acetyl Sitagliptin |
Sitagliptin Impurity 9 | 1234321-81-3 | C13H12F3NO3 | 287.23 | |
Sitagliptin Impurity 12 | 1234321-83-5 | C13H14F3NO3 | 289.25 | |
Sitagliptin impurity 11 | 763105-70-0 | C6H9F3N4O | 210.16 | Trifluoroacetic Acid (2Z)-Piperazinylidenehydrazide; N'-[(2Z)-Piperazin-2-ylidene]trifluoroacetohydrazide; N-[(2Z)-Piperazin-2-ylidene]-2,2,2-trifluoroacetohydrazide |
Sitagliptin impurity 10 | 837430-15-6 | C6H5F3N4O | 206.13 | 2,2,2-Trifluoro-N'-(pyrazin-2-yl)acetohydrazide; 2,2,2-Trifluoro-2-(2-pyrazinyl)hydrazide Acetic Acid; 1-(Pyrazin-2-yl)-2-trifluoroacetyl Hydrazine |
Sitagliptin Fumarate Adduct | 2088771-60-0 | C20H19F6N5O5 | 523.4 | Sitagliptin Tablets EP Impurity FP-A |
Sitagliptin FP Impurity B | 2088771-61-1 | C16H13F6N5O2 | 421.3 | Sitagliptin Triazecine Impurity; EX-A3082; Sitagliptin Triazecine Analog; (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione |
Sitagliptin EP Impurity B HCl (Sitagliptin Defluoro Impurity 6 HCl) | 486459-70-5 | C16H16F5N5O.HCl | 425.78 | |
Sitagliptin Enamine impurity | 767340-03-4 | C16H13F6N5O | 405.31 | (2Z)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one; 2,3-Desdihydrogen rac-Sitagliptin; (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin -7(8H)-yl]-1-(2, |
Rac-Sitagliptin 3-Ketone | 764667-65-4 | C16H12F6N4O2 | 406.29 | 1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-1,3-butanedione; Sitagliptin dioxo impurity; 4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)buta |
Sitagliptin Defluoro Impurity 5 | 486460-31-5 | C16H16F5N5O | 389.32 | |
Sitagliptin Defluoro Impurity 4 | 1271773-97-7 | C15H19F2NO4 | 315.31 | |
Sitagliptin Defluoro Impurity 3 (Sitagliptin impurity I) | 851307-12-5 | C15H19F2NO4 | 315.31 | (3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid |
Sitagliptin Deamino Impurity 1 | 1253056-18-6 | C16H12F6N4O | 390.29 | (E)-1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one; 3-Desamino-2,3-dehydro Sitagliptin |
Sitagliptin carbamoyl glucuronide | 940002-59-5 | C23H23F6N5O9 | 627.45 | 1-[N-[(1R)-3-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]carbamate] |
Sitagliptin | 486460-32-6 | C16H15F6N5O | 407.32 | MK-0431; MK 0431; MK0431; Brande name: Januvia, Xelevia, Janumet; Sitagliptin; EC 690-730-1; HSDB 7516; HSDB7516; HSDB-7516; Januvia; LEZ 763; LEZ-763; LEZ763; Tesavel; Xelevia; |
Sitafloxacin isomer III (RRS) | 127254-10-8 | C19H18ClF2N3O3 | 409.818 | 7-((R)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 3-Quinolinecarboxylicacid,7-[(7R)-7-amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl |
Sitafloxacin Dechloro Impurity | 500569-52-8 | C19H19F2N3O3 | 375.37 | |
Sitafloxacin | 127254-12-0 | C19H18ClF2N3O3 | 409.81 | 7-((S)-7-amino-5-azaspiro[24]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; DU 6859; DU-6859; DU6859; DU 6859A; DU-6859A; DU6859A; Sitafloxacin; Sitafloxacin hydrate, Sitafloxacin anhydrous, Tr |
Sitafloxacin | 163253-35-8 | C19H18ClF2N3O3.3/2H2O | 436.84 | DU-6859a |
Sissotrin | 5928-26-7 | C22H22O10 | 446.4 | Biochanin A-beta-D-glucoside |
S-Isopropylisothiourea hydrobromide | 4269-97-0 | C4H11N2SBr | 199.11 | 2-Isopropyl-2-thiopsuedourea Hydrobromide; IPITU hydrobromide; S-Isopropylthiuronium bromide; S-isopropyl ITU |
Sisomicin | 32385-11-8 | C19H37N5O7 | 447.5 | Antibiotic 6640; SCH 13475; Rickamicin; Sisomycin; Sissomicin |
SIS3 HCl | 521984-48-5 | C28H27N3O3.HCl | 489.99 | (2E)-1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-propenone hydrochloride |
Sirtinol | 410536-97-9 | C26H22N2O2 | 394.474 | |
SirReal2 | 709002-46-0 | C22H20N4OS2 | 420.55 | |
Siramesine hydrochloride | 224177-60-0 | C30H32ClFN2O | 491.04 | 1'-(4-(1-(4-fluorophenyl)-1H-indol-3-yl)butyl)-3H-spiro[isobenzofuran-1,4'-piperidine]; Siramesine free base; Lu-28-179; Lu 28-179; Lu28-179; Lu-28179; Lu 28179; Lu28179 |
Siramesine fumarate | 163630-79-3 | C30H31FN2O·C4H4O4 | 570.7 | Lu 28-179; Siramesine fumarate salt; 1'-[4-[1-(4-fluorophenyl)indol-3-yl]butyl]spiro[1H-2-benzofuran-3,4'-piperidine] fumarate |
Siramesine | 147817-50-3 | C30H31FN2O | 454.58 | 1'-[4-[1-(4-fluorophenyl)indol-3-yl]butyl]spiro[1H-2-benzofuran-3,4'-piperidine] 1-(4-fluorophenyl)-3-(4-(4-(4-fluorophenyl)-1-piperidinyl)-1-butyl)-1H-indole Lu 28-179 Lu-28-179 Siramesine |
Siraitic acid B | 183374-16-5 | C29H42O5 | 470.64 | |
Siraitic acid A | 183374-15-4 | C29H44O5 | 472.66 | |
Siponimod | 1230487-00-9 | C29H35F3N2O3 | 516.6 | BAF312; Mayzent; 1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidine-3-carboxylic acid |
Sipatrigine | 130800-90-7 | C15H16Cl3N5 | 372.68 | 2-(4-Methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-4-pyrimidinamine |
Sinapine | 18696-26-9 | C16H24NO5+ | 310.36 | Sinapoylcholine; O-sinapoylcholine |
Sinapaldehyde glucoside | 154461-65-1 | C17H22O9 | 370.4 | Sinapaldehyde 4-O-beta-D-glucopyranoside |
Sinalbin | 19253-84-0 | C14H19NO10S2 | 425.43 | 4-Hydroxybenzyl glucosinolate; p-Hydroxybenzylglucosinolate |
Sialylfucosyllacto-N-tetraose | 84061-53-0 | C43H72N2O33 | 1145.03 | Sialyl-LNF II; Sialyl-lea (19-9 antigen); Neu5Ac(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc |
Simvastatin-d6 | 1002347-71-8 | C25H32O5D6 | 424.61 | 2,2-(Dimethyl-d6)butanoic Acid(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro -3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl] -1-naphthalenyl Ester; (+)-Simvastatin-d6; Cholestat-d6; Lipex-d6; Novo-Simvastatin-d6; Simvotin-d6; Sinvaco |
Simvastatin-d3 | 1002347-61-6 | C25H35D3O5 | 421.58 | (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methyl-2-(methyl-d3)butanoate |
Simvastatin-d11 | 1002347-74-1 | C25H27O5D11 | 429.64 | |
Simvastatin Impurity H | 79952-42-4 | C19H28O4 | 320.43 | (4R,6R)-6-[2-[(1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-Hexahydro-8-hydroxy-2,6-dimethyl-1-naphthalenyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one; Lovastatin Diol Lactone; Monacolin J; 6(R)-[2-(8(S)-Hydroxy]-2(S),6(R)-dimethyl-1,2,6,7,8,8a(R)-hexahydro-1(S)-naphthyl |
Simvastatin Impurity G | 121624-18-8 | C25H36O5 | 416.56 | 2,2-Dimethylbutanoic Acid (1S,7S,8S,8aR)-1,2,3,7,8,8a- Hexahydro-7-methyl-3-methylene-8-[2-[(2R,4R)-tetrahydro -4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester; 6'-Exomethylene Simvastatin |
Simvastatin Impurity D | 476305-24-5 | C50H76O10 | 837.13 | Simvastatin Dimer Impurity |
Simvastatin Ethyl Ester | 864357-87-9 | C27H44O6 | 464.63 | |
Simvastatin EP Impurity I | 79902-42-4 | C23H34O5 | 390.51 | 2'-Ethyl Simvastatin |
Simvastatin EP Impurity F | 79952-44-6 | C24H36O5 | 404.55 | (2R)-2-Methylbutanoic Acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7- dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester; Epilovastatin; Epi Lovastatin |
Simvastatin EP Impurity C | 210980-68-0 | C25H36O4 | 400.56 | Dehydro Simvastatin |
Simonsinol | 155709-40-3 | C27H26O3 | 398.5 | 3'',5,5'-Triallyl-1,1':3',1''-terphenyl-2,2',4''-triol |
Simmitecan Hydrochloride | 1247847-78-4 | C34H38N4O6.HCl | 635.16 | [1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-10-(2-propen-1-yl)-1H-pyrano[3',4':6,7]indolizino[1,2- b]quinolin-9-yl ester, hydrochloride (1:1);951290-31-6 (Simmitecan); |
Simmitecan | 951290-31-6 | C34H38N4O6 | 598.7 | Camptothecin L-P. |
Simiarenone | 2318-78-7 | C30H48O | 424.7 | (3R,3aR,5aR,5bS,11aS,11bR,13aS,13bR)-3-Isopropyl-3a,5a,8,8,11b,13 a-hexamethyl-1,2,3,3a,4,5,5a,5b,6,8,10,11,11a,11b,12,13,13a,13b-o ctadecahydro-9H-cyclopenta[a]chrysen-9-one |
Simiarenol acetate | 4965-99-5 | C32H52O2 | 468.8 | (3R,3aR,5aR,5bS,9S,11aS,11bR,13aS,13bR)-3-Isopropyl-3a,5a,8,8,11b ,13a-hexamethyl-2,3,3a,4,5,5a,5b,6,8,9,10,11,11a,11b,12,13,13a,13 b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl acetate |
Simetryn | 1014-70-6 | C8H15N5S | 213.3 | 2,4-BIS(ETHYLAMINO)-6-METHYLTHIO-1,3,5-TRIAZINE;GY-BON;GYBON(R);G32911;AURORA KA-3877;SIMETRYN |
Simeprevir sodium salt | 1241946-89-3 | C38H47N5O7S2·xNa | 749.94 | TMC 435 sodium salt; TMC 435 sodium |
Simeprevir | 923604-59-5 | C38H47N5O7S2 | 749.942 | TMC435; TMC435350; TMC-435350 |
Simendan | 131741-08-7 | C14H12N6O | 280.29 | 2-[[4-(4-methyl-6-oxo-4,5-dihydro-1h-pyridazin-3-yl)phenyl]hydrazinylidene]propanedinitrile; ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile; simendan; simendan R--[4-(1,4,5,6-Tetrahydro-4-methyl-6-oxo-3-pyridazinyl) |
Simazine-D10 | 220621-39-6 | 6-Chloro-N,N'-diethyl- D10-1,3,5-triazine-2,4- diamine | ||
SIM010603 | 1032265-67-0 | C22H25FN4O2 | 396.458 | SIM 010603; SIM-010603. |
Silymarin | 65666-07-1 | C25H22O10 | 482.44 | |
SILYLGERMANE | 13768-63-3 | H6GeSi | ||
Silybin B | 142797-34-0 | C25H22O10 | 482.44 | (2R,3R)-2-[(2S,3S)-2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 1,4-Benzodioxin, 4H-1-benzopyran-4-one deriv.; NSC 227190; Silibinin B; Silybin a1 |
Silybin | 22888-70-6 | C25H22O10 | 482.46 | SILYBIN; SILYBIN A; SILYBIN (A AND B); SILYMARIN; SILYMARIN I; SILYBININ; SILYBIN (MIX); SILIBININ |
Silver vanadium oxide(AgVO3) | 13497-94-4 | O | 206.8079 | SILVER METAVANADATE; SILVER VANADATE; SILVER VANADATE(V); SILVER VANADIUM OXIDE; SILVER ORTHOVANADATE; silvervanadiumoxide(agvo3); Sivermetavanadate; Vanadicacid,silver(1+)salt |
Seganserin | 87729-89-3 | C29H28F2N3O | 472.5489264 | |
Sedoheptulose-7-phosphate | 2646-35-7 | C7H13O10P.Ba | 425.474 | Sedoheptulose-7-phosphate; (2,3,4,5,7-pentahydroxy-6-oxo-heptoxy)phosphonic acid |
Sedoheptulose-1,7-diphosphate dibarium salt | 815-91-8 | C7H12O13P2 2Ba | 640.76 | Sedoheptulose-1,7-bisphosphate dibarium salt |
Sedoheptulose anhydride monohydrate | 469-90-9 | C7H12O6 H2O | 210.18 | 2,7-Anhydro-b-D-altro-heptulopyranose; Sedoheptulosan |
SEDECAMYCIN | 23477-98-7 | C27H35NO8 | 501.56900 | |
Sedanolide | 6415-59-4 | C12H18O2 | 194.3 | Neocnidilide; 3-butyl-3a,4,5,6-tetrahydro-3H-2-benzofuran-1-one; Sedanolid |
Securitinine | 13861-71-7 | C14H17NO3 | 247.29 | (6S,10S,11aS,11bS)-9,10,11,11a-Tetrahydro-10-methoxy-8H-6,11b-methanofuro[2,3-c]pyrido[1,2-a]azepin-2(6H)-one |
Securinol A | 5008-48-0 | C13H17NO3 | 235.28 | (5S,10aR,10bR,12R)-12-hydroxy-4,5,8,9,10,10a-hexahydro-2H,7H-5,10b-ethanofuro[2,3-a]quinolizin-2-one |
Securinine | 5610-40-2 | C13H15NO2 | 217.264 | (-)-securinin;securinan-11-one;securinin;Securinan-11-on |
Saxagliptin Impurity 12 | 709031-38-9 | C10H16N2O3 | 212.25 | (S)-Boc-2-carbamoyl-2,3-dihydro-1H-pyrrole |
Saxagliptin hydrochloride | 709031-78-7 | C18H25N3O2·HCl | 351.9 | Saxagliptin HCl; BMS-477118; (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrochloride |
Saxagliptin Cyclic Amidine Impurity | 1350800-76-8 | C18H25N3O2 | 315.42 | (1aS,4S,6aR,7aS)-6-Amino-1,1a,4,6a,7,7a-hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-3H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one |
Saxagliptin | 361442-04-8 | C18H25N3O2 | 315.417 | BMS-477118, Onglyza. |
Sarmentosin | 71933-54-5 | C11H17NO7 | 275.3 | (2E)-4-(beta-D-Glucopyranosyloxy)-2-(hydroxymethyl)-2-butenenitrile |
S- (+)-Rolipram | 85416-73-5 | C16H21NO3 | 275.34 | |
Ruxolitinib sulfate | 1092939-16-6 | C17H20N6O4S | 404.44 | |
Ruxolitinib phosphate | 1092939-17-7 | C17H21N6O4P | 404.36 | INCB018424 phosphate |
RO4389620 | 625114-41-2 | C19H20ClN3O4S | 421.89 | RO-4389620;Piragliatin;(2R)-2-(3-Chloro-4-(methylsulfonyl)phenyl)-3-((1R)-3-oxocyclopentyl)-N-pyrazinylpropanamide |
RO-3306 | 872573-93-8 | C18H13N3OS2 | 351.44 | RO-3306; RO 3306; RO3306. |
RO3201195 | 249937-52-8 | C19H18FN3O4 | 371.368 | RO3201195; RO-3201195; RO 3201195 |
RO31-8220 | 125314-64-9 | C25H23N5O2S | 457.552 | RO31-8220; RO 31-8220; RO-31-8220; RO318220 |
RO314724 | 112105-54-1 | C19H35N3O6 | 401.504 | RO314724; RO 31-4724. |
RO-3 | 1026582-88-6 | C16H22N4O2 | 302.37 | 5-[[4,5-Dimethoxy-2-(methylethyl)phenyl]methyl]-2,4-pyrimidinediamine; RO-3; RO 3; RO3 |
Ro18-5362 | 101387-97-7 | C22H25N3O2S | 395.52 | 2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfanyl]-5,5,7,7-tetramethyl-3H-cyclopenta[f]benzimidazol-6-one; Ro-18-5362 |
RO1138452 | 221529-58-4 | C19H23N3O | 309.413 | Ro-1138452; CAY10441; CAY-10441; N-(4-(4-Isopropoxybenzyl)phenyl)-4,5-dihydro-1H-imidazol-2-amine |
Quazolast | 86048-40-0 | C12H7ClN2O3 | 262.649 g/mol | |
quaterthiophene | 5632-29-1 | C16H10S4 | 330.51 | 2,2':5',2'':5'',2'''-Quaterthiophene;5632-29-1;quaterthiophene;alpha-Quarterthienyl;FXEJOIFDICYSSO-UHFFFAOYSA-N;NSC700135 |
QUATERNIUM-80 | 134737-05-6 | |||
QUATERNIUM-33 | 86221-07-0 | |||
Quaternium 73 | 15763-48-1 | C23H39IN2S2 | 534.603 | Pionin; Kankohso 201; 3-Heptyl-2-((3-heptyl-4-methyl-4-thiazolin-2-ylidene)methyl)-4-methylthiazolium iodide |
QS-21 | 141256-04-4 | C92H148O46 | 1990.1 | |
QS11 | 944328-88-5 | C36H33N5O2 | 567.68 | QS-11; (2S)-2-[[2-(2,3-dihydro-1H-inden-5-yloxy)-9-[(4-phenylphenyl)methyl]purin-6-yl]amino]-3-phenylpropan-1-ol |
QL47 | 1469988-75-7 | C27H21N5O2 | 447.48794 | QL47; QL 47; QL-47 |
Qingyangshengenin B | 106758-54-7 | C49H78O16 | 923.14 | |
Qingyangshengenin A | 106644-33-1 | C49H72O17 | 933.09 | |
P-SULFONAMIDO STYRENE | 2633-64-9 | C8H9NO2S | 183.23 | P-SULFONAMIDO STYRENE; 4-SULFONAMIDOSTYRENE; Benzenesulfonamide, 4-ethenyl- (9CI); 4-Sulfamoylstyrene; p-Vinylbenzenesulfonamide; 4-ethenylbenzenesulfonamide |
PTC299 | 1219951-09-3 | PTC 299; PTC-299 | ||
PTC-209 hydrobromide | 1217022-63-3 | C17H14Br3N5OS | 576.1 | N-(2,6-dibromo-4-methoxyphenyl)-4-(2-methylimidazo[1,2-a]pyrimidin-3-yl)thiazol-2-amine hydrobromide |
PTC-209 | 315704-66-6 | C17H13Br2N5OS | 495.19 | |
PTC-028 | 1782970-28-8 | C19H12F5N5 | 405.32 | PTC028; PTC 028; 6-(5,6-Difluoro-2-methylbenzimidazol-1-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine |
PTACH | 848354-66-5 | C20H26N2O2S2 | 390.56 | NCH 51;Cpd 51;S-(7-Oxo-7-((4-phenylthiazol-2-yl)amino)heptyl) 2-methylpropanethioate;S-[6-(4-Phenyl-2-thiazolylcarbamoyl)hexyl] thioisobutyrate;2-Methylpropanethioicacid S-[7-oxo-7-[(4-phenyl-2-thiazolyl)amino]heptyl]ester |
PTAC oxalate | 201939-40-4 | C12H19N3S2.C2H2O4 | 359.46 | (1R,5R,6R)-6-[4-(Propylthio)-1,2,5-thiadiazol-3-yl]-1-azabicyclo[3.2.1]octane oxalate |
Silver tetraborate, decahydrate | 12271-95-3 | Ag2B4O12 | 450.9787 | pentasilver;tetraborate;decahydrate;Silvertetraborate,decahydrate;CTK0I4073;12271-95-3 |
Silodosin-d4 | 1426173-86-5 | C25H28F3N3O4D4 | 499.57 | 2,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carboxamide-d4; (R)-1-(3-Hydroxypropyl)-5-[2-[[2-[2-(2,2,2- trifluoroethoxy)phenoxy]ethyl]amino]propyl]indoline-7-carboxamide-d4; KAD 3213-d4; |
Silodosin Related Impurity | 1338365-54-0 | C22H25N3O2 | 363.46 | 5-(2-Aminopropyl)-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile; 3-(7-Cyano-5-(2-(amino)propyl)indolin-1-yl)propyl Benzoate |
Silodosin Metabolite | 1357252-79-9 | C25H30F3N3O5 | 509.52 | |
Silodosin Impurity 8 | 1638212-09-5 | C33H36F3N3O4 | 595.65 | |
Silodosin Impurity 6 | 160970-86-5 | C27H34F3N3O5 | 537.58 | (R)-1-[3-(Acetyloxy)propyl]-2,3-dihydro-5-[2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-Indole-7-carboxamide; O-Acetyl Silodosin |
Silodosin Impurity 2 HCl (Nitrile Impurity) | 1889255-72-4 | C25H30F3N3O3. HCl | 477.53 36.46 | |
Silodosin Glucuronide | 879396-70-0 | C31H40F3N3O10 | 671.66 | |
Silodosin Dehydro Impurity | 175870-21-0 | C25H30F3N3O4 | 493.53 | 1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carboxamide; Dehydro Silodosin |
Silodosin b-D-glucuronide sodium salt | 879292-24-7 | C31H40F3N3O10 | 671.66 | 3-[7-(Aminocarbonyl)-2,3-dihydro-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indol-1-yl]propyl b-D-glucopyranosiduronic acid monosodium salt |
Silodosin (R-isomer) | 160970-54-7 | C25H32F3N3O4 | 495.53 | KMD-3213; KMD3213; KMD 3213; KAD 3213; KAD 3213; KAD3213; Silodosin. trade names Rapaflo, Silodyx, Rapilif, Silodal, Urief, Urorec. |
Silmitasertib | 1009820-21-6 | C19H12ClN3O2 | 349.774 | CX-4945; CX 4945; 5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid |
Silk powder | 9009-99-8 | 0 | SILK POWDER; Silk, powd. | |
Silk amino acid | 96690-41-4 | 0 | Protein hydrolyzates, silk; Silkhydrolyzed; Proteinhydrolysate, Seide-; Silk, hydrolyzates; Silk,hydrolyzates; silk hydrolysates | |
Silicotungstic acid | 11130-20-4 | H4O40SiW12 •H2O | 2878.32 | DODECA-TUNGSTOSILICIC ACID; 12-TUNGSTOSILICIC ACID; SILICOTUNGSTIC ACID; TUNGSTOSILICIC ACID |
Silicone rubber | 63394-02-5 | |||
SILICONE OIL | 68083-14-7 | C6H18OSi2 | ||
Silicon, isotope ofmass 32 | 15092-72-5 | Si | 31.9741 | |
SILICON TETRAISOCYANATE 98+% | 3410-77-3 | C4N4O4Si | 196.16 | |
Silicon dioxide | 7631-86-9 | SiO2 | 60.08 | Silica |
SILICLAD | 39443-39-5 | C18H40O3Si | 0 | SILICLAD; SILICLAD GLIDE 10 |
Silicified Microcrystalline Cellulose | 9004-34-6 | |||
Silicic acid, sodium salt, hydrolysis products with chlorotrimethylsilane and dichloroethenylmethylsilane | 68584-83-8 | C2H3 * | 27.04522 | ichloroethenylmethylsilane; silicicacid,sodiumsalt,hydrolysisproductswithchlorotrimethylsilaneandd; Silicicacid,sodiumsalt,hydrolysisproductswithchlorotrimethylsilaneanddichloroethenylmethylsilane; vinylmodifiedsilicaqresininpoly(dimethylsiloxane); VINYL |
Silicic acid, lithium magnesium sodium salt | 53320-86-8 | LiMgNaO6Si2 | 206.40317 | |
Silicic acid hydrate | 1343-98-2 | H2O3Si | 60.08 (anhydrous basis) | Silicicacid(H2SiO3); Mikronisil; Metasilicicacid; Cubosic; dihydroxysilanone; Silicaacid |
Sertraline oxime impurity | 152642-35-8 | C16H13Cl2NO | 306.19 | 4-(3',4'-Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one Oxime; 4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone Oxime; |
Sertraline Impurity G HCl | 79645-15-1 | C17H17Cl2N. HCl | 306.24 36.46 | (1R,4R)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine Hydrochloride; (1R-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine Hydrochloride; (R,R)-Sertraline Hydrochloride |
Sertraline Impurity C (Sertraline 4-Chlorophenyl Impurity HCl) | 79646-00-7 | C17H18ClN . HCl | 271.79 36.46 | (1S-cis)-4-(4-Chlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine Hydrochloride; 3-Dechloro Sertraline Hydrochloride |
Sertraline Impurity (SRTRC-3) | 79560-19-3 | C16H12Cl2O | 291.18 | (+/-)-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone; 4-(3,4-Dichlorophenyl)-1-oxo-1,2,3,4-tetrahydronaphthalene; 4-(3,4-Dichlorophenyl)-1-tetralone; CP 52608; Sertraline Tetralone; Sertralone; rac 4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalen |
Selegiline-d5 HCl | 1217705-21-9 | C13H12D5N·HCl | 228.78 | Selegiline D5 Hydrochloride; [2H5]-R-(-)-Deprenyl hydrochloride |
Serotonin-d4 | 58264-95-2 | C10H8N2OD4 | 180.24 | |
Schleicheol 1 | 256445-66-6 | C30H52O2 | 444.74 | 7beta-Methoxystigmast-5-en-3beta-ol |
Schizandriside | 71222-06-5 | C25H32O10 | 492.52 | (2R,3R,4S,5R)-2-[[(1S,2R,3R)-7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy]oxane-3,4,5-triol |
Schizandrin | 7432-28-2 | C24H32O7 | 432.51 | Schizandrol; Schizandrol-A; Wuweizi alcohol-A |
Schizandrer A | 82042-38-4 | C30H32O9 | 536.577 | Benzo(3,4)cycloocta(1,2-f)(1,3)benzodioxole-5,6-diol, 5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-, 5-benzoate, stereoisomer; Benzo(3,4)cycloocta(1,2-f)(1,3)benzodioxole-5,6-diol, 5,6,7,8-tetrahydro-6,7-dimethyl-1,2,3,13-tetramethoxy-, 5-benzoat |
Schisanwilsonin I | 1181216-84-1 | C28H34O9 | 514.571 | 2-Butenoic acid, 2-methyl-, (5S,6R,7S,13aS)-5,6,7,8-tetrahydro-6-hydroxy-1,2,3,13-tetramethoxy-6,7-dimethylbenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-5-yl ester, (2E)- |
SB 242084 hydrochloride | 1260505-34-7 | C21H19ClN4O2.HCl | 431.32 | 6-chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxamide hydrochloride |
SB 242084 | 181632-25-7 | C21H19ClN4O2 | 394.85 | 6-chloro-5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-2,3-dihydroindole-1-carboxamide;dihydrochloride 181632-25-7 6-Chloro-5-methyl-N-(6-((2-methylpyridin-3-yl)oxy)pyridin-3-yl)indoline-1-carboxamide dihydrochloride SB 242084 (hydrochloride) 6 |
SB 228357 | 181629-93-6 | C22H17F4N3O2 | 431.39 | N-[3-Fluoro-5-(3-pyrindyl)phenyl]-2,3-dihydro-5-methoxy-6-(trifluoromethyl)-1H-indole-1-carboxamide |
SB 224289 HYDROCHLORIDE | 180083-23-2 | C32H32N4O3.HCl | 557.09 | |
SB 224289 hydrochloride | 180084-26-8 | C32H32N4O3.HCl | 557.09 | 1'-Methyl-5-[[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydrospiro[furo[2,3-f]indole-3,4'-piperidine hydrochloride; [4-[2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]phenyl]-(1'-methylspiro[6,7-dihydro-2H-furo[2,3 |
SB 223412 | 174636-32-9 | C25H22N2O2 | 382.45 | 3-Hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]-4-quinolinecarboxamide; 3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide |
SB 222200 | 174635-69-9 | C26H24N2O | 380.48 | 3-Methyl-2-phenyl-N-[(1S)-1-phenylpropyl]-4-quinolinecarboxamide |
SB 221284 | 196965-14-7 | C16H14F3N3OS | 353.36 | 2,3-Dihydro-5-(methylthio)-N-3-pyridinyl-6-(trifluoromethyl)-1H-indole-1-carboxamide |
S-(+)-O-Desmethyl-Venlafaxine | 142761-12-4 | C16H25NO2 | 263.38 | (S)-(+)-4-[2-(Dimethylamino)-1-(1-hydroxycyclo-hexyl)ethyl]phenol |
S(+)-N6-(2-PHENYLISOPROPYL)ADENOSINE (S( +)-PIA) | 38594-97-7 | C19H23N5O4 | 385.41702 | |
S-(+)-Methoprene | 65733-16-6 | C19H34O3 | 310.47 | [S-(E,E)]-11-Methoxy-3,7,11-trimethyl-2,4-dodecadienoic Acid 1-Methylethyl Ester; (+)-Methoprene; (7S)-Methoprene; Altosid XR Briquets; Altoside CP 10; Altoside CP 2; Diacon II; Extinguish; Precor; S-Methoprene; ZR 2458; d-Methoprene |
S-(+)-Manidipine-d4 | 1217836-12-8 | C35H34N4O6D4 | 614.72 | (4S)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[4-(Diphenylmethyl)-1-piperazinyl]ethyl-d4 Methyl Ester; (+)-Manidipine-d4 |
S-(+)-Manidipine | 126451-47-6 | C35H38N4O6 | 610.7 | (4S)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[4-(Diphenylmethyl)-1-piperazinyl]ethyl Methyl Ester; (+)-Manidipine |
S-(-)-TERGURIDE MALEATE SALT | 37686-85-4 | C24H32N4O5 | 456.53 | |
quinethazone | 73-49-4 | C10H12ClN3O3S | 289.74 | 2-Ethyl-7-chloro-1,2,3,4-tetrahydro-4-oxoquinazoline-6-sulfonamide; 2-Ethyl-7-chloro-2,3-dihydro-4(1H)-quinazolone-6-sulfonamide; Aquamox; CL 36010; Hydromox; Idrokin; Quimethazin; Quinethazon; Quinethazonum; 7-Chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-6-qu |
Quinestriol | 152-43-2 | C25H32O2 | 364.53 | (8R,9S,13S,14S,17R)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol Estrovis Ethinyl Estradiol 3 Cyclopentyl Ether Ethinyl Estradiol 3-Cyclopentyl Ether Parke Davis Brand of Quinestrol Quinestrol |
Quinelorane hydrochloride | 97548-97-5 | C14H22N4.2HCl | 319.27 | (5aR,9aR)-5,5a,6,7,8,9,9a,10-Octahydro-6-propyl-pyrido[2,3-g]quinazolin-2-amine Dihydrochloride; (5aR-trans)-5,5a,6,7,8,9,9a,10-Octahydro-6-propyl-pyrido[2,3-g]quinazolin-2-amine Dihydrochloride; LY 163502 |
Prostaglandin H1 | 52589-22-7 | C20H34O5 | 354.5 | PGH1; 9S,11R-epidioxy-15S-hydroxy-13E-prostaenoic acid; 9alpha,11alpha-epidioxy-15(S)-hydroxy-13-trans-prostenoic acid |
RP 67580 | 135911-02-3 | C29H30N2O2 | 438.57 | (3aR,7aR)-Octahydro-2-[1-imino-2-(2-methoxyphenyl)ethyl]-7,7-diphenyl-4H-isoindol |
Royleanone | 6812-87-9 | C20H28O3 | 316.4 | 1-hydroxy-4b,8,8-trimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenan threne-3,4-dione |
Roxithromycin Impurity I | 425365-66-8 | C45H84N2O17 | 925.17 | (9E)-2'-O-[(2-Methoxyethoxy)methyl] Erythromycin 9-[O-[(2-Methoxyethoxy)methyl] oxime] |
Roxithromycin Impurity H | 425365-65-7 | C41H76N2O14 | 821.07 | (3R,4S,5S,6R,7R,9R,11S,12R,13R,14R,Z)-6-(((2S,3S,5R,6R)-5-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(((2-methoxyethoxy)methoxy |
Roxithromycin Impurity F | 118267-18-8 | C40H74N2O15 | 823.02 | (9E)-9-[O-[(2-Methoxyethoxy)methyl]oxime]-N-demethyl Erythromycin; (E)-N-Demethylroxithromycin; N-Demethylroxithromycin; |
Rivaroxaban Related Compound (5-Chloro-2-Thiophenecarboxylic Acid N-Methylamide) | 97799-98-9 | C6H6ClNOS | 175.64 | 5-chloro-N-methyl-2-thiophenecarboxamide, |
Ritonavir | 155213-67-5 | C37H48N6O5S2 | 720.95 | Norvir; ABT-538; A-84538; 538, ABT; ABT 538; ABT-538; ABT538; Abbott 84538 |
Ritodrine Hydrochloride | 23239-51-2 | C17H21NO3.HCl | 323.81 | NSC 291565 |
Ritobegron ethyl hydrochloride | 476333-91-2 | C23H32ClNO5 | 437.96 | KUC 7483; ethyl 2-(4-(2-(((1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl)amino)ethyl)-2,5-dimethylphenoxy)acetate hydrochloride; |
Sialyllacto-N-fucopentaose V | 89458-13-9 | C43H72N2O33 | 1145.03 | Fuc(a1-2)Gal(b1-3)[Neu5Ac(a2-6)]GlcNAc(b1-3)Gal(b1-4)Glc; Monofucosyl monosialyllacto-N-tetraose; Sialyl LNF V |
Sialylglycopeptide | 189035-43-6 | C112H189N15O70 | 2865.76 | SGP(a2,6) |
Sialyl Lewis X methyl glycoside | 141612-87-5 | C32H54N2O23 | 834.77 | Neu5Ac-a-2-3-Gal-b-1-4[Fuc-a-1-3]GlcNAc-b-Ome; Methyl O-[5-acetamido-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonic acid)-2-a-3-O-b-D-galactopyranosyl]-1-b-4-O-[(a-L-fucopyranosyl)-1-a-3]-2-acetamido-2-deoxy-b-D-glucopyranoside |
S-ethyl N-[4-(trifluoromethyl)phenyl] Isothiourea hydrochloride | 163490-78-6 | C10H11F3N2S·HCl | 284.7 | EPIT hydrochloride; TFPI hydrochloride; EPIT HCl; TFPI HCl |
S-Hydroxy topiramate | 198215-62-2 | C12H21NO9S | 355.36 | 4,5-O-[(1S)-2-Hydroxy-1-methylethylidene]-2,3-O-(1-methylethylidene)-b-D-fructopyranose 1-sulfamate; 9-Hydroxy topiramate |
SI-2 | 380537-35-9 | C15H15N5 | 265.3 | EPH 116; 1-Methyl-N-[(E)-1-pyridin-2-ylethylideneamino]benzimidazol-2-amine |
Shz 1 | 326886-05-9 | C13H11BrN2O3S | 355.21 | 2-[(5-Bromo-2-hydroxyphenyl)methylene]hydrazide benzenesulfonic acid; (E)-N'-(5-bromo-2-hydroxybenzylidene)benzenesulfonohydrazide |
SHU 9119 | 168482-23-3 | C54H71N15O9 | 1074.24 | (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-9-(naphthalen-2-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide |
SHP099 HCl | 1801747-11-4 | C16H20Cl3N5 | 388.72 | 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine hydrochloride; SHP099; SHP-099; SHP 099. SHP-099 hydrochloride, SHP-099 HCl. |
SHP099 | 1801747-42-1 | C16H19Cl2N5 | 352.26 | 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine; SHP099; SHP-099; SHP 099. |
Showdomycin | 16755-07-0 | C9H11NO6 | 229.19 | |
Shizukolidol | 90332-92-6 | C15H20O3 | ||
Shizukaol D | 142279-42-3 | C33H38O9 | 578.7 | Shizukaol D |
Shizukaol C | 142279-41-2 | C36H42O10 | 634.7 | |
Shizukaol B | 142279-40-1 | C40H44O13 | 732.779 | |
Shizukaol A | 131984-98-0 | C31H34O6 | 502.607 | |
Shizukanolide H | 1136932-34-7 | C17H20O5 | ||
Shizukanolide F | 120061-96-3 | C15H18O4 | 262.301 | 13-Hydroxyshizukanolide C; Deacetylshizukanolide H; (4aS,5R,5aS,6aR,6bS)-3,5-bis(hydroxymethyl)-6b-methyl-4a,5,5a,6,6a,6b-hexahydrocyclopropa[2,3]indeno[5,6-b]furan-2(4H)-one |
Shizukanolide C | 78749-47-0 | C15H18O3 | 246.3 | 13-Deoxyshizukanolide F;Deacetylchloranthalactone C |
Shiraiachrome A | 124709-39-3 | C30H26O10 | 546.528 | (13S,14S)-1,5,8,12-Tetramethoxy-13-acetyl-14-hydroxy-14-methyl-6,7-propano-4,9-dihydroxyperylene-3,10-dione |
Shikonofuran A | 85022-66-8 | C18H20O5 | 316.35 | 1,4-Benzenediol,2-[4-[(1S)-1-(acetyloxy)-4- methyl-3-pentenyl]-2-furanyl]- |
Shikonin | 54952-43-1 | C16H16O5 | (±)-Alkannin; (±)-Shikalkin; (±)-Shikonin; (±)-5,8-Dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-1,4-naphthoquinone; 1,4-Naphthalenedione, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)- | |
Shikonin | 517-89-5 | C16H16O5 | 288.30 | 5,8-Dihydroxy-2-[(1R)-1-hydroxy-4-methyl-pent-3-enyl]naphthalene-1,4-dione |
Shikimic acid | 138-59-0 | C7H10O5 | 174.15 | Shikimate |
SHH Antagonist | 315703-52-7 | C19H18N4OS | 350.44 | |
Shepherdin | 861224-28-4 | C41H64N12O12S | 949.09 | NSC-741765, NSC741765 |
Shellac | 9000-59-3 | Lacca | ||
Shegansu B | 291535-65-4 | C30H26O8 | 514.53 | Parvifolol D |
Shea butter | 68424-60-2 | 0 | Glycerides, C16-22 and C18-unsatd.; SheaButter,SwedenOrigin; Glyceride, C16-22- und C18-ungettigt; C16-C22 AND C18-UNSATURATED GLYCERIDES); MANGO BUTTER (MANGIFERA INDICA); MANGO OIL (MANGIFERA INDICA); glycerides, C16-22 and C18-unsaturated | |
Shanciol B | 208106-53-0 | C25H26O6 | 422.48 | |
Shancigusin I | 1435488-35-9 | C28H34O14 | 594.56 | |
SGC-CBP30 | 1613695-14-9 | C28H33ClN4O3 | 509.03962 | SGCCBP30; SGC CBP30. |
SGC707 | 1687736-54-4 | C16H18N4O2 | 298.34 | SGC-707; SGC 707. |
SGC2085 HCl | 1821908-49-9 | C19H25ClN2O2 | 348.87 | (2S)-2-amino-N-[[4-(3,5-dimethylphenoxy)-3-methylphenyl]methyl]propanamide;hydrochloride; 1821908-48-8 (SGC2085 free base) |
SGC2085 | 1821908-48-8 | C19H24N2O2 | 312.41 | SGC2085; SGC-2085; SGC 2085 |
SGC GAK 1 | 2226517-76-4 | C18H17BrN2O3 | 389.24 | SGC-GAK-1; BCP30478; 6-Bromo-N-(3,4,5-trimethoxyphenyl)-4-quinolinamine |
SGC AAK1 1 | 2247894-32-0 | C21H25N5O3S | 427.52 | AAK1 inhibitor 1; N-(6-(3-((N,N-diethylsulfamoyl)amino)phenyl)-1H-indazol-3-yl)cyclopropanecarboxamide |
SGC 0946 | 1561178-17-3 | C28H40BrN7O4 | 618.57 | |
SGA360 | 680611-86-3 | C19H17F3N2O2 | 362.4 | 3-(2,4-dimethoxyphenyl)-1-prop-2-enyl-7-(trifluoromethyl)indazole |
SF1670 | 345630-40-2 | C19H17NO3 | 307.34 | |
SF1126 | 936487-67-1 | C39H48N8O14 | 852.855 | SF 1126, SF-1126 |
SF 11 | 443292-81-7 | C27H30N2O2S | 446.6 | N-(4-Ethoxyphenyl)-4-(hydroxydiphenylmethyl)-1-piperidinecarbothioamide |
SEW 2871 | 256414-75-2 | C20H16N2OS | 332.419 | 5-[4-Phenyl-5-(trifluoromethyl)thiophen-2-yl]-3-[3-(trifluoromethyl)phenyl]1,2,4-oxadiazole; SEW2871; SEW2871; SEW2871 |
Sevoflurane | 28523-86-6 | C4H3F7O | 200.1 | Sevofluran; Ultane; 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane; Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl ester; Fluoromethyl 1,1,1,3,3,3-Hexafluoro-2-propyl ester |
Sevelamer HCl | 152751-57-0 | (C3H7N.C3H5ClO.HCl)x | 186.08 | 2-Propen-1-amine Hydrochloride polymer with 2-(Chloromethyl)oxirane; 2-Propen-1-amine Hydrochloride polymer with (Chloromethyl)oxirane; (Chloromethyl)oxirane polymer with 2-Propen-1-amine Hydrochloride; Allylamine Hydrochloride-epichlorhydrin Copolymer; A |
Sevelamer Carbonate | 845273-93-0 | C7H14ClNO4 | 211.642 | KW-9144; KW 9144; KW9144 |
Sevelamer | 52757-95-6 | C6H12ClNO | 149.62 | |
Setosusin | 182926-45-0 | C29H38O8 | 514.6 | |
SETOPERONE > 95 % | 86487-64-1 | C21H24FN3O2S | 401.5 | |
Setomimycin | 69431-87-4 | C34H28O9 | 580.6 | |
Setmelanotide | 920014-72-8 | C49H68N18O9S2 | 1117.31 | (4R,7S,10S,13R,16S,19R,22R)-22-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20 |
Setiptiline maleate | 85650-57-3 | C23H23NO4 | 377.43 | 2,3,4,9-tetrahydro-2-methyl-1H-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridyl maleate;Bisopool;MO-8282;MOD-20;Teciptiline maleate;1H-Dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine,2,- 3,4,9-tetrahydro-2-methyl-,(2Z)-2- butenedioate (1:1);2-methyl-2,3,4,9-tetrahydro- |
Setiptiline | 57262-94-9 | C19H19N | 261.36 | Org-8282; 2,3,4,9-tetrahydro-2-methyl-1H-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine; |
Setipiprant | 866460-33-5 | C24H19FN2O3 | 402.42 | 2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid;ACT129968;2-[8-fluoro-2-(naphthalene-1-carbonyl)-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl]acetic acid;8-Fluoro-1,2,3,4-tetrahydro-2-(1-naphthalenylcarbonyl)-5H-pyrido[4,3-b]in |
S-ETHYL-L-CYSTEINE | 2629-59-6 | C5H11NO2S | 149.21 | H-CYS(ET)-OH; S-ETHYL-L-CYSTEINE; S-ethyl-L-cysteine crystalline; 5-ETHYL-L-CYSTEINE; 3-(Ethylthio)alanine; Aids034431 |
Sessilifoline A | 929637-35-4 | C22H31NO5 | 389.5 | (1S,3S,5R,6S,7R,10S,11R,12R,16S)-11-Ethyl-7-methyl-3-[(2S,4S)-4-methyl-5-oxotetrahydro-2-furanyl]-9,17-dioxa-2-azapentacyclo[10.5.0.01,5.02,16.06,10]heptadecan-8-one |
Sesartemin | 77394-27-5 | C23H26O8 | 430.5 | (+)-Sesartemin |
Sesamoside | 117479-87-5 | C17H24O12 | 420.4 | (1aR,1bS,2S,5aR,6R,6aS)-2-(beta-D-Glucopyranosyloxy)-1a,1b,2,5a,6,6a-hexahydro-5a,6-dihydroxy-1a-methyloxireno[4,5]cyclopenta[1,2-c]pyran-5-carboxylic acid methyl ester; methyl (1aR,1bS,2S,5aR,6R,6aS)-5a,6-dihydroxy-1a-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-tri |
Sesamin | 607-80-7 | C20H18O6 | 354.358 | Fagarol; Sezamin; Asarinin; Pseudocubebin; 5-[(3S,3aR,6S,6aR)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-1,3-benzodioxole |
Salicylic acid D-glucuronide | 7695-70-7 | C13H14O9 | 314.24 | 2-Carboxyphenyl b-D-glucopyranosiduronic acid |
Sertraline-d3 HCl | 1217741-83-7 | C17H14D3Cl2N.HCl | 345.71 | 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine-d3 Hydrochloride; |
Sertraline-2,3-Dichloro Impurity | 1198084-29-5 | C17H17Cl2N HCl | 306.24 36.46 | (1S,4R)-4-(2,3-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methylnaphthalenamine Hydrochloride; rac-cis-2,3-Dichloro Sertraline Hydrochloride |
Sertraline Tetralone Impurity | 155748-61-1 | C16H12Cl2O | 291.18 | (4R)-(3',4'-Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one; (R)-4-(3,4-Dichlorophenyl)-1-tetralone; |
Serotonin HCl | 153-98-0 | C10H12N2O.HCl | 212.68 | 5-HT HCl; Serotonin hydrochloride; 3-(2-aminoethyl)-1H-indol-5-ol hydrochloride; 5-Hydroxytryptamine hydrochloride |
Sermorelin acetate | 114466-38-5 | C151H250N44O44S | 3417.985 | Geref; GHRH (1-29); H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
sermorelin | 86168-78-7 | C149H246N44O42S | 3357.88 | SERMORELIN; SERMORELIN ACETATE; YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2; TYR-ALA-ASP-ALA-ILE-PHE-THR-ASN-SER-TYR-ARG-LYS-VAL-LEU-GLY-GLN-LEU-SER-ALA-ARG-LYS-LEU-LEU-GLN-ASP-ILE-MET-SER-ARG-NH2; TYR-ALA-ASP-ALA-ILE-PHE-THR-ASN-SER-TYR-ARG-LYS-VAL-LEU-GLY-GLN-LEU |
Serlopitant | 860642-69-9 | C29H28F7NO2 | 555.53 | VPD 737; MK-0594;3-((3aR,4R,5S,7aS)-5-((1R)-1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)-4-(4 fluorophenyl)octahydro-2H-isoindol-2-yl)cyclopent-2-en-1-one |
2-(4-Methoxybenzyl)phenyl6-O-(ethoxycarbonyl)-beta-D-glucopyranoside | 408504-26-7 | C23H28O9 | 448.46 | ethyl [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[2-[(4-methoxyphenyl)methyl]phenoxy]oxan-2-yl]methyl carbonate |
Serdemetan | 881202-45-5 | C21H20N4 | 328.419 | JNJ-26854165; JNJ26854165; JNJ 26854165 |
Seratrodast | 112665-43-7 | C22H26O4 | 354.44 | AA 2414 |
Seratrodast | 103186-19-2 | C22H26O4 | 354.43944;g/mol | SERATRODAST; 112665-43-7; Bronica; AA-2414; Abbott73001; ABT-001 |
SER-601 | 1048038-90-9 | C28H38N2O2 | 434.6 | N-(Adamant-1-yl)-6-isopropyl-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide; 4-Oxo-1-pentyl-6-(propan-2-yl)-N-(tricyclo[3.3.1.1~3,7~]decan-1-yl)-1,4-dihydroquinoline-3-carboxamide |
Sequosempervirin D | 864719-19-7 | C21H24O5 | 356.42 | 4-[(1R)-1-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-(4-hydroxyphenyl)prop-2-enyl]-2-methoxyphenol |
Sequosempervirin B | 864719-17-5 | C18H20O5 | 316.4 | (2S,3S,4E)-3-(4-Hydroxy-3-methoxyphenyl)-5-(4-hydroxyphenyl)-4-pentene-1,2-diol |
Sequirin C | 18194-29-1 | C17H18O5 | 302.33 | 4-[(S,E)-1-[(S)-1,2-Dihydroxyethyl]-3-(4-hydroxyphenyl)-2-propenyl]-1,2-benzenediol |
Sepinol | 72061-63-3 | C16H14O7 | 318.3 | (2R,3R)-2-(3,5-Dihydroxy-4-methoxyphenyl)-3,7-dihydroxy-2,3-dihyd ro-4H-chromen-4-one |
Sephin 1 | 951441-04-6 | C8H9ClN4 | 196.64 | 2-[(E)-(2-Chlorophenyl)methylideneamino]guanidine |
Sephin 1 | 13098-73-2 | C8H9ClN4 | 196.6 | 2-[(2-chlorophenyl)methylideneamino]guanidine; NSC 65390 |
SEPHAROSE CL-6B | 62610-50-8 | 0 | SEPHAROSE CL-6B; SEPHAROSE(R) CL-6B; high resolution agarose; sepharose(R) cl-6B for chromatography; Agarose beads 6% B-CL (Cross-l; Agarose beads 6% B-CL (Cross-linked) | |
SEPHADEX G-25 | 9041-35-4 | 0 | SEPHADEX G-25; SEPHADEX G-25 COARSE; SEPHADEX G-25 FINE; SEPHADEX G-25 MEDIUM; SEPHADEX G-25 SUPERFINE; SEPHADEX(R) G-25; PDX GF 25 (100-300); PDX GF 25 (50-150) | |
Selegiline HCl | 14611-52-0 | C13H18ClN | 223.74 | Selegiline Hydrochloride; Eldepryl; Selegiline Hcl; Zelapar; L-Deprenyl hydrochloride; Deprenalin; Deprenyl; E 250, E250, E-250; DEPRENYL HYDROCHLORIDE;D-(+)-DEPRENYL HYDROCHLORIDE;L-DEPRENYL HYDROCHLORIDE;N,ALPHA-DIMETHYL-N-2-PROPYNYL-BENZENEETHANAMINE H |
Selegiline D5 | 1189731-50-7 | C13H14D3N | 190.28 | rac Deprenyl-d3 |
Selatinib | 1275595-86-2 | C29H26ClFN4O3S | 565.07 | UNII-6TLR8U8O3C;N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfinyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine |
Seladelpar | 851528-79-5 | C21H23F3O5S | 444.46 | MBX8025; RWJ-800025;(R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid |
SELACHYL ALCOHOL | 593-31-7 | C21H42O3 | 342.56 | A-OLEYL GLYCERYL ETHER; SELACHYL ALCOHOL; (Z)-3-(9-octadecenyloxy)propane-1,2-diol; 1-O-[(Z)-9-Octadecenyl]glycerol; 3-[(Z)-9-Octadecenyloxy]-1,2-propanediol; 3-[[(Z)-9-Octadecenyl]oxy]propane-1,2-diol; Einecs 209-787-7; Glyceryl monooleyl ether |
SEL120-34A | 1609522-33-9 | C15H18Br2N4 | 414.14 | SEL120; SEL120-34 |
Seglitide | 81377-02-8 | C44H56N8O7 | 808.98 | MK 678; MK-678 |
Segetalin B | 164991-89-3 | C24H32N6O5 | 484.557 | |
Segetalin A | 161875-97-4 | C33H42F3N7O8- | 721.7238896 | segetalin A; Cyclo(L-alanylglycyl-L-valyl-L-prolyl-L-valyl-L-tryptophyl); Vaccarin D |
Secukinumab | 875356-43-7 | C6584H10134N1754O2042S44 | 147944.39 | Cosentyx |
Secretin (rat) | 121028-49-7 | C129H216N42O42 | 3027.38 | |
Secretin (human) | 108153-74-8 | C130H220N44O40 | 3039.44 | |
Secoisolariciresinol monoglucoside | 63320-67-2 | C26H36O11 | 524.56 | Secoisolariciresinol beta-D-glucoside |
Secoisolariciresinol Diglucoside | 148244-82-0 | C32H46O16 | 686.71 | 2,3-Bis(3-Methoxy-4-hydroxybenzyl)butane-1,4-diol 1,4-diglucoside; SDG |
Secoisolariciresinol diferulate | 56973-66-1 | C40H42O12 | 714.8 | 9,9'-Di-O-(E)-feruloylsecoisolariciresil |
Secoisolariciresinol | 29388-59-8 | C20H26O6 | 362.4 | (2R,3R)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol |
Sec-O-Glucosylhamaudol | 80681-44-3 | C21H26O10 | 438.43 | |
Secodihydro-hydramicromelin B | 1212148-58-7 | C15H18O8 | 326.3 | |
Seco Rapamycin (sodium salt) | 148554-65-8 | C51H78NNaO13 | 936.15 | sodium;(2S)-1-[2-[(2R,3R,6S)-2-hydroxy-6-[(2S,9S,11R,13R,14R,17R,21R)-14-hydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaenyl]-3-methyloxan-2-yl]-2-oxoacetyl]piperidine-2-c |
SBI0206965 | 1884220-36-3 | C21H21BrN4O5 | 489.33 | 2-((5-bromo-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide; SBI0206965; SBI-0206965; SBI 0206965. |
Scopolamine N-Oxide hydrobromide | 6106-81-6 | C17H22BrNO5 | 400.3 | Hyoscine N-oxide hydrobromide; Scopolamine aminoxide hydrobromide |
Scopolamine hydrobromide trihydrate | 6533-68-2 | C17H28BrNO7 | 438.31 | Scopolamine HBr trihydrate |
Scopolamine HBr (Hyoscine HBr) | 114-49-8 | C17H21NO4.HBr | 384.26 | N/A |
Scopolamine | 51-34-3 | C17H21NO4 | 303.35 | 1aH,5aH-Tropan-3a-ol, 6b,7b-epoxy-, (-)-tropate (ester) (8CI);3-Oxa-9-azatricyclo[3.3.1.02,4]nonane, benzeneacetic acid deriv. |
Scopine HCl | 85700-55-6 | C8H14ClNO2 | 191.66 | Bay o 9867 |
Scopine | 498-45-3 | C8H13NO2 | 155.19 | |
Scoparone | 120-08-1 | C11H10O4 | 206.2 | 6,7-dimethoxycoumarin; |
Scoparinol | 130838-00-5 | C27H38O4 | 426.6 | (1R,4S,4aR,8R,8aR)-8-(Hydroxymethyl)-4-[(3E)-5-hydroxy-3-methyl-3 -penten-1-yl]-4a,8-dimethyl-3-methylenedecahydro-1-naphthalenyl b enzoate |
S-Clopidogrel N-Methyl Impurity | 1346605-15-9 | C16H18ClNO2S | 323.84 | Methyl (2S)-(2-Chlorophenyl)-2-[N-methyl-N-(2-thiophen-2-ylethyl)amino]acetate; Methyl (2S)-(2-Chlorophenyl)-2-[methyl(2-thiophen-2-ylethyl)amino]ethanoate; Clopidogrel Impurity I |
Sclerotiorin | 549-23-5 | C21H23ClO5 | 390.9 | [(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-7-methyl-6,8-dioxoisochromen-7-yl] acetate |
Scleroglucan polysaccharide | 39464-87-4 | |||
Sclareolide | 564-20-5 | C16H26O2 | 250.38 | Norambreinolide |
Sclareol glycol | 38419-75-9 | C16H30O2 | 254.41 | 1-Naphthaleneethanol,decahydro-2-hydroxy- 2,5,5,8a-tetramethyl-,(1R,2R,4aS,8aS)-; Ambroxdiol; Sukurarerin; (1R,2R,4aS,8aS)-1-(2-hydroxyethyl)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-2-ol |
Sclareol | 515-03-7 | C20H36O2 | 308.5 | (1R,2R,4aS,8aS)-1-[(3R)-3-hydroxy-3-methylpent-4-en-1-yl]-2,5,5,8a-tetramethyldecahydronaphthalen-2-ol |
Scillascilloside B-1 | 2023822-41-3 | C40H64O13 | 752.939 | |
Scillascillone | 2023822-40-2 | C30H44O6 | 500.676 | |
Scillascillol | 2023822-39-9 | C30H46O6 | 502.692 | |
Scillascillin | 52706-07-7 | C17H12O6 | 312.3 | (3R)-5,7-Dihydroxy-4H,6'H-spiro[chromene-3,5'-cyclobuta[f][1,3]be nzodioxol]-4-one |
SC-III3 | 1660110-65-5 | C19H14ClNO5 | 371.77 | SC-III3; (E)-3-(4-chlorophenyl)-N-(7-hydroxy-6-methoxy-2-oxo-2H-chromen-3-yl) acrylamide |
Sciadopitysin | 521-34-6 | C33H24O10 | 580.6 | Amentoflavone-7,4',4'''-trimethyl ether | Sciadopitysin | I-7,I-4',II-4'-tri-O-methylamentoflavone | Jin Song biflavone | 5,7-dihydroxy-8-[5-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)-2-methoxyphenyl]-2-(4-methoxyphenyl)chromen-4-one | Sciadopytissin |
Scholaricine | 99694-90-3 | C20H24N2O4 | 356.4 | Methyl (19S)-12,19-dihydroxy-2,16-didehydrocuran-17-oate |
Schisanwilsonin H | 1181216-83-0 | C30H32O9 | 536.577 | Arisanschinin K; Schisantherrin A |
Schisantherin E | 64917-83-5 | C30H34O9 | 538.59 | (6S,7S,8S)-5,6,7,8-Tetrahydro-1,2,10,11,12-pentamethoxy-6,7-dimethyldibenzo[a,c]cyclooctene-3,7,8-triol 8-benzoate; |
Schisantherin D | 64917-82-4 | C29H28O9 | 520.53 | Cycloocta(1,2-f:3,4-f')bis(1,3)benzodioxole-5,6-diol, 5,6,7,8-tetrahydro-13,14-dimethoxy-6,7-dimethyl-, 5-benzoate, stereoisomer |
Schisantherin C | 64938-51-8 | C28H34O9 | 514.56 | Schizantherin C; Tigloygomisin Q |
Schisantherin A | 58546-56-8 | C30H32O9 | 536.574 | Gomisin C; (5S,6S,7S,13aS)-5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-benzo[3,4]cycloocta[1,2-f][1,3]benzodioxole-5,6-diol 5-benzoate |
Schisanhenol B | 102681-52-7 | C22H26O6 | 386.444 | Benzo(3,4)cycloocta(1,2-f)(1,3)benzodioxol-1-ol, 5,6,7,8-tetrahydro-2, 3,13-trimethoxy-6,7-dimethyl-, stereoisomer; schisanhenol B |
Schisanhenol | 69363-14-0 | C23H30O6 | 402.487 | |
Schisandrone | 98619-25-1 | C21H24O5 | Arisantetralone C | |
schisandrin C | 61301-33-5 | C22H24O6 | 384.42 | Wuweizisu-C |
SCH900776 S-isomer | 891494-64-7 | C15H18BrN7 | 376.25 | (S)-6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-A]pyrimidin-7-amine;6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-((3S)-piperidin-3-yl)pyrazolo(1,5-a)pyrimidin-7-amine;SCH-900776 S-isomer |
SCH900776 | 891494-63-6 | C15H18BrN7 | 376.262 | SCH-900776; SCH 900776, MK-8776. |
SCH772984 | 942183-80-4 | C33H33N9O2 | 587.688 | SCH-772984; SCH 772984. |
Sch59498 | 224157-99-7 | C17H25N5O | 315.41 | 2-hexyl-5-methyl-(6aR,9aS)-3,4,5,8-tetrahydrocyclopenta[4,5]imidazo[2,1-b]purin-4-one; 2-Hexyl-5-methyl-7,8-propano-1,4,7beta,8beta-tetrahydro-5H-imidazo[2,1-b]purine-4-one; (6aR,9aS)-2-Hexyl-5,6a,7,8,9,9a-hexahydro-5-methylcyclopent[4,5]imidazo[2,1-b]pur |
SCH-51344 | 171927-40-5 | C16H20N4O3 | 316.36 | Ras/Rac Transformation Blocker, SCH 51344; SCH-51344; 6-Methoxy-4-(2-((2-hydroxyethoxyl)-ethyl)amino)-3-methyl-1H-pyrazolo[3,4-b]quinoline; 2-(2-((6-Methoxy-3-methyl-1H-pyrazolo[3,4-b]quinolin-4-yl)amino)ethoxy)ethanol; 2-{2-[(6-methoxy-3-methyl-1H-pyrazo |
SCH-50911 | 733717-87-8 | C8H15NO3 | 173.21 | (S)-2-(5,5-dimethylmorpholin-2-yl)acetic acid |
Sch412348 | 377727-26-9 | C22H21F2N9O | 465.46 | (7-(2-(4-difluorophenyl)-1-piperazinyl)ethyl)-2-(2-furanyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amine; SCH 412348; SCH-412348; SCH412348 |
SCH1473759 (HCl salt) | 1094067-13-6 | C20H27ClN8OS | 463.00 | SCH-1473759 (hydrochloride); CHEMBL1650533; CS-3477 |
SCH-1473759 | 1094069-99-4 | C20H26N8OS | 426.54 | SCH1473759; SCH 1473759. |
SCH 79797 dihydrochloride | 1216720-69-2 | C23H25N5.2HCl | 444.41 | N3-Cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine dihydrochloride |
Sch 725674 | 877061-66-0 | C18H32O5 | 328.0 | |
SCH 58261 | 160098-96-4 | C18H15N7O | 345.366 | 2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine |
SCH 563705 | 473728-58-4 | C23H27N3O5 | 425.48 | 3-[[3,4-dioxo-2-[[(1R)-1-(4-propan-2-ylfuran-2-yl)propyl]amino]cyclobuten-1-yl]amino]-2-hydroxy-N,N-dimethylbenzamide |
SCH 546738 | 906805-42-3 | C23H31Cl2N7O | 492.44 | 3-amino-6-chloro-5-[(3S)-4-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-3-ethylpiperazin-1-yl]pyrazine-2-carboxamide |
SCH 529074 | 922150-11-6 | C31H36Cl2N6 | 563.56 | N3-[2-[[4-[Bis(4-chlorophenyl)methyl]-1-piperazinyl]methyl]-4-quinazolinyl]-N1,N1-dimethyl-1,3-propanediamine |
SCH 527123 | 473727-83-2 | C21H23N3O5 | 397.42 | 2-hydroxy-N,N-dimethyl-3-(2-((1-(5-methylfuran-2-yl)propyl)amino)-3,4-dioxocyclobut-1-enylamino)benzamide; MK-7123; SCH-527123; SCH527123 |
SCH 442416 | 316173-57-6 | C20H19N7O2 | 389.42 | 2-(2-Furanyl)-7-[3-(4-methoxyphenyl)propyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine |
SCH 39166 hydrobromide | 1227675-51-5 | C19H20ClNO.HBr | 394.73 | (6aS-trans)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-benzo[d]naphth[2,1-b]azepin-12-ol hydrobromide; Ecopipam hydrobromide |
Sch 38519 | 114970-20-6 | C24H25NO8 | 455.4 | |
S-benzyl-L-Cysteine-3-13C-N-T-BOC | 201612-59-1 | C6H5CH2S[13C]H2CH(NH-t-BOC)COOH | 312.39 | |
S-benzyl-L-Cysteine-3-13C | 79761-09-4 | C6H5CH2S[13C]H2CH(NH2)COOH | 212.27 | |
S-Benzyl-DL-cysteine-2,3,3-d3 | 51494-04-3 | C6H5CH2SCD2CD(NH2)COOH | 214.3 | 2-amino-3-benzylsulfanyl-2,3,3-trideuteriopropanoic acid |
S-benzyl-DL-Cysteine-1-13C | 77284-35-6 | C6H5CH2SCH2CH(NH2)[13C]OOH | 212.27 | |
S-BENZOYL-MAG-3 > 95 % | 103725-47-9 | C15H17N3O6S | 367.38 | |
SBE-13 HCl | 1052532-15-6 | C24H28Cl2N2O4 | 479.398 | SBE 13 HCl; SBE13 HCl |
SBE13 | 775294-82-1 | C24H27ClN2O4 | 442.94 | STK510569;N-[[4-[(6-chloropyridin-3-yl)methoxy]-3-methoxyphenyl]methyl]-2-(3,4-dimethoxyphenyl)ethanamine |
SBC-115076 | 489415-96-5 | C31H33N3O5 | 527.62 | SBC-115076; SBC 115076; SBC115076. |
Sbc-1107326 | 1629166-02-4 | C26H27N3O2 | 413.51 | N-(4-{[4-(4-Methylphenyl)-2-phenyl-1-piperazinyl]carbonyl}phenyl)acetamide |
SB756050 | 447410-57-3 | C21H28N2O8S2 | 500.59 | 1,4-bis[(3,4-dimethoxyphenyl)sulfonyl]-1,4-diazepane; SB756050; F1018-1711; 1,4-bis((3,4-dimethoxyphenyl)sulfonyl)-1,4-diazepane; SB-756050; SB 756050; SB756050 |
SB-743921 HCl | 940929-33-9 | C31H34Cl2N2O3 | 553.524 | SB-743921; SB 743921; SB743921. |
SB742457 | 607742-69-8 | C19H19N3O2S | 353.44 | GSK 742457 |
SB705498 | 501951-42-4 | C17H16BrF3N4O | 429.23 | |
Saxagliptin monohydrate | 945667-22-1 | C18H27N3O3 | 333.43 | BMS-477118 hydrate; Onglyza hydrate |
SB 747651A dihydrochloride | 1781882-72-1 | C16H22N8O.2HCl | 415.32 | 2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-4-piperidinyl-1H-imidazo[4,5-c]pyridine-7-methanamine dihydrochloride |
SB 742457 hydrochloride | 607742-55-2 | C19H19N3O2S.HCl | 389.9 | GSK-742457 hydrochloride; RVT-101 hydrochloride; Intepirdine hydrochloride; 3-Phenylsulfonyl-8-piperazin-1-yl-quinoline hydrochloride |
SB 706504 | 911110-38-8 | C24H19F3N8O | 492.46 | N-Cyano-N'-[2-[[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7,8-dihydro-7-oxopyrido[2,3-d]pyrimidin-2-yl]amino]ethyl]guanidine; 1-cyano-2-[2-[[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxopyrido[2,3-d]pyrimidin-2-yl]amino]ethyl]guanidine |
SB 706375 | 733734-61-7 | C20H22BrF3N2O5S | 539.36 | 2-Bromo-4,5-dimethoxy-N-[3-[[(3R)-1-methyl-3-pyrrolidinyl]oxy]-4-(trifluoromethyl)phenyl]benzenesulfonamide |
SB 699551 dihydrochloride | 864741-95-7 | C34H45N3O.2HCl | 584.66 | N-[2-(Dimethylamino)ethyl]-N-[[4'-[[(2-phenylethyl)amino]methyl][1,1'-biphenyl]-4-yl]methyl]cyclopentanepropanamide dihydrochloride |
SB 657510 | 474960-44-6 | C19H22BrClN2O5S | 505.81 | 2-Bromo-N-[4-chloro-3-[[(3R)-1-methyl-3-pyrrolidinyl]oxy]phenyl]-4,5-dimethoxybenzenesulfonamide |
SB 612111 hydrochloride | 371980-98-2 | C24H29ClNO.HCl | 454.86 | (5S,7S)-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-1-methyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-ol hydrochloride |
SB 612111 hydrochloride | 371980-94-8 | C24H29Cl2NO.HCl | 454.86 | 7-[[4-(2,6-Dichlorophenyl)-1-piperidinyl]methyl]-6,7,8,9-tetrahydro-1-methyl-5H-benzocyclohepten-5-ol hydrochloride |
SB 611812 | 345892-71-9 | C17H16Cl3F3N2O3S | 491.74 | 2,6-Dichloro-N-[4-chloro-3-[2-(dimethylamino)ethoxy]phenyl]-4-(trifluoromethyl)benzenesulfonamide |
SB 452533 | 459429-39-1 | C18H22BrN3O | 376.29 | N-(2-Bromophenyl)-N'-[2-[ethyl(3-methylphenyl)amino]ethyl]-urea; 1-(2-bromophenyl)-3-[2-(N-ethyl-3-methylanilino)ethyl]urea |
SB 4 | 100874-08-6 | C14H10BrNOS | 320.2 | 2-[[(4-Bromophenyl)methyl]thio]benzoxazole |
SB 399885 hydrochloride | 402713-81-9 | C18H21Cl2N3O4S.HCl | 482.81 | N-(3,5-Dichloro-2-methoxyphenyl)-4-methoxy-3-(1-piperazinyl)benzenesulfonamide hydrochloride |
SB 328437 | 247580-43-4 | C21H18N2O5 | 378.38 | methyl 2-naphthoylamino-3-(4-nitrophenyl)propionate; SB 328437; SB-328437 |
SB 277011A dihydrochloride | 1226917-67-4 | C28H30N4O.2HCl | 511.49 | N-[trans-4-[2-(6-Cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl]-4-quinolinecarboxamide dihydrochloride |
SB 271046 Hydrochloride | 209481-24-3 | C20H23Cl2N3O3S2 | 488.45 | 5-chloro-N-(4-methoxy-3-piperazin-1-ylphenyl)-3-methyl-1-benzothiophene-2-sulfonamide;hydrochloride 209481-20-9 SB 271046 HYDROCHLORIDE SB-271046A SB 271046 (Hydrochloride) 209481-24-3 5-chloro-N-(4-methoxy-3-(piperazin-1-yl)phenyl)-3-methylbenzo[b] |
SB 268262 | 217438-17-0 | C18H15N3O4S2 | 401.46 | N-Methyl-N-(2-methylphenyl)-3-nitro-4-(2-thiazolylsulfinyl)-benzamide |
SB 265610 | 211096-49-0 | C14H9BrN6O | 357.16 | 1-(2-bromophenyl)-3-(7-cyano-2H-benzotriazol-4-yl)urea; N-(2-Bromophenyl)-N'-(7-cyano-1H-benzotriazol-4-yl)urea |
SB 258741 hydrochloride | 201038-58-6 | C19H30N2O2S.HCl | 386.98 | |
SB 258719 hydrochloride | 1217674-10-6 | C18H30N2O2S.HCl | 374.97 | 3-Methyl-N-[(1R)-1-methyl-3-(4-methyl-1-piperidinyl)propyl]-N-methylbenzenesulfonamide hydrochloride; N,3-dimethyl-N-[(2R)-4-(4-methylpiperidin-1-yl)butan-2-yl]benzenesulfonamide hydrochloride |
SB 258585 hydrochloride | 1216468-02-8 | C18H22IN3O3S.HCl | 523.82 | 4-Iodo-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]benzenesulfonamide hydrochloride |
SB 243213 dihydrochloride | 200940-23-4 | C22H19F3N4O2.2HCl | 501.33 | 2,3-Dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-6-(trifluoromethyl)-1H-Indole-1-carboxamide dihydrochloride |
SB 218795 | 174635-53-1 | C25H20N2O3 | 396.44 | (R)-[[2-Phenyl-4-quinolinyl)carbonyl]amino]-methyl ester benzeneacetic acid; methyl (2R)-2-phenyl-2-[(2-phenylquinoline-4-carbonyl)amino]acetate |
SB 216641 hydrochloride | 193611-67-5 | C28H30N4O4.HCl | 523.03 | N-[3-[3-(Dimethylamino)ethoxy]-4-methoxyphenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxamide hydrochloride |
SB 215505 | 162100-15-4 | C19H16ClN3O | 337.81 | 6-Chloro-2,3-dihydro-5-methyl-N-5-quinolinyl-1H-indole-1-carboxamide |
SB 206553 hydrochloride | 1197334-04-5 | C17H16N4O.HCl | 328.8 | 3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']dipyrrole-1(2H)-carboxamide hydrochloride; 1-methyl-N-pyridin-3-yl-6,7-dihydropyrrolo[2,3-f]indole-5-carboxamide hydrochloride |
SB 205607 dihydrobromide | 1217628-73-3 | C23H24N2O.2HBr | 506.28 | (R*,S*)-(±)-2-Methyl-4aa-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12aa-octahydroquinolino[2,3,3-g]isoquinoline dihydrobromide |
SB 205384 | 160296-13-9 | C17H18N2O3S | 330.4 | 4-Amino-5,6,7,8-tetrahydro-7-hydroxy-2-methyl-[1H]benzothieno[2,3-b]pyridine-3-carboxylic acid 2-butynyl ester |
SB 204990 | 154566-12-8 | C18H22Cl2O5 | 389.27 | (3R,5S)-rel-5-[6-(2,4-Dichlorophenyl)hexyl]tetrahydro-3-hydroxy-2-oxo-3-furanacetic acid |
SB 204741 | 152239-46-8 | C14H14N4OS | 286.35 | N-(1-Methyl-1H-indolyl-5-yl)-N''-(3-methyl-5-isothiazolyl)urea; 1-(1-methyl-1H-indol-5-yl)-3-(3-methylisothiazol-5-yl)urea |
SB 204070 | 148688-01-1 | C19H27ClN2O4.HCl | 419.34 | 8-Amino-7-chloro-2,3-dihydro-1,4-benzodioxan-5-carboxylic acid, 1'-butyl-4'-piperidinylmethyl ester; (1-Butyl-4-piperidinyl)methyl 8-amino-7-chloro-1,4-benzodioxane-5-carboxylate hydrochloride |
SB 203580 hydrochloride | 869185-85-3 | C21H17FN3OSCl | 413.9 | 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole hydrochloride |
SB 203186 hydrochloride | 207572-69-8 | C16H20N2O2.HCl | 308.81 | 1-Piperidinylethyl-1H-indole-3-carboxylate hydrochloride |
SB 202474 | 172747-50-1 | C17H17N3O | 279.3 | SB-202474; SB202474; 4-[5-ethyl-2-(4-methoxyphenyl)-1H-imidazol-4-yl]pyridine |
SB 202190 hydrochloride | 350228-36-3 | C20H14FN3O·HCl | 367.8 | SB 202190 HCl; 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]phenol hydrochloride |
SB 200646 hydrochloride | 143797-62-0 | C15H14N4O.HCl | 302.76 | N-(1-Methyl-1H-indol-5-yl)-N'-3-pyridinylurea; 1-(1-methylindol-5-yl)-3-pyridin-3-ylurea hydrochloride |
Sazetidine A hydrochloride | 1197329-42-2 | C15H20N2O2.HCl | 296.797 | 6-[5-[(2S)-2-Azetidinylmethoxy]-3-pyridinyl]-5-hexyn-1-ol hydrochloride |
Saxitoxin dihydrochloride | 35554-08-6 | |||
Saxalin | 36150-06-8 | C16H15ClO5 | 322.74 | 4-(3-Chloro-2-hydroxy-3-methylbutoxy)-7H-furo[3,2-g][1]benzopyran-7-one; Saxaline |
Saxagliptin-13C3 | 1246812-44-1 | C1513C3H25N3O2 | 318.39 | (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile-13C3 |
Saxagliptin Impurity 7 | 1350800-77-9 | C18H24N2O3 | 316.4 | (1aS,4S,6aR,7aS)-Hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-1H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-3,6-dione |
Saxagliptin Impurity 16 | 709031-43-6 | C23H33N3O4 | 415.54 | N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-Carbamic Acid 1,1-Dimethylethyl Ester; Boc-Saxagliptin |
Saxagliptin Impurity 15 | 1496712-39-0 | C18H27N3O3 | 333.43 | (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo [3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carboxamide; 3-Descarbonitrile 3-Acetamido Saxagliptin |
Saxagliptin Impurity 14 | 197142-36-2 | C11H17NO4 | 227.26 | (1S,3S,5S)-2-Boc-2-azabicyclo[3.1.0]hexane-3-carboxylic Acid; (1S,3S,5S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic Acid |
Sarmentocymarin | 98633-61-5 | C30H46O8 | 534.69 | Sarmentogenin 3-O-sarmentoside; 3-[(3S,5R,8R,9S,10S,11R,13R,14S,17R)-11,14-dihydroxy-3-[(2R,4S,5S,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one |
Sarkomycin | 874-21-5 | C7H8NaO3+ | 163.12600 | |
Sarizotan HCl | 195068-07-6 | C22H22ClFN2O | 384.88 | 1-[(2R)-3,4-dihydro-2H-chromen-2-yl]-N-[[5-(4-fluorophenyl)pyridin-3-yl]methyl]methanamine;hydrochloride; EMD128130; sarizotan; 177976-12-4 (Sarizotan 2 HCl salt); 351862-32-3 (Sarizotan free base); sarizotan hydrochloride |
Sarizotan | 351862-32-3 | C22H21FN2O | 0 | Sarizotan; 467LU0UCUW; CHEMBL220808; UNII-467LU0UCUW; 177975-08-5; AC1OCFD8 |
Sarisan | 18607-93-7 | C11H12O3 | 192.21 | 1,3-Benzodioxole, 5-methoxy-6-(2-propenyl)- |
sarilumab | 1189541-98-7 | C6388H9918N1718O1998S44 | 144130 | Kevzara |
Saridegib | 1037210-93-7 | C29H48N2O3S | 504.768 | IPI 926 |
Saredutant | 142001-63-6 | C31H35Cl2N3O2 | 552.55 | (S)-N-methyl-N(4-(4-acetylamino-4-phenylpiperidino)-2-(3,4-dichlorophenyl)butyl)benzamide |
Sarecycline hydrochloride | 1035979-44-2 | C24H30ClN3O8 | 523.96 | (4S,4aS,5aR,12aS)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-7-((methoxy(methyl)amino)methyl)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride; P005672; P-005672; P 005672; P005672 HCl |
Sardomozide HCl | 138794-73-7 | C11H16Cl2N6 | 303.19 | (E)-2-(4-carbamimidoyl-2,3-dihydro-1H-inden-1-ylidene)hydrazinecarboximidamide dihydrochloride; CGP 48664; CGP-48664; CGP48664; SAM 486A; SAM-486A; SAM486A; Sardomozide |
Sardomozide | 149400-88-4 | C11H14N6 | 230.275 | CGP 48664; CGP-48664; CGP48664; SAM 486A; SAM-486A; SAM486A |
Sarcosine-d3 (methyl-d3) | 118685-91-9 | C3H7NO2 | 92.11 | N-Methyl-d3-glycine |
Sarcandrone B | 1190225-48-9 | C33H30O8 | 554.6 | (2E)-1-{2,6-Dihydroxy-3-[(2R,4R)-7-hydroxy-5,8-dimethoxy-2-phenyl -3,4-dihydro-2H-chromen-4-yl]-4-methoxyphenyl}-3-phenyl-2-propen- 1-one |
Sarcandrolide D | 1207185-03-2 | C37H42O12 | 678.72 | |
Saralasin | 34273-10-4 | C42H65N13O10 | 912 | (Sar1,Val5,Ala8)-Angiotensin II; Aralasin; Saralasinum |
Sarafotoxin S6c | 121695-87-2 | C103H147N27O37S5 | 2516 | |
Sarafotoxin S6b | 116303-65-2 | C110H159N27O34S5 | 2564 | |
Sarafotoxin S6a | 126738-34-9 | C105H156N28O34S5 | 2514.85 | |
Sarafloxacin HCl | 91296-87-6 | C20H17F2N3O3·HCl | 421.83 | Sarafloxacin HCl; Sarafloxacin Hydrochloride; A-56620; A 56620; A56620; |
Saracatinib Difumarate | 893428-72-3 | C27H32ClN5O5.2C4H4O4 | 774.17 | AZD 0530 difumarate; (E)-but-2-enedioic acid;N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine |
Saracatinib | 379231-04-6 | C27H32ClN5O5 | 542.03 | AZD 0530; AZD-0530; AZD0530 |
SAR7334 hydrochloride | 1333207-63-8 | C21H24Cl3N3O | 440.79 | SAR7334; CPA-1588; 4-(((1R,2R)-2-((R)-3-aminopiperidin-1-yl)-2,3-dihydro-1H-inden-1-yl)oxy)-3-chlorobenzonitrile; 1333207-63-8; 1333210-07-3; C21H22ClN3O |
SAR7334 | 1333210-07-3 | C21H22ClN3O | 367.87 | SAR7334; CPA-1588; 4-(((1R,2R)-2-((R)-3-aminopiperidin-1-yl)-2,3-dihydro-1H-inden-1-yl)oxy)-3-chlorobenzonitrile; 1333207-63-8; 1333210-07-3; C21H22ClN3O |
SAR629 | 1221418-42-3 | C20H19F2N5O | 383.40 | (4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)(1H-1,2,4-triazol-1-yl)methanone |
SAR-407899 hydrochloride | 923262-96-8 | C14H17ClN2O2 | 280.75 | 6-(piperidin-4-yloxy)isoquinolin-1(2H)-one hydrochloride; SAR407899; SAR 407899; SAR-407899; SAR407899 HCl |
SAR-407899 | 923359-38-0 | C14H16N2O2 | 244.29 | SAR407899;6-Piperidin-4-yloxy-2H-isoquinolin-1-one;6-(Piperidin-4-yloxy)isoquinolin-1(2H)-one |
SAR-405 | 1523406-39-4 | C19H21ClF3N5O2 | 443.85 | |
SAR260301 | 1260612-13-2 | C19H22N4O3 | 354.41 | SAR-260301; SAR 260301 |
SAR-20347 | 1450881-55-6 | C21H18ClFN4O4 | 444.84 | 2-(2-Chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]-4-oxazolecarboxamide; SAR-20347; SAR 20347; SAR20347. |
SAR191801 | 1234708-04-3 | C22H20N6O3 | 416.43 | HPGDS-IN-1; SCHEMBL2493135; 1234708-04-3; C22H20N6O3; 2-Pyridin-2-yl-pyrimidine-5-carboxylic acid 3-[5-(1-hydroxy-1-methyl-ethyl)-1,2,4-oxadiazol-3-yl]-benzylamide; N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyrimidine-5-c |
SAR156497 | 1256137-14-0 | C27H24N4O4 | 468.5 | |
SAR131675 | 1433953-83-3 | C18H22N4O4 | 358.39 | 2-amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide; SAR131675; SAR 131675; SAR-131675 |
SAR131675 | 1092539-44-0 | C18H22N4O4 | 358.40 | SAR131675; SAR 131675; SAR-131675. |
SAR125844 | 1116743-46-4 | C25H23FN8O2S2 | 550.631 | SAR125844; SAR 125844; SAR-125844 |
SAR-020106 | 1184843-57-9 | C19H19ClN6O | 382.852 | SAR020106; SAR 020106; SAR-20106; SAR20106; SAR 20106. |
Sar-[D-Phe8]-des-Arg9-Bradykinin | 126959-88-4 | C47H66N12O11 | 975.11 | Sar[DPhe8][des-Arg9]BK; [N-methylglycine,D-Phe8,des-Arg9]bradykinin |
SAR 216471 hydrochloride | 1279829-64-9 | C28H31ClN8O3.HCl | 599.51 | 5-Chloro-N-[6-[5-methyl-4-(1-oxobutyl)-1H-pyrazol-1-yl]-3-pyridazinyl]-1-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-1H-indole-3-carboxamide hydrochloride |
Sapropterin Related Compound ((6S)-5,6,7,8-Tetrahydro-L-Biopterin Sulfate) | 109784-74-9 | C9H15N5O3.H2SO4 | 339.33 | (6S)-2-Amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-4-tetrahydro-(1H)-pteridinone sulfate salt |
Saquinavir Mesylate | 149845-06-7 | C39H54N6O8S | 766.95 | Invirase; Ro 31-8959/003 |
Saquinavir | 127779-20-8 | C38H50N6O5 | 670.8 | Invirase; Fortovase; saguinavir; Ro 31-8959; Ro 31 8959; Ro318959 |
Sapropterin dihydrochloride | 69056-38-8 | C9H17Cl2N5O3 | 314.17 | BioMarin T 1401, Biopten, Kuvan, SUN 0588; Shiratori SN 0588; (6R)-5,6,7,8-Tetrahydrobiopterin Dihydrochloride |
Saprisartan | 146623-69-0 | C25H22BrF3N4O4S | 611.43 | Saprisartan; GR-138950; Saprisartan potassium; GR 138950; 3-[[3-bromo-2-[2-(trifluoromethylsulfonylamino)phenyl]-1-benzofuran-5-yl]methyl]-5-cyclopropyl-2-ethylimidazole-4-carboxamide |
Saprirearine | 453518-30-4 | C20H24O2 | 296.4 | (9aS)-7,8,9,9a-Tetrahydro-9a-hydroxy-6-methyl-9-(1-methylethenyl)-2-(1-methylethyl)-1H-phenalen-1-one |
Sappanone A | 104778-14-5 | C16H12O5 | 284.3 | (3E)-3-[(3,4-dihydroxyphenyl)methylidene]-7-hydroxychromen-4-one |
Sappanchalcone | 94344-54-4 | C16H14O5 | 286.3 | (2E)-3-(3,4-Dihydroxyphenyl)-1-(4-hydroxy-2-Methoxyphenyl)-2-propen-1-one; 3-(3,4-Dihydroxyphenyl)-1-(4-hydroxy-2-Methoxyphenyl)prop-2-en-1-one |
Salicylcurcumin | 1236545-54-2 | C19H16O4 | 308.3 | Salicylcurcuminoid; 1,7-Bis(2-hydroxyphenyl)-5-hydroxy-1,4,6-heptatriene-3-one |
Salcaprozate sodium, 99% | 203787-91-1 | C15H20NNaO4 | 301.3134 | |
Salbutamol-D9 acetate | 1781417-68-2 | 2-(tert-Butyl-D9-amino)- 1-(4-hydroxy-3-hydroxy- methylphenyl)ethanol acetate; Albuterol-D9 acetate | ||
Salbutamol Related Compound 3 | 54030-32-9 | C8H8O3 | 152.15 | 3-(Hydroxymethyl)-4-hydroxybenzaldehyde; Salbutamol Impurity Q; |
Salbutamol Related Compound 2 | 51234-21-0 | C9H8O4 | 180.16 | Salbutamol Related Compound 2 |
RS4317 | 91431-42-4 | C16H15ClO6 | 338.74 | (4-acetyloxy-6-chloro-2,3-dimethoxynaphthalen-1-yl) acetate; 6-chloro-2,3-dimethoxynaphthalene-1,4-diol diacetate; lonapalene; RS 43179; RS-43179 |
SAG 21k | 946002-48-8 | C29H28ClF2N3O2S | 556.07 | 3-Chloro-4,7-difluoro-N-[[2-methoxy-5-(4-pyridinyl)phenyl]methyl]-N-trans-4-(methylamino)cyclohexyl]benzo[b]thiophene-2-carboxamide |
SAG | 912545-86-9 | C28H28ClN3OS | 490.06 | Smoothened agonist; 3-chloro-N-[4-(methylamino)cyclohexyl]-N-[(3-pyridin-4-ylphenyl)methyl]-1-benzothiophene-2-carboxamide |
Safrolglycol | 7154-01-0 | C10H12O4 | 196.20 | 3-(3,4-Methylenedioxyphenyl)propane-1,2-diol |
Safranine O, C.I. 50240 | 477-73-6 | CH20H19NCl | 350.85 | |
Safotibant | 633698-99-4 | C25H34N4O5S | 502.63 | N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[(4-methoxy-2,6-dimethylphenyl)sulfonyl-methylamino]ethoxy]-N-methylacetamide;LF-22-0542;LF22-0542;LF-220542;LF220542 |
SAfit2 | 1643125-33-0 | C46H62N2O10 | 802.99 | [(1R)-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2S)-1-[(2S)-2-cyclohexyl-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate |
Safironil | 134377-69-8 | C15H23N3O4 | 309.361 g/mol | Safironil; UNII-CK4M8AX1LN; 134377-69-8; n,n'-bis(3-methoxypropyl)pyridine-2,4-dicarboxamide; AC1Q5FZL; CK4M8AX1LN |
Safingol | 15639-50-6 | C18H39NO2 | 301.5 | L-threo-Dihydrosphingosine; L-threo-Sphinganine; L-threo-2-Amino-1,3-octadecanediol; (2S,3S)-2-aminooctadecane-1,3-diol |
Safinamide-d4 | 1147299-63-5 | C17H15FN2O2D4 | 306.38 | 2S)-2-[({4-[(3-fluorophenyl)(D2)methoxy]phenyl}(D2)methyl)amino]propanamide - See more at: https://www.clearsynth.com/en/CSP06226.html#sthash.si3Klp5O.dpuf |
Safinamide mesylate | 202825-46-5 | C17H19FN2O2.CH4O3S | 398.45 | PNU-151774E,FCE28073 |
Safinamide Impurity 8 | 690969-16-5 | C14H13FO2 | 232.26 | 4-[(3-Fluorophenyl)methoxy]benzenemethanol |
Safinamide Impurity 5 | 1160513-60-9 | C17H18FNO3 | 303.34 | (S)-2-((4-((3-Fluorobenzyl)oxy)benzyl)amino)propanoic acid; (2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanoic acid |
Safinamide Impurity 2 | 1000370-24-0 | C21H16F2O2 | 338.36 | 3-(3-Fluorobenzyl)-4-((3-fluorobenzyl)oxy)benzaldehyde |
Safinamide Impurity 1 | 1000370-27-3 | C24H24F2N2O2 | 410.47 | (S)-2-((3-(3-fluorobenzyl)-4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide - See more at: https://www.clearsynth.com/en/CSP01140.html#sthash.mrupusLk.dpuf |
Safinamide | 133865-89-1 | C17H19FN2O2 | 302.34 | SAFINAMIDE:(S)-(+)-2-[4-(3-FLUOROBENZYLOXY)BENZYLAMINO]PROPANAMIDE METHANSULFONATE;FCE 26743;Safinamide;2(S)-[4-(3-Fluorobenzyloxy)benzylamino]propionamide |
Safflower Yellow | 36338-96-2 | C43H42O22 | 910.78 | Carthamine; (2R,6Z)-6-({(3Z,5S)-2,5-Dihydroxy-3-[(2E)-1-hydroxy-3-(4-hydroxyphenyl)-2-propen-1-ylidene]-4,6-dioxo-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]-1-cyclohexen-1-yl} methylene)-2,5-dihydroxy-4-[(2E)-3-(4-hyd |
safflower seed oil | 8001-23-8 | SAFFLOWER OIL; SAFFLOWER OIL, HIGH OLEIC; SAFFLOWER SEED OIL; carthamustinctoriusoil; fatsandglyceridicoils,safflower; Hi-oleicsaffloweroil; oils,edible:safflower; oils,glyceridic,safflower | ||
Safflor Yellow A | 85532-77-0 | C27H30O15 | 594.52 | |
S-adenosylmethionine | 485-80-3 | C15H23N6O5S+ | 399.44500 | |
Sacubitril Impurity 4 | 149709-44-4 | C22H25NO5 | 383.44 | LBQ-657; LBQ 657; LBQ657; Sacubitrilat; UNII-SPI5PBF81S; LBQ657; CHEMBL417007; (2R,4S)-4-(3-carboxypropanoylamino)-2-methyl-5-(4-phenylphenyl)pentanoic acid |
S-Adenosyl-L-methionine tosylate | 71914-80-2 | C15H23N6O5S.C7H7O3S | 570.63 | S-ADENOSYLMETHIONINE TOSYLATE; S-Adenosyl-L-methionine tosylate; S-(5'-ADENOSYL)-L-METHIONINE P-TOLUENESULFONATE; S-(5'-ADENOSYL)-L-METHIONINE TOLUENE-4-SULFONATE; SAM-E; S-(5'-ADENOSYL)-L-METHIONINETOLUENE- &; S-ADENOSYL-L-METHIONINE (SAME); S-(5''-Ade |
S-Adenosyl-L-methionine p-toluenesulfonate | 52248-03-0 | C15H23N6O5S·C7H7O3S | 570.64 | (3S)-5'-[(3-Amino-3-carboxylatopropyl)methylsulphonio]-5'-deoxyadenosine); SAMe p-toluenesulfonate; S-Adenosylmethionine Tosylate; Adomet; Ademetionine |
S-ADENOSYL-L-METHIONINE IODIDE SALT | 3493-13-8 | C15H23IN6O5S | 526.35 | SAM-E IODIDE SALT; S-(5'-ADENOSYL)-L-METHIONINE IODIDE; S-ADENOSYL-L-METHIONINE IODIDE SALT; S-ADENOSYLMETHIONINE IODIDE; S-ADENOSYL METHIONINE IODIDE SALT; ADENOSYL-L-METHIONINE, S-IODIDE SALT; S-(5'-deoxy-5'-adenosyl)methionine iodide; S-(5'-Adenosyl)-L |
S-ADENOSYL-L-METHIONINE CHLORIDE SALT | 24346-00-7 | C15H23ClN6O5S | 434.9 | ACTIVE METHIONINE; ADENOSYL-L-METHIONINE, S-CHLORIDE SALT; SAM-E CHLORIDE SALT; SAM CHLORIDE; S-ADENOSYL-L-METHIONINE CHLORIDE; S-ADENOSYL-L-METHIONINE CHLORIDE SALT; S-ADENOSYL METHIONINE CHLORIDE SALT; S-(5'-ADENOSYL)-L-METHIONINE CHLORIDE |
S-Adenosyl-L-Methionine | 29908-03-0 | C15H22N6O5S | 398.438 | Ademetionine; AdoMet; MSI-195; MSI 195; MSI195; SAMe; S-adenosylmethionine. Heptral; Gumbaral. S-Adenosyl-L-methionine; S-Adenosyl methionine; SAMe; AdoMet; (2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfoni |
S-ADENOSYL-D-HOMOCYSTEINE | 53276-26-9 | C14H20N6O5S | 384.4108;g/mol | (2R)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]butanoicacid; 53276-26-9; (R)-2-Amino-4-((((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)thio)butanoicacid; S-Adenosyl-D-homocy |
Sacubitril-(2S, 4S)-Isomer | 149709-63-7 | C24H29NO5 | 411.5 | |
Sacubitril sodium | 149690-05-1 | C24H29NO5.Na | 434.47 | sodium 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate; Sacubitril sodium; AHU377; AHU 377; AHU-377; LCZ696. |
Sacubitril Impurity 7 | 1012341-52-4 | C23H29NO4 | 383.49 | |
Sacubitril Impurity 6 | 1012341-54-6 | C23H29NO4 | 383.49 | |
Sacubitril Impurity 5 | 1012341-56-8 | C23H29NO4 | 383.49 | |
Sacubitril Impurity 3 | 1038925-00-6 | C18H19NO | 265.36 | (3S,5S)-5-[(Biphenyl-4-yl)methyl]-3-methylpyrrolidin-2-one; |
Sacubitril Enantiomer | 761373-05-1 | C24H29NO5 | 411.5 | |
S-(1,2-Dichlorovinyl)-Glutathione | 96614-59-4 | C12H17Cl2N3O6S | 402.26 | |
S,S-exo-lurasidone hydrochloride | 139563-18-1 | C28H37ClN4O2S | 529.137 | (3aR,4S,7R,7aS)-2-{(1S,2S)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylMethyl]cyclohexylMethyl}hexahydro-4,7-Methano-2H-isoindole-1,3-dione hydrochloride |
S,S-Diphenylsulfimide | 36744-90-8 | C12H11NS | 201.29 | imino(diphenyl)-$l^{4}-sulfane;S,S-Diphenylsulfilimine;S,S-DIPHENYLSULFIMIDE;36744-90-8;LEXXWUCMDYEREL-UHFFFAOYSA-N;S,S-Diphenylsulphimine |
S,S-Atorvastatin | 110862-48-1 | C33H35FN2O5 | 558.65 | (1betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (R*,R*)- |
S,N-Diacetyl-L-cysteine ethyl ester | 19547-89-8 | C9H15NO4S | 233.28 | S,N-Diacetyl-L-cysteine ethyl ester; S,N-Diacetylcysteine monoethyl ester |
S, S-Isovalganciclovir Impurity | 1401562-13-7 | C14H23N6O5Cl | 390.83 | (S,S)-Iso Valganciclovir Hydrochloride; (2S)-3-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-L-valine 2-Hydroxypropyl Ester Hydrochloride |
S, R-Isovalganciclovir Impurity | 1356932-18-7 | C14H22N6O5 | 354.36 | (R,S)-Iso Valganciclovir; (R)-[(S)-3-[(2-Amino-6-oxo-1,6-dihydropurin-9-yl)methoxy)-2-hydroxypropyl)-2,3-dimethylbutanoate |
S-(TRIFLUOROMETHYL)DIBENZOTHIOPHENIUM-3-SULFONATEETHANOLATE | 160656-62-2 | C15H13F3O4S2 | 378.39 | |
S-(TRIFLUOROMETHYL)-3,7-DINITRODIBENZOTHIOPHENIUM TRIFLUOROMETHANESULFONATE | 129922-37-8 | C14H6F6N2O7S2 | 492.33 | S-(TRIFLUOROMETHYL)-3,7-DINITRODIBENZOTHIOPHENIUM TRIFLUOROMETHANESULFONATE; S-(TRIFLUOROMETHYL)-3,7-DINITRODIBENZOTHIOPHENIUM TRIFLUOROMETHANESULPHONATE |
S-(Trichlorovinyl)-L-cysteine | 98025-31-1 | C5H6Cl3NO2S | 250.53 | S-(1,2,2-Trichlorovinyl)-L-cysteine; S-(Trichloroethenyl)-L-cysteine; L-3-(Trichlorovinylthio)-alanine; S-(1,2,2-Trichloroethenyl)-L-cysteine |
S-(Methylthio) hexanoate | 20756-86-9 | C7H14OS | 162.24986 | Methyl-6-Mercaptohexanoate; Hexanoic acid, 6-mercapto-, methyl ester |
S-(5'-Adenosyl)-L-methionine chloride dihydrochloride | 86867-01-8 | C15H23ClN6O5S·2HCl | 507.82 | SAM chloride dihydrochloride; Active methionine; AdoMet |
S-(5-(Acetylamino)-2-hydroxyphenyl)-L-cysteine | 53446-10-9 | C11H14N2O4S | 384.33 | S-(5-(Acetylamino)-2-hydroxyphenyl)-L-cysteine; 3-Cysteinylacetaminophen trifluoroacetic acid salt |
S-(4-Nitrophenyl)mercapturic acid | 91088-55-0 | C11H12N2O5S | 284.29 | N-Acetyl-S-(4-nitrophenyl)-L-cysteine; N-Acetyl-3-[(p-nitrophenyl)thio]alanine |
S-(4,5-dihydro-2-methyl-3-furyl) ethanethioate | 26486-14-6 | C7H10O2S | 158.22 | S-(4,5-Dihydro-2-methyl-3-furyl) ethanethioate; 2-Methyl-4,5-dihydrofuran-3-thiol acetate |
S-(3-carbamoylsulfanyl-2-dimethylaminopropyl) aminomethanethioate | 15263-53-3 | C7H15N3O2S2 | 237.35 | 2-dimethylamino-1,3-bis(carbamoylthio)propane; carbamicacid,thio-,s,s'-(2-(dimethylamino)trimethylene)ester; carbamothioicacid,s,s'-(2-(dimethylamino)-1,3-propanediyl)ester; s,s'-(2-(dimethylamino)-1,3-propanediyl)dicarbamothioate; sanvex; t-1258 |
S-(2-diethylaminoethyl) 4-aminobenzenecarbothioate | 120-49-0 | C13H20N2OS | 252.376 g/mol | |
S-(2-acetamidoethyl) 3-oxobutanethioate | 23255-41-6 | C8H13NO3S | 203.259 g/mol | |
S-(2,5-Dimethyl-3-furyl) 3-methylbutanethioate | 55764-28-8 | C11H16O2S | 212.311 | S-(2,5-dimethyl-3-furyl) 3-methylbutanethioate; Butanethioic acid, 3-methyl-, S-(2,5-dimethyl-3-furanyl) ester; 2,5-DIMETHYL-3-FURANTHIOISOVALERATE; 2,5-DIMETHYL-3-THIOISOVALERYLFURAN; 3-Methylthiobutyric acid S-(2,5-dimethyl-3-furyl) ester |
S-(2,4-DINITROPHENYL)-GLUTATHIONE | 26289-39-4 | C16H19N5O10S | 473.42 | |
S-(1, 2, 2-Trichlorovinyl)-Glutathione | 111574-85-7 | C12H16Cl3N3O6S | 436.70 | |
S(+)--Vigabatrin | 74046-07-4 | C6H11NO2 | 129.16 | S(+)--Vinyl GABA, S(+)-4-Aminohexenoic acid |
S-(+)-O-Desmethyl-Venlafaxine d6 | 1062609-99-7 | C16H19D6NO2 | 269.37 | |
S(-)-N,N-dimethyl-1-ferrocenylethylamine | 31886-57-4 | C14H19FeN | 257.15 | (S)-(-)-[1-(DIMETHYLAMINO)ETHYL]FERROCENE; (S)-(-)-N,N-DIMETHYL-1-FERROCENYLETHYLAMINE; (S)-(-)-N,N-Dimethyl-1-ferroceneylethylamine; (S)-alpha-(N,N-Dimethylamino)ethylferrocene,; (S)-(-)-N N-DIMETHYL-1-FERROCENYL- &; Ferrocene, (1S)-1-(dimethylamino) |
S-(-)-Etomidate | 56649-47-9 | C14H16N2O2 | 244.30 | 1-[(1S)-1-Phenylethyl]-1H-Imidazole-5-carboxylic Acid Ethyl Ester; (S)-1-(1-Phenylethyl)-,1H-imidazole-5-carboxylic Acid Ethyl Ester; |
S-(-)-Carvedilol | 95094-00-1 | C24H26N2O4 | 406.49 | (-)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol; (-)-Carvedilol; (S)-Carvedilol; |
S(-)-BAY K 8644 | 98625-26-4 | C16H15F3N2O4 | 356.30 | Methyl (4S)-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate;Bay-K-8644 (S)-(-)-;(S)-(-)-Bay-K-8644;(4S)-1,4-Dihydro-2,6-dimethyl-5-nitro-4-(2-trifluoromethyl)phenyl)-3-pyridinecarboxylicacidmethylester;S-(-)-1,4-dihydr |
S-(-)-2,2-DIBROMO-1,1'-BINAPHTHYL | 150024-49-0 | C20H13Br2 | 413.12522 | S-(-)-2,2-DIBROMO-1,1'-BINAPHTHYL |
S 9947 | 332378-43-5 | C29H27N3O3 | 465.54 | |
S 5751 | 209268-36-0 | C25H31NO4S | 441.58 | (Z)-7-[(1S,3S,4R,5R)-4-[(5-hydroxy-1-benzothiophene-3-carbonyl)amino]-6,6-dimethyl-3-bicyclo[3.1.1]heptanyl]hept-5-enoic acid |
S 38093 | 862896-30-8 | C17H24N2O2 | 288.38 | S-38093; S38093; 4-[3-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)propoxy]benzamide |
S 33138 | 245514-32-3 | C22H23N3O2 | 361.44 | N-[4-[2-[(3aS,9bR)-8-cyano-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]ethyl]phenyl]acetamide; S33138; 245514-32-3; S-33138; S33138; CHEMBL62823 |
S 32826 | 1103672-43-0 | C21H34NO4PNa2 | 441.45 | [4-(Tetradecanoylamino)benzyl]phosphonic acid disodium salt |
S 32212 hydrochloride | 847871-78-7 | C25H28N4O2.HCl | 452.98 | 1,2-Dihydro-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-3H-benz[e]indole-3-carboxamide hydrochloride |
S 25585 | 263849-50-9 | C22H23F3N4O6S | 528.5 | 1-Benzoyl-2-[[trans-4-[[[[2-nitro-4-(trifluoromethyl)phenyl]sulfonyl]amino]methyl]cyclohexyl]carbonyl]hydrazine; N-[[4-(benzamidocarbamoyl)cyclohexyl]methyl]-2-nitro-4-(trifluoromethyl)benzenesulfonamide |
S 24795 | 304679-75-2 | C14H13BrINO | 418.07 | 2-[2-(4-Bromophenyl)-2-oxoethyl]-1-methylpyridinium iodide; 1-(4-bromophenyl)-2-(1-methylpyridin-1-ium-2-yl)ethanone;iodide |
S 2101 | 1239262-36-2 | C16H15F2NO.HCl | 311.75 | (1R,2S)-rel-2-[3,5-Difluoro-2-(phenylmethoxy)phenyl]cycloprpanamine hydrochloride; HY-110277 |
S 18986 | 175340-20-2 | C10H12N2O2S | 224.28 | (3aS)-2,3,3a,4-Tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazine-5,5-dioxide |
S 14506 hydrochloride | 286369-38-8 | C24H26FN3O2.HCl | 443.94 | 4-Fluoro-N-[2-[4-(7-methoxy-1-naphthalenyl)-1-piperazinyl]ethyl]benzamide hydrochloride |
S 14506 | 135722-25-7 | C24H26FN3O2 | 407.48 | S-14506; 4-fluoro-N-[2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl]benzamide |
S 12 | 258264-62-9 | C17H12BrNO5 | 390.18 | NSC201630; MLS000029787; SMR000010018; 3-[2-(1,3-benzodioxol-5-yl)-2-oxoethyl]-5-bromo-3-hydroxy-1,3-dihydro-2H-indol-2-one |
S 07662 | 883226-64-0 | C16H16N2O2S | 300.38 | N-[(2-Methyl-3-benzofuranyl)methyl]-N'-(2-thienylmethyl)urea; 1-[(2-methyl-1-benzofuran-3-yl)methyl]-3-(thiophen-2-ylmethyl)urea |
Ruxolitinib | 941678-49-5 | C17H18N6 | 306.37 | INCB018424; INCB-018424; (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile |
Rutinulose | 1360593-47-0 | C12H22O10 | 326.30 | 6-O-(a-LRhamnopyranosyl)-D-glucopyranose; 6-O-(6-Deoxy-a-L-mannopyranosyl)-D-glucopyranose |
Rutinose | 90-74-4 | C12H22O10 | 326.3 | 6-O-(Deoxy-a-L-mannopyranosyl)-D-glucopyranose; 6-O-(a-L-Rhamnopyranosyl)-D-glucopyranose |
Rutin trihydrate | 250249-75-3 | C27H30O16 3H2O | 664.56 | Quercetin-3-rutinoside hydrate; 3-[[6-O-(6-Deoxy-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-4H-1-benzopyran-4-one; Vitamin P hydrate; (+)-Rutin trihydrate |
Rutin sulfate | 12768-44-4 | C27H30O16.H2SO4 | 708.60 | rutin sulfate; 3-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one sulfate; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-o-(6-deoxy-alpha-L-mannopyranosyl)-beta-D |
RUTIN HYDRATE 95 | 207671-50-9 | 0 | RUTIN HYDRATE 95; RUTIN HYDRATE 95% | |
Ruthenium,dichloro[[2-(1-methylethoxy-kO)phenyl]methylene-kC](tricyclohexylphosphine)-,(SP-5-41)- | 203714-71-0 | C28H45 Cl2 O P Ru | 600.61 | RUTHENIUM, DICHLORO[[2-(1-METHYLETHOXY)PHENYL]METHYLENE](TRICYCLOHEXYLPHOSPHINE); DICHLORO(O-ISOPROPOXYPHENYLMETHYLENE)(TRICYCLOHEXYLPHOSPHINE)RUTHENIUM(II); HOVEYDA-GRUBBS CATALYST 1ST GENERATION; Dichloro[[2-(1-methylethoxy-O)phenyl]methylene](tricycloh |
Ruthenium,[N-[(1S,2S)-2-(amino-kN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-kN]chloro[(1,2,3,4,5,6-h)-1-methyl-4-(1-methylethyl)benzene]- | 192139-90-5 | C31H35 Cl N2 O2 Ru S | 0 | (S,S)-N-(p-Toluenesulfonyl)-1,2-diphenylethanediamine(chloro)(p-cymene)ruthenium(II); [N-[(1S,2S)-2-(Amino-KN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-KN]chloro[(1,2,3,4,5,6-η:)-1-methyl-4-(1-methylethyl)benzene]-ruthenium; RuCl(p-cymene)[(S,S |
Ruthenium(III) chloride trihydrate | 13815-94-6 | RuCl3.3(H2O) | 261.47 | RUTHENIUM(III) CHLORIDE-3-HYDRATE; RUTHENIUM(III) CHLORIDE TRIHYDRATE; RUTHENIUM CHLORIDE, HYDRATED; RutheniumTrichloridePuriss; RUTHENIUM TRICHLORIDE TRIHYDRATE pure; Rutheniumchloride.trihydrate |
Ruthenium(III) chloride hydrate | 14898-67-0 | RuCl3 | 207.43 | RUTHENIUM(+3)CHLORIDE HYDRATE; RUTHENIUM CHLORIDE, HYDROUS; RUTHENIUM(III) CHLORIDE HYDRATE; RUTHENIUM(III) CHLORIDE N-HYDRATE; RUTHENIUM(III) CHLORIDE; RUTHENIUM TRICHLORIDE HYDRATE; RUTHENIUM TRICHLORIDE N-HYDRATE; RutheniumchloridehydrateRu |
Ruthenium(III) chloride | 10049-08-8 | RuCl3 | 207.43 | RUTHENIUM TRICHLORIDE; Ruthenium triehloride; Ruthenic chloride; RUTHENIUM CHLORIDE; RUTHENIUM CHLORIDE (TRI); Ruthenium(III)trichloride |
Roxindole hydrochloride | 108050-82-4 | C23H26N2O.HCl | 382.93 | 3-[4-(3,6-Dihydro-4-phenyl-1(2H)-pyridinyl)butyl]-1H-indol-5-ol hydrochloride |
Roxatidine Impurity 2 | 73278-98-5 | C15H24N2O | 248.37 | |
Roxatidine Acetate HCl | 93793-83-0 | C19H29ClN2O4 | 384.9 | Roxatidine Acetate Hydrochloride; ROXATIDINE ACETATE HCl; Gastralgin; Altat; Roxit; HOE 760; HOE760; HOE-760; N-(3-(3-(N(1)-piperidinylmethyl)phenoxy)propyl)acetoxyacetamide; TZU 0460;TZU-0460; TZU0460 |
Roxatidine | 78273-80-0 | C17H26N2O3 | 306.41 | |
Rotundine | 483-14-7 | C21H25NO4 | 355.43 | (13aS)-5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo[a,g]quinolizine; O,O-Dimethyl-N-demethyl-cyclanoline; Gindarine; (-)-2,3,9,10-Tetramethoxyberbine; (-)-Corydalis B; (-)-S-Tetrahydropalmatine; (-)-Tetrahydropalmatine; (S)-Tetrahydropalmatine; |
Rolofylline metabolite M1-trans | 160943-06-6 | C20H28N4O3 | 372.46 | |
Rolofylline metabolite M1-cis | 161167-65-3 | C20H28N4O3 | 372.46 | |
Rolodine | 1866-43-9 | C14H14N4 | 238.293 | Rolodine; BW 58 271; 2-Methyl-N-benzyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine; 4-(Benzylamino)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine; NSC-106570 |
rolitetracycline | 751-97-3 | C27H33N3O8 | 527.57 | (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1, |
Rolipram | 61413-54-5 | C16H21NO3 | 275.34 | ZK-62711; SB 95952; 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one |
Rolapitant (1S,2S,3S)-Isomer | 1214741-27-1 | C25H26F6N2O2 | 500.49 | |
Rifampicin Quinone | 13983-13-6 | C43H56N4O12 | 820.95 | 1,4-Dideoxy-1,4-dihydro-3-[(E)-[(4-methyl-1-piperazinyl)imino]methyl]-1,4-dioxo-Rifamycin; Rifampin Quinone; 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino |
Rifampicin N-Oxide | 125833-03-6 | C43H58N4O13 | 838.96 | 3-[[(4-Methyl-4-oxido-1-piperazinyl)imino]methyl]rifamycin; 3-[[(4-methyl-1-piperazinyl)imino]methyl]rifamycin N-4'-Oxide; |
Rifalazil | 129791-92-0 | C51H64N4O13 | 941.08 | RIFALAZIL; KRM 1648; 3'-Hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin; 5,12-Dihydroxy-2,4-dimethyl-10-[4-(2-methyl-propyl)-l-piperazinyl]-2,7-[oxy(5-acetoxy-7,9-dihydroxy-3-methoxy-4,6,8,10,14-pentamethyl-15-oxo-l,ll,13-pentadecatriene-l,15-diyl) |
Riboflavin 5'-(Dihydrogen Phosphate) Monosodium Salt Dihydrate | 6184-17-4 | C17H20N4O9P. Na. 2 H2O | 478.33 | |
Riboflavin-5'-Phosphate Sodium | 130-40-5 | C17H20N4NaO9P | 478.33 | Flavin Mononucleotide; Riboflavin sodium phosphate |
Rengyol | 93675-85-5 | C8H16O3 | 160.2 | trans-1-(2-Hydroxyethyl)-1,4-cyclohexanediol |
Rengynic acid | 517883-38-4 | C8H14O4 | 174.2 | (cis-1,4-Dihydroxycyclohexyl)acetic acid |
Reneilmol | 260968-11-4 | C15H28O3 | 256.386 | 6,7,10-Isodaucanetriol; (3S,3aS,4R,5S,8R,8aR)-5,8a-dimethyl-3-propan-2-yl-1,2,3,3a,4,6,7,8-octahydroazulene-4,5,8-triol |
REMOXIPRIDE HYDROCHLORIDE | 73220-03-8 | C16H24BrClN2O3 | 407.73 | Remoxipride Hydrochloride; Remoxipride HCl; Roxiam; A 33547 hydrochloride; UNII-QS4S72U30K; QS4S72U30K; Remoxipride Hydrochloride Anhydrous ; Remoxipride Monohydrochloride; Remoxipride Monohydrochloride Monohydrate; Remoxipride Monohydrochloride;3-bromo-N |
Remogliflozin etabonate | 442201-24-3 | C26H38N2O9 | 522.59 | GSK189075A; GSK-189075A; GSK 189075A; GSK189075; GSK-189075; GSK 189075; Remogliflozin etabonate.beta-D-Glucopyranoside, 5-methyl-4-((4-(1-methylethoxy)phenyl)methyl)-1-(1-methylethyl)-1H-pyrazol-3-yl, 6-(ethyl carbonate); |
Remogliflozin | 329045-45-6 | C23H34N2O7 | 450.53 | Remogliflozin A; Remogliflozin - GSK 189074; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[5-methyl-1-propan-2-yl-4-[(4-propan-2-yloxyphenyl)methyl]pyrazol-3-yl]oxyoxane-3,4,5-triol |
RCM 1 | 339163-65-4 | C20H12N2OS4 | 424.58 | RCM1; RCM 1; 2-[[2-Oxo-2-(2-thienyl)ethyl]thio]-4,6-di-2-thienyl-3-pyridinecarbonitrile |
RE-0004095 (PS701685) | 1399412-15-7 | C32H38N4O6S | 606.73 | |
RE-0004090 (PS360814) | 254737-96-7 | C30H34N4O5S | 562.68 | |
R-Doxylamine | 1391849-33-4 | C17H22N2O | 270.37 | N,N-Dimethyl-2-[(1R)-1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine; (R)-N,N-Dimethyl-2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethanamine |
R-Doxazosin | 70918-17-1 | C23H25N5O5 | 451.49 | (R)-1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-piperazine |
RD3-0028 | 3886-39-3 | C8H8S2 | 168.28 | 1,4-dihydro-2,3-benzodithiine; 1,4-dihydro-2,3-benzodithiin |
Quinic Acid | 77-95-2 | C7H12O6 | 192.17 | 1,3,4,5-tetrahydroxy-,[1R-(1-.alpha.,3-.alpha.,4-.alpha.,5-.beta.)]-Cyclohexanecarboxylicacid; 3,4,5-tetrahydroxy-(-)-cyclohexanecarboxylicaci; 5-beta))-h; 5beta)]-alph; Chinasaure; Cyclohexanecarboxylicacid,1,3,4,5-tetrahydroxy-,(-)-; cyclohexanecarboxyl |
Quinfamide | 62265-68-3 | C16H13Cl2NO4 | 354.19 | 2-Furancarboxylic Acid 1-(2,2-Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinyl Ester; 1-(Dichloroacetyl)-6-(2-furoyloxy)-1,2,3,4-tetrahydro-6-quinoline; Amenide; Amenox; Win 40014; |
ruthenium(+3) cation heptaacetate | 55466-76-7 | C14H21O14Ru3+2 | 716.517 | |
RUTHENIUM SULFATE | 41860-99-5 | O4RuS | 197.13 | RUTHENIUM SULFATE |
Ruthenium on alumina powder | 7440-18-8 | Ru | 101.07 | Ru; Rutherium black; RUTHENIUM METAL; RUTHENIUM SINGLE ELEMENT STANDARD; RUTHENIUM SPONGE; RUTHENIUM STANDARD; RUTHENIUM PLASMA EMISSION SPECTROSCOPY STANDARD; RUTHENIUM PLASMA EMISSION STANDARD |
RuBi-GABA | 1028141-88-9 | C42H39F6N5O2P2Ru | 922.8 | (bis(2,2'-Bipyridine-N,N')triphenylphosphine)-4-aminobutyric acid ruthenium hexafluorophosphate complex |
RU-SKI 43 | 1043797-53-0 | C22H30N2O2S | 386.55 | |
Rurioctocog alfa pegol | 1417412-83-9 | C21H40N4O10 | 508.569 | Adynovate; (2S)-2-amino-6-[4-[1,3-bis(2-methoxyethylcarbamoyloxy)propan-2-yloxy]butanoylamino]hexanoic acid |
Rupintrivir | 223537-30-2 | C31H39FN4O7 | 598.66 | Ethyl (2E,4S)-4-[[(2R,5S)-2-[(4-fluorophenyl)methyl]-6-methyl-5-[[(5-methyl-3-isoxazolyl)carbonyl]amino]-1,4-dioxoheptyl]amino]-5-[(3S)-2-oxo-3-pyrrolidinyl]-2-pentenoate; AG-7088; AG7088; AG 7088 |
Rupestonic acid | 115473-63-7 | C15H20O3 | 248.32 | |
Rupesin E | 924901-58-6 | C15H22O5 | 282.33 | |
Rupatadine trihydrochloride | 156611-76-6 | C26H26ClN3.3HCl | 525.339 | Rupatadine HCl; 8-chloro-11-[1-[(5-methylpyridin-3-yl)methyl]piperidin-4-ylidene]-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridine;trihydrochloride |
Rupatadine Impurity C | 1224515-72-3 | C45H43Cl2N5 | 724.78 | 11,11'-[3,5-Pyridinediylbis(methylene-1,4-piperidinediyl)]bis[8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
Rupatadine Impurity B | 156523-04-5 | C26H24ClN3O | 429.95 | (4-(8-chloro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(6H)-ylidene)piperidin-1-yl)(5-methylpyridin-3-yl)methanone |
Rupatadine Impurity 2 | 1422960-88-0 | C33H34ClN4 | 522.12 | (5-Methyl-3-pyridinyl)methyl Rupatadine |
Rubifolic acid | 80489-65-2 | C30H48O4 | 472.71 | 30-Hydroxyursolic acid |
RUBIDIUM PERMANGANATE | 13465-49-1 | O4MnRb | 204.41 | RUBIDIUM PERMANGANATE; Permanganicacid(HMnO4),rubidiumsalt; Permanganic acid rubidium salt |
Rubidium nitrate | 13126-12-0 | RbNO3 | 147.47 | Nitric acid, rubidium salt; nitricacid,rubidiumsalt; RUBIDIUM NITRATE; RUBIDIUM ATOMIC SPECTROSCOPY STANDARD SOLUTION; RUBDIUM NITRATE; Rubidiumnitratewhitextl; RUBIDIUM NITRATE, 99.99%; RUBIDIUM NITRATE, 99.7% |
Rubidium carbonate | 584-09-8 | Rb2CO3 | 230.94 | Carbonicacid,dirubidiumsalt; dirubidiumcarbonate; dirubidiummonocarbonate; RUBIDIUM CARBONATE; Rubidium carbonate, 99.8% metals basis; RUBIDIUM CARBONATE (99%-RB); RUBIDIUM CARBONATE (99.8+%-RB); Rubidiumcarbonate; 99.99% |
RuBi-4AP | 851956-02-0 | C30H28Cl2N8Ru | 672.58 | bis(2,2'-Bipyridine-N,N')bis(4-aminopyridine-N1) ruthenium(2+) dichloride complex; Rubi-4-aminopyridine |
RSV-IN-1 | 861139-16-4 | C20H21N5O4S | 427.48 | N-(2-hydroxyethyl)-4-methoxy-N-methyl-3-(6-methyl-[1,2,4]triazolo[3,4-a]phthalazin-3-yl)benzenesulfonamide |
Rubanthrone A | 441764-20-1 | C17H14O10 | 378.30 | |
RU-24969 | 66611-26-5 | C14H16N2O | 228.29 | 5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole;3-(1,2,3,6-Tetrahydropyridine-4-yl)-5-methoxy-1H-indole;5-Methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole succinate |
RU(PHEN)3CL2 | 14323-06-9 | C30H24C12N6Ru | 640.54 | |
RU 58841 | 154992-24-2 | C17H18F3N3O3 | 369.34 | 4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile 4-(4,4-dimethyl-2,5-dioxo-3-(4-hydroxybutyl)-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile Benzonitrile, 4-(3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-im |
RU 24969 hemisuccinate | 66611-27-6 | 287.34 | 5-Methoxy-3-(1,2,5,6-tetrahydro-4-pyridinyl)-1H-indole hemisuccinate | |
RU 24213 | 67383-44-2 | C19H25NO.HCl | 319.87 | 3-[2-[2-phenylethyl(propyl)amino]ethyl]phenol hydrochloride |
R-Tirofiban | 158808-86-7 | C22H36N2O5S | 440.61 | N-(Butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-D-tyrosine |
R-Thalidomide | 2614-06-4 | C13H10N2O4 | 258.24 | |
RTA-408 | 1474034-05-3 | C33H44F2N2O3 | 554.723 | Propanamide, N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoro- |
RSVA 405 | 140405-36-3 | C17H20N4O2 | 312.37 | 2-[[4-(Diethylamino)-2-hydroxyphenyl]methylene]hydrazide-4-pyridinecarboxylic acid; RSVA405 |
RSV604 racemate | 676128-62-4 | C22H17FN4O2 | 388.39 | |
RSV604 R enantiomer | 932108-20-8 | C22H17FN4O2 | 388.39 | |
RSV-604 | 5676128-63-5 | C22H17FN4O2 | 388.4 | (S)-1-(2-Fluorophenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea, RSV-604 |
RSV604 | 676128-63-5 | C22H17FN4O2 | 388.39 | 1-(2-Fluorophenyl)-3-[(3S)-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]urea; |
RSPACER CEP | 159299-31-7 | C41H59N2O7PSi | 750.98 | RSPACER CEP |
RSM-932A | 850807-63-5 | C46H38Br2Cl2N4 | 877.55 | RSM932A; TCD 717;1,1'-([1,1'-biphenyl]-4,4'-diylbis(methylene))bis(4-((4-chlorophenyl)(methyl)amino)quinolin-1-ium) bromide |
RSC-3388 | 337307-06-9 | C49H44F2N4O5S | 839 | N-[[1-[2-(2,4-difluorobenzoyl)benzoyl]-4-[2-methylpropyl-[(2-phenylphenyl)methyl]amino]pyrrolidin-2-yl]methyl]-3-[4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]prop-2-enamide |
RSC133 | 1418131-46-0 | |||
RS-127445 | 199864-87-3 | C17H16FN3 | 281.33 | MT500 |
RS-102221 | 185376-97-0 | C27H31F3N4O7S | 612.621 | RS-102221; RS 102221; RS102221 |
RS-1 | 312756-74-4 | C20H16Br2N2O3S | 524.23 | 3-(benzylsulfamoyl)-4-bromo-N-(4-bromophenyl)benzamide 3-((benzylamino)sulfonyl)-4-bromo-N-(4-bromophenyl)benzamide RS-1 compound |
RS 79948 hydrochloride | 186002-54-0 | C19H28N2O3S.HCl | 400.96 | (8aR,12aS,13aS)-5,8,8a,9,10,11,12,12a,13,13a-dechydro-3-methoxy-12-(ethylsulfonyl)-6H-isoquino[2,1-g][1,6]naphthyridine hydrochloride |
RS 67506 hydrochloride | 168986-61-6 | C18H28ClN3O4S.HCl | 454.41 | 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-2-methylsulphonylamino)ethyl-4-piperidinyl]-1-propanone hydrochloride; RS67506 HCl; RS67506 HCl; RS67506; RS 67506; RS-67506 |
RS 67333 hydrochloride | 168986-60-5 | C19H29ClN2O2.HCl | 389.36 | 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-butyl-4-piperidinyl]-1-propanone hydrochloride; RS 67333 HCl; RS 67333; RS67333; RS-67333 |
RS 56812 hydrochloride | 143339-12-2 | C18H21N3O2.HCl | 347.84 | (R)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-(1-methyl-1H-indol-3-yl)-2-(1-methyl-1H-indol-3-yl)-2-oxoacetamide hydrochloride |
RS 504393 | 300816-15-3 | C25H27N3O3 | 417.5 | 6-methyl-1'-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one |
Rp-cCMPS | 87063-79-4 | C9H11N3O6PS · Na | 343.2 | Cytidine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Rp-cAMPS, triethyl ammonium salt | 151837-09-1 | C10H11N5O5PS · C6H16N | 446.5 | Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, triethyl ammonium salt |
Rp-cAMPS, sodium salt | 73208-40-9 | C10H11N5O5PS · Na | 367.3 | Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
R-Palmitoyl-(2-methyl) ethanolamide | 179951-56-5 | C19H39NO2 | 313.5 | RP-2ME; (R)-palmitic monoisopropanolamide; N-[(2R)-2-hydroxypropyl]hexadecanamide |
Rp-8-PIP-cAMPS | 156816-36-3 | C15H20N6O5PS · Na | 450.4 | 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, sodium salt |
Roxatidine oxalate | 110925-92-3 | C19H28N2O7 | 396.43 | ROXATIDINE OXALATE; Roxtidine oxalate |
Rp,Rp-c-diGMPSS | 1259875-41-6 | C20H24N10O12P2S2 (free acid) | 722.6 (free acid) | Cyclic diguanosine monophosphorodithioate, Rp- isomers, sodium salt |
Rp-2',3'-cAMPS | 118275-99-3 | C10H11O5N5PS · Na | 367.3 | Adenosine- 2', 3'- cyclic monophosphorothioate, endo / Rp- isomer, sodium salt |
Rp,Sp-c-diGMPSS | 1259875-47-2 | C20H24N10O12P2S2 (free acid) | 722.6 (free acid) | Cyclic diguanosine monophosphorodithioate, Rp- / Sp- isomers, sodium salt |
Roxithromycin Impurity J | 134834-12-1 | C40H73ClN2O14 | 841.49 | |
Roxithromycin Impurity E | 1460313-66-9 | C40H74N2O15 | 823.04 | (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,Z)-4-(((2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-6-(((2S,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-10-(((2-methoxyethoxy)methoxy)imin |
Roxithromycin Impurity D | 134931-00-3 | C41H76N2O15 | 837.07 | (9Z)-Roxithromycin; (9Z)-9-[O-[(2-Methoxyethoxy)methyl]oxime] Erythromycin; Oxacyclotetradecane Erythromycin Derivative |
Roxithromycin Impurity C | 13127-18-9 | C37H68N2O13 | 748.94 | 9-Erythromycin 9-Oxime; 9-Erythromycin A Oxime; Erythromycin Oxime |
Roxithromycin | 80214-83-1 | C41H76N2O15 | 837.05 | Roxithromycin; Roxithromycinum; RU 28965; RU-28965; RU28965; RU 965; RU-965; RU965; Rulide; |
Rotundifuran | 50656-65-0 | C22H34O4 | 362.5 | |
Rotundatin | 144506-16-1 | C15H14O4 | 258.27 | 2,5,9-Trihydroxy-4-methoxy-9,10-dihydrophenanthrene |
Rotundanonic acid | 173357-19-2 | C30H46O5 | 486.693 | 3-Oxo-19,23-dihydroxyurs-12-ene-28-oic acid |
Rottlerin | 82-08-6 | C30H28O8 | 516.55 | 3'-[(8-Cinnamoyl-5,7-dihydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)methyl]-2',4',6'-trihydroxy-5'-methylacetophenone |
Rotigotine Sulfate | 128478-69-3 | C19H25NO4S2 | 395.45 | (6S)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthalenol 1-(Hydrogen Sulfate); (S)-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]- 1-naphthalenol Hydrogen Sulfate (Ester); |
Rotigotine Hydrochloride | 125572-93-2 | C19H26ClNOS | 351.93 | Rotigotine hydrochloride; Rotigotine HCl; Rotigotine (Hydrochloride); (S)-6-(Propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride; (6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride |
Rotigotine HCl | 102120-99-0 | C19H26ClNOS | 351.93 | 5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthalenol Hydrochloride; |
Rotigotine | 99755-59-6 | C19H25NOS | 315.47 | |
rotigaptide | 355151-12-1 | 0 | rotigaptide | |
Rosuvastatin Substituted Hydroxy Pentenoic Acid | 910867-11-7 | C20H24FN3O5S | 437.49 | |
Rosuvastatin Sodium Salt (Mixture of (3R,5R), (3S,5S), (3R,5S) and (3S,5R) Isomers) | 1007871-86-4 | C22H27FN3O6S. Na | 503.53 | |
Rosuvastatin Sodium Salt | 147098-18-8 | C22H27FN3O6S. Na | 503.53 | 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(N-methyl-N-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid sodium salt |
Rosuvastatin Methyl Ester | 147118-40-9 | C23H30FN3O6S | 495.57 | (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic Acid Methyl Ester; |
Rosuvastatin lactone | 503610-43-3 | C22H26FN3O5S | 463.53 | N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methyl-methanesulfonamide; Rosuvastatin-5S-lactone |
Rosuvastatin Isopentyl Ester | 1197348-98-3 | C27H38FN3O6S | 551.68 | (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic Acid 3-Methylbutyl Ester; |
Rosuvastatin Impurity Sodium Salt (5-Oxo Rosuvastatin Sodium Salt) | 1620823-61-1 | C22H25FN3O6S. Na | 501.51 | |
Rosuvastatin Impurity C | 1422619-13-3 | C22H26FN3O6S | 479.523 | 5-Oxo Rosuvastatin; (3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic Acid; 3-Hydroxy-5-keto Rosuvastatin |
Rosuvastatin Impurity (N-[4-(4-Fluorophenyl)-5-Hydroxymethyl-6-Isopropylpyrimidin-2-yl]-N-Methylmethanesulfonamide) | 147118-36-3 | C16H20FN3O3S | 353.42 | 5-(Hydroxymethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine; 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-n-methylsulfonyl)amino] pyrimidine-5-yl-metrhanol; |
Rosuvastatin Ethyl Ester | 851443-04-4 | C24H32FN3O6S | 509.6 | |
Rosuvastatin EP Impurity I Calcium Salt | 1335110-44-5 | C22H27FN3O6S . 1/2Ca | 500.58 | |
Rosuvastatin Calcium Salt | 147098-20-2 | C22H28FN3O6S.1/2Ca | 500.57 | ZD4522; ZD 4522; ZD-4522 |
Rosuvastatin acyl-b-D-glucuronide | 503610-44-4 | C28H36FN3O12S | 657.66 | |
Rosuvastatin Acetonide | 289042-12-2 | C29H40FN3O6S | 577.72 | (4R,6S)-6-[(1E)-2-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester |
Rosuvastatin 5-Methyl Pyrimidine | 953776-62-0 | C16H20FN3O2S | 337.42 | N-[4-(4-Fluorophenyl)-5-methyl-6-(1-methylethyl)-2-pyrimidinyl]-N-methylmethanesulfonamide |
Rosuvastatin 4,6-Diene Impurity | 1422954-13-9 | C22H26FN3O5S | 463.53 | |
Rosuvastatin 2,6-Diene Lactone Impurity | 1246665-85-9 | C22H24FN3O4S | 445.52 | N-[5-[(1E)-2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethenyl]-4-(4-fluorophenyl)-6-(1-methylethyl)-2-pyrimidinyl]-N-methylmethanesulfonamide |
Rosuvastatin | 287714-41-4 | C22H28FN3O6S | 481.54 | (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid Calcium, Rosuvastatin Crestor rosuvastatin rosuvastatin calcium ZD 4522 ZD4522 |
Rostaporfin | 284041-10-7 | C37H42Cl2N4O2Sn | 764.379 | SnET2; Sn(IV) etiopurpurin; Purlytin; tin ethyl etiopurpurin dichloride; tin etiopurpurin dichloride |
Rostafuroxin | 156722-18-8 | C23H34O4 | 374.521 | PST-2238; PST 2238; (3S,5R,8R,9S,10S,13S,14S,17S)-17-(furan-3-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol |
Rosoxacin | 40034-42-2 | C17H14N2O3 | 294.31 | 1-ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid; PD-107522;Win-35213 |
Rosonabant | 861151-12-4 | C21H21Cl3N4O | 451.78 | E6776; (R)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-4,5-dihydro-1H-pyrazole-3-carboxamide |
Rosmarinic acid racemate | 537-15-5 | C18H16O8 | 360.31 | 3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid |
Rosmarinic acid | 20283-92-5 | C18H16O8 | 360.31 | 3-(3,4-DIHYDROXYPHENYL)ACRYLIC ACID-1-CARBOXY-2-(3,4-DIHYDROXYPHENYL)ETHYL ESTER;3,4-DIHYDROXYCINNAMIC ACID (R)-1-CARBOXY-2-(3,4-DIHYDROXYPHENYL)ETHYL ESTER;[4ar-(4aa,9b,10a,10ab)]-1,3,4,9,10,10a-hexahydro-5,6,9-trihydroxy-1,1-dimethyl-7-(1-methylethyl)-2 |
Rosmanol | 80225-53-2 | C20H26O5 | 346.423 | UNII-F25TV383OC; (4bR,8aS,9S,10S)-3,4,10-Trihydroxy-2-isopropyl-8,8-dimethyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epoxymethano)phenanthren-12-one; AK101906; SCHEMBL459610 |
Roslin-2 | 29574-21-8 | C13H19N4·Br | 311.2 | 1-Benzyl-3,5,7-triaza-1-azoniaadamantane bromide |
Rosin-fumaric acid reaction product | 65997-04-8 | |||
Rosin,polymd. | 65997-05-9 | |||
Rosin | 8050-09-7 | C15H20O6 | 296.32 | |
Rosin | 85026-55-7 | C15H20O6 | (2E)-3-phenylprop-2-en-1-yl beta-D-glucopyranoside | |
Rosiglitazone-d3 | 1132641-22-5 | C18H16D3N3O3S | 360.45 | 5-[[4-[2-((Methyl-d3)-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione; BRL-49653-d3 |
Rosiglitazone sodium | 316371-83-2 | C18H19N3NaO3S | 380.42 | rosiglitazone sodium; 5-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione sodium salt; 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzylidine]-2,4-thiazolidinedione Sodium |
Rosiglitazone potassium salt | 316371-84-3 | C18H18N3O3S·K | 395.5 | 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidin-3-ide-2,4-dione potassium salt |
Rosiglitazone Maleate | 155141-29-0 | C18H19N3O3S.C4H4O4 | 473.5 | Rosiglitazone Maleate; Avandia; Avandaryl; BRL-49653C; BRL49653C; BRL 49653C; BRL-49653-C; |
Rosiglitazone Impurity (5-[4-N-(2-Pyridylamino)ethoxy]benzylidene] thiazolidine-2,4-dione) | 643764-88-9 | C17H15N3O3S | 341.39 | 5-[4-[N-(2-Pyridylamino)ethoxy]benzylidene]thiazolidine-2,4-dione |
Rosiglitazone Impurity (5-(4-Fluorobenzyl)-2,4-thiazolidinedione) | 291536-42-0 | C10H8FNO2S | 225.24 | 5-(4-Fluorobenzyl)-2,4-thiazolidinedione |
Rosiglitazone hydrochloride | 302543-62-0 | C18H19N3O3S.HCl | 393.89 | BRL-49653 HCl |
Rosiglitazone | 122320-73-4 | C18H19N3O3S | 357.43 | Avandia; 5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione; Brl-49653 |
Roseoflavin | 51093-55-1 | C18H23N5O6 | 405.4 | 8-Dimethylaminoriboflavin, Roseoflavine |
Rosenonolactone | 508-71-4 | C20H28O3 | ||
Rosmarinus Officinalis Leaf Extract | 84604-14-8 | 0 | FEMA 2992; ROSEMARY OIL, ARTIFICIAL; ROSEMARY OIL, MORROCAN; ROSEMARY OIL NORTH AFRICAN; ROSEMARY OIL, SPANISH; ROSEMARY OIL SPANISH RECON; ROSEMARY OIL TUNISIAN RECON; ROSEMARY OIL, TUNISIA TYPE | |
Rose, Rosa centifolia, ext. | 84604-12-6 | 0 | Rose, Rosa centifolia, ext.; ROSA CENTIFOLIA FLOWER EXTRACT; ROSEABSOLUTEFRENCH; CABBAGEROSEEXTRACT; Rose, Rosa centifolia, Extrakt; CABBAGE ROSE (ROSA CENTIFOLIA) EXTRACT, CABBAGE ROSE EXTRACT; ROSEWATER ESSENCE; Absolute french rose | |
Rolapitant HCl hydrate | 914462-92-3 | C25H26F6N2O2.ClH.H2O | 554.95 | (5S,8S)-8-(((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one hydrochloride.; SCH619734 SCH-619734; SCH 619734; Rolapitant HCl; Rolapitant hydrochloride, Rolapitant, brand name: Varubi. |
Ropinirole N-Oxide | 1076199-41-1 | C16H24N2O2 | 276.38 | 1,3-Dihydro-4-[2-(oxidodipropylamino)ethyl]-2H-indol-2-one; |
Ropinirole HCl | 91374-20-8 | C16H24N2O·HCl | 296.84 | SKF-101468A |
Ropinirole | 91374-21-9 | C16H24N2O | 260.38 | 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one |
Ropidoxuridine | 93265-81-7 | C9H11IN2O4 | 338.10 | 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone;5-Iodo-2-pyrimidinone-2'-deoxyribose;IPdR;1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one |
Ronopterin | 206885-38-3 | C9H16N6O2 | 240.27 | (1R,2S)-1-[(6R)-2,4-diamino-5,6,7,8-tetrahydropteridin-6-yl]propane-1,2-diol; 4-aminotetrahydrobiopterin |
Ronomilast | 418794-42-0 | C21H13Cl2FN4O2 | 443.25 | AWD 12353; N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-oxoacetamide; |
Ronidazole-D3 | 1015855-87-4 | 2-Carbamoyloxymethyl- 1-methyl-D3-5-nitro-1H- imidazole | ||
Ronidazole | 7681-76-7 | C6H8N4O4 | 200.15 | 1-Methyl-5-nitro-1H-imidazole-2-methanol 2-Carbamate; (1-Methyl-5-nitroimidazol-2-yl)methyl Carbamate; 1-Methyl-2-carbamoyloxymethyl-5 -nitroimidazole; Dugro; MCMN; Ridzol; Ridzol P; Ridzole; Ronida BT; |
Roniciclib | 1223498-69-8 | C18H21F3N4O3S | 430.446 | BAY10-00394; BAY1000394; BAY 1000394. |
Ronacaleret | 753449-67-1 | C25-H31-F2-N-O4 | 447.52 | SB 751689;(R)-3-(3-(3-((1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl)amino)-2-hydroxypropoxy)-4,5-difluorophenyl)propanoic acid;753449-67-1 (HCl salt); |
Romiplostim | 267639-76-9 | |||
Romidepsin | 128517-07-7 | C24H36N4O6S2 | 540.7 | FR 901228, NSC 630176, FK228, Depsipeptide |
Rolapitant (1S,2S,3R)-Isomer | 1214741-29-3 | C25H26F6N2O2 | 500.49 | Rolapitant (1S,2S,3R)-Isomer |
Rolapitant (1S,2R,3S)-Isomer | 1214741-28-2 | C25H26F6N2O2 | 500.49 | |
Rolapitant (1S,2R,3R)-Isomer | 1214741-30-6 | C25H26F6N2O2 | 500.49 | |
Rolapitant (1R,2S,3R)-Isomer | 552292-73-6 | C25H26F6N2O2 | 500.49 | |
Rolapitant (1R,2R,3S)-Isomer | 1214741-25-9 | C25H26F6N2O2 | 500.49 | |
Rolapitant (1R,2R,3R)-Isomer | 1214741-26-0 | C25H26F6N2O2 | 500.49 | |
Roflumilast-d4 N-Oxide | 1794760-31-8 | C17H10Cl2F2N2O4D4 | 423.24 | 3-(Cyclopropylmethoxy-d4)-N-(3,5-dichloro-1-oxido-4-pyridinyl)-4-(difluoromethoxy)benzamide; N-(3,5-Dichloro-1-oxopyridin-4-yl)-4-difluoromethoxy-3-(cyclopropyl-d4) methoxybenzamide |
Roflumilast-d4 | 1398065-69-4 | C17H10Cl2D4F2N2O3 | 407.20 | 3-(Cyclopropyl-d4)methoxy-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide |
Roflumilast-d3 | 1189992-00-4 | C17H11Cl2F2N2O3D3 | 406.23 | 3-{[(1-~2~H)Cyclopropyl(~2~H_2_)methyl]oxy}-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide |
Roflumilast N-Oxide | 292135-78-5 | C17H14Cl2F2N2O4 | 419.21 | 3-(Cyclopropylmethoxy)-N-(3,5-dichloro-1-oxido-4-pyridinyl)-4-(difluoromethoxy)benzamide; N-(3,5-Dichloro-1-oxopyridin-4-yl)-4-difluoromethoxy-3-cyclopropyl- methoxybenzamide; |
RofluMilast interMediate | 162401-62-9 | |||
Roflumilast Impurity H | 162401-30-1 | |||
Roflumilast Impurity E | 1391052-76-8 | |||
Roflumilast Impurity D | 1243391-44-7 | |||
Roflumilast Impurity 1 | 162401-43-6 | C17H14Cl2F2N2O3 | 403.22 | 4-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-3-(difluoromethoxy)benzamide; |
Roflumilast Dimer | 1352122-37-2 | C29H24Cl2F4N2O6 | 643.42 | |
Roflumilast | 162401-32-3 | C17H14Cl2F2N2O3 | 403.207 | BY217; BY-217; BY 217; B 9302-107; B9302-107; B-9302-107; BYK 20869; BYK-20869; BYK20869; Daxas; Daliresp |
Rofecoxib-d5 | 544684-93-7 | C17H9O4SD5 | 319.39 | 4-[4-(Methylsulfonyl)phenyl]-3-(phenyl-d5)-2(5H)-furanone; 3-(4-Methanesulfonylphenyl)-2-(phenyl-d5)-2-buten-4-olide; 3-(Phenyl-d5)-4-[4-(Methylsulfonyl)phenyl]-2(5H)-furanone; |
Rofecoxib | 162011-90-7 | C17H14O4S | 314.4 | MK966; MK966; MK 966; MK0966; MK0966; MK 0966; Rofecoxib; brand name: Vioxx; Ceoxx; Ceeoxx. 4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone |
Roemerine | 548-08-3 | C18H17NO2 | 279.33 | Remerine |
Rocaglamide | 84573-16-0 | C29H31NO7 | 505.56 | (1R,2R,3S,3aR,8bS)-2,3,3a,8b-Tetrahydro-1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-3-phenyl-1H-cyclopenta[b]benzofuran-2-carboxamide;NSC 326408;Roc-A;Rocaglamide A;1H-Cyclopenta(b)benzofuran-2-carboxamide, 2,3,3a,8b-tetrahydro-1,8b-dih |
ROC-325 | 1859141-26-6 | C28H27ClN4OS | 503.06 | ROC 325; ROC325; 1-[2-[2-[(7-chloroquinolin-4-yl)amino]ethyl-methylamino]ethylamino]-4-methylthioxanthen-9-one |
Robustine | 2255-50-7 | C12H9NO3 | 215.205 | 4-Methoxyfuro[2,3-b]quinolin-8-ol; 8-Hydroxydictamnine |
Robustaflavone | 49620-13-5 | C30H18O10 | 538.47 | 6-[5-(5,7-dihydroxy-4-oxo-4H-chromen-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one |
Robtin | 4382-34-7 | C15H12O6 | 288.3 | (2S)-7-Hydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-4H-chromen- 4-one |
Robtein | 2679-65-4 | C15H12O6 | 288.25 | 2',3,4,4',5-Pentahydroxychalcone |
Robotnikinin | 1132653-79-2 | C25H27ClN2O4 | 455 | N-[(4-Chlorophenyl)methyl]-2-(5,12-dioxo-2-phenyl-1-oxa-4-azacyclododec-8-en-6-yl)acetamide |
Robinose | 552-74-9 | C12H22O10 | 326.30 | 6-O-(6-Deoxy-a-L-mannopyranosyl)-b-D-galactopyranose; Rha(a1-6)b-Gal; 6-O-a-rhamnopyranosyl-b-galactopyranoside; Robinobiose |
Robinin | 301-19-9 | C33H40O19 | 740.664 | Kaempferol-3-O-gal-rham-7-O-rham; Kaempferol-3-O-robinoside-7-O-rhamnoside |
Robenacoxib | 220991-32-2 | C16H13F4NO2 | 327.27 | 5-Ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]benzeneacetic Acid; |
RO-9187 | 876708-03-1 | C9H12N6O5 | 284.23 | |
RO9021 | 1446790-62-0 | C18H25N7O | 355.45 | 6-[(1R,2S)-2-Amino-cyclohexylamino]-4-(5,6-dimethyl-pyridin-2-ylamino)-pyridazine-3-carboxylic acid amide |
RO8994 | 1309684-94-3 | C31H31Cl2FN4O4 | 613.51 | RO-8994 |
RO8191 | 691868-88-9 | C14H5F6N5O | 373.2 | Ro 494-8191; 2-[2,4-bis(trifluoromethyl)imidazo[1,2-a]1,8-naphthyridin-8-yl]-1,3,4-oxadiazole; 8-(1,3,4-oxadiazol-2-yl)-2,4-bis(trifluoromethyl)imidazo[1,2-a][1,8]naphthyridine |
RO-5256390 | 1043495-96-0 | C13H18N2O | 218.30 | RO5256390;(S)-4-((S)-2-phenylbutyl)-4,5-dihydrooxazol-2-amine;(4S)-4-[(2S)-2-phenylbutyl]-4,5-dihydro-1,3-oxazol-2-amine |
RO-5203648 | 1043491-54-8 | C9H8Cl2N2O | 231.07 | (4S)-4-(3,4-dichlorophenyl)-4,5-dihydro-1,3-oxazol-2-amine;RO5203648;(S)-4-(3,4-dichlorophenyl)-4,5-dihydrooxazol-2-amine |
Ro5203280 | 1062243-51-9 | C27H35F2N7O3 | 543.62 | Ro5203280; Ro-5203280; Ro 5203280. |
RO5166017 | 1048346-74-2 | C12H17N3O | 219.29 | (4S)-4-[(N-ethylanilino)methyl]-4,5-dihydro-1,3-oxazol-2-amine;RO-5166017;(S)-4-[(ethyl-phenyl-amino)-methyl]-4,5-dihydro-oxazol-2-ylamine |
RO5126766 | 946128-88-7 | C21H18FN5O5S | 471.463 | RO5126766; RO 5126766; RO-5126766; CH5126766; CH-5126766; CH 5126766. |
RO5068760 | 947182-25-4 | C28H27FIN3O6 | 647.442 | RO5068760; RO 5068760; RO-5068760. |
RO5045337 | 939981-39-2 | C38H48Cl2N4O4S | 727.786 | R7112, RG7112, RG 7112; RG-7112; RO5045337; RO 5045337; RO-5045337 |
RO-5028442 | 920022-47-5 | C25H28ClN3O2 | 437.968 | RO 5028442; [6-chloro-1-[2-(dimethylamino)ethyl]indol-3-yl]-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylmethanone |
RO4987655 | 874101-00-5 | C20H19F3IN3O5 | 565.288 | CH4987655; RO4987655. |
RO4929097 | 847925-91-1 | C22H20F5N3O3 | 469.4 | RO-4929097; 2,2-dimethyl-N-[(7S)-6-oxo-5,7-dihydrobenzo[d][1]benzazepin-7-yl]-N'-(2,2,3,3,3-pentafluoropropyl)propanediamide |
RO4927350 | 876755-27-0 | C27H28N4O6S | 536.603 | RO4927350; RO 4927350; RO-4927350. |
RO-46-8443 | 175556-12-4 | C31H35N3O8S | 609.69 | RO468443; 4-tert-butyl-N-[6-[(2R)-2,3-dihydroxypropoxy]-5-(2-methoxyphenoxy)-2-(4-methoxyphenyl)pyrimidin-4-yl]benzenesulfonamide; AC1NSM3O; SCHEMBL795046; GTPL1011; Ro 46-8443 |
RO462005 | 150725-87-4 | C23H27N3O6S | 473.54 | RO462005; RO-462005; RO 462005; Ro-46-2005; Ro 46-2005; Ro46-2005. |
RO10-5824 | 189744-46-5 | C17H20N4 | 280.37 | 2-methyl-5-((4-phenyl-5,6-dihydropyridin-1(2H)-yl)methyl)pyrimidin-4-amine; RO10-5824; RO 10-5824; RO-10-5824; RO105824; RO 105824; RO-105824. |
RO-0335 | 867365-76-2 | C21H13BrCl2FN3O4S | 573.214 | RO-0335, RO0335, RO 0335 |
Ro 90-7501 | 293762-45-5 | C20H16N6 | 340.39 | 2-[2-(4-aminophenyl)-3H-benzimidazol-5-yl]-3H-benzimidazol-5-amine; Ro 90-7501; 293762-45-5; GNF-Pf-5510; STK367782; CBChromo1_000149; AC1LGN68; Cambridge id 5180073; CBDivE_006377; R0529_SIGMA; CHEMBL578741; SCHEMBL10002475; STOCK2S-20922; CTK8E9490; DTX |
Ro 8-4304 hydrochloride | 1312991-77-7 | C21H23FN2O3.HCl | 406.88 | 4-[3-[4-(4-Fluorophenyl)-1,2,3,6-tetrahydro-1(2H)-pyridinyl]-2-hydroxypropoxy]benzamide hydrochloride; Ro 8-4304; Ro84304; Ro-8-4304; Ro 8-4304 hydrochloride; Ro 8-4304 HCl |
Ro 6842262 | 1396006-71-5 | C28H26N4O4 | 482.53 | 1-[4'-[4-Methyl-5-[[[(1R)-1-phenylethoxy]carbonylamino]-1H-1,2,3-triazol-1-yl][1,1'-biphenyl]-4-yl]cyclopropanecarboxylic acid |
Ro 67-7476 | 298690-60-5 | C17H18FNO2S | 319.39 | (2S)-2-(4-Fluorophenyl)-1-[(4-methylphenyl)sulfonyl]-pyrrolidine |
Ro 67-4853 | 302841-89-0 | C19H19NO4 | 325.36 | (9H-Xanthen-9-ylcarbonyl)-carbamic acid butyl ester; Ro67-4853; Ro 67-4853; Ro-67-4853 |
Ro 64-5229 | 246852-46-0 | C17H19Cl2N3O | 352.26 | (Z)-1-[2-Cycloheptyloxy-2-(2,6-dichlorophenyl)ethenyl]-1H-1,2,4-triazole; (Z)-1-[2-Cycloheptyloxy-2-(2,6-dichlorophenyl)ethenyl]-1H-1,2,4-triazole; (Z)-1-[2-Cycloheptyloxy-2-(2,6-dichlorophenyl)ethenyl]-1H-1,2,4-triazole (9CI); 1-[(1Z)-2-(Cycloheptyloxy)- |
Ro 61-8048 | 199666-03-0 | C17H15N3O6S2 | 421.45 | Ro61-8048; Ro 61-8048; Ro-61-8048; Ro618048; Ro 618048; Ro-618048 |
Ro 5-3335 | 30195-30-3 | C13H10ClN3O | 259.69 | 7-Chloro-1,3-dihydro-5-(1H-pyrrol-2-yl)-2H-1,4-benzodiazepin-2-one; 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-pyrrol-2-yl- (7CI,8CI); NSC 66020 |
RO 5263397 | 1357266-05-7 | C10H11FN2O | 194.21 | |
Ro 51 | 1050670-85-3 | C17H23IN4O4 | 474.29 | 2-[[4-Amino-5-[5-iodo-4-methoxy-2-(1-methylethyl)phenoxy]-2,4-pyrimidinyl]amino]-1,3-propanediol; Ro51; Ro-51; CHEMBL494161; 1050670-85-3; SCHEMBL4970553 |
Ro 48-8071 fumarate | 189197-69-1 | C27H31BrFNO6 | 564.44 | Ro 48-8071; Ro48-8071; Ro-48-8071; Ro 488071; Ro488071; Ro-488071 |
Ro 48-8071 | 161582-11-2 | C23H27BrFNO2 | 448.37 | Ro-48-8071 |
Ro 41-1049 hydrochloride | 127917-66-2 | C12H13ClFN3OS | 301.77 | Ro 41-1049 hydrochloride; UNII-19Z49HUF4G; N-(2-Aminoethyl)-5-(3-fluorophenyl)-4-thiazolecarboxamide hydrochloride; Ro 41-1049 (hydrochloride); AC1NSKEH; R107_SIGMA |
Ro 32-0432 hydrochloride | 151342-35-7 | C28H28N4O2.HCl | 489.01 | 3-[(8S)-8-[(Dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione hydrochloride; RO 32-0432 HCL; RO 32-0432 HYDROCHLORIDE; BISINDOLYLMALEIMIDE XI, HCL; BISINDOLYLMALEIMIDE XI HYDROCHLORIDE; BISIN |
Ro 31-8220 Mesylate | 138489-18-6 | C25H23N5O2S.CH4O3S | 553.65 | Bisindolylmaleimide IX Mesylate |
Ro 28-1675 | 300353-13-3 | C18H22N2O3S2 | 378.51 | Ro 028-1675; Ro 0281675 |
RO 28-1674 | 599164-57-5 | C18H22N2O3S2 | 378.51 | (S)-3-cyclopentyl-2-(4-(methylsulfonyl)phenyl)-N-(thiazol-2-yl)propanamide |
RO 28-0450 | 300352-96-9 | C18H22N2O3S2 | 378.51 | 3-Cyclopentyl-2-(4-methanesulfonyl-phenyl)-N-thiazol-2-yl-propionamide |
Ro 26-4550 trifluoroacetate | 1217448-66-2 | C26H30N4O3.CF3CO2H | 560.57 | methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate; 2,2,2-trifluoroacetic acid; Ro26-4550 |
RO 25-6981 hydrochloride | 919289-58-0 | C22H29NO2.HCl | 375.93 | 4-[(1R,2S)-3-(4-benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl]phenol hydrochloride |
Ro 25-6981 | 169274-78-6 | C22H29NO2.C4H4O4 | 455.54 | 4-[(1R,2S)-3-(4-benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl]phenol;(Z)-but-2-enedioic acid Ro 25-6981 (Maleate) Ro 25-6981 maleate 169274-78-6 1312991-76-6 SCHEMBL16669133 C22H29NO2.C4H4O4 4008AH 4-((1R,2S)-3-(4-Benzylpiperidin-1-yl)-1-hydroxy- |
Ro 20-1724 | 29925-17-5 | C15H22N2O3 | 278.35 | 4-(3-Butoxy-4-methoxyphenyl)methyl-2-imidazolidone; 4-[(3-Butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone; 4-(3-Butoxy-4-methoxy benzyl)-2-imidazolidinone; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidone; DL-4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; R |
Ro 19-4603 | 99632-94-7 | C15H17N3O3S | 319.38 | 5,6-Dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylic acid 1,1-dimethylethyl ester; Ro19-4603; Ro 19-4603; Ro-19-4603 |
Ro 15-4513 | 91917-65-6 | C15H14N6O3 | 326.31 | 8-Azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester |
Ro 15-2344 | 84377-97-9 | C15H14N4O5 | 0 | 4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 5,6-dihydro-5-methyl-8-nitro-6-oxo-, ethyl ester; 5,6-Dihydro-5-methyl-8-nitro-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine-3-carboxylic acid ethyl ester; Ro 15-2344; Nitromazenil |
Risperidone-d4 | 1020719-76-9 | C23H23D4FN4O2 | 414.52 | 3-[2-4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one-d4 |
Rivastigmine-d5 | 1133229-22-7 | C14H17N2O2D5 | 255.37 | (S)-3-(1-(dimethylamino)ethyl)phenyl (ethyl-d5)(methyl)carbamate |
Ro 106-9920 | 62645-28-7 | C10H7N5OS | 245.26 | 6-(Phenylsulfinyl)tetrazolo[1,5-b]pyridazine |
RK-682 calcium salt (2:1) | 332131-32-5 | C42H70CaO10 | 775.1 | TAN 1364B, CI 010 |
RK-33 | 1070773-09-9 | C23H20N6O3 | 428.44 | RK 33; RK33 |
RK-24466 | 213743-31-8 | C23H22N4O | 370.5 | |
RK-20448 | 479501-40-1 | C29H34N6O | 482.62 | 7-[4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-4-amine |
RJR-2403 oxalate | 220662-95-3 | C12H16N2O4 | 252.27 | (E)-Metanicotine oxalate; Rivanicline oxalate; RJR 2403 oxalate |
RJR-2403 | 15585-43-0 | C10H14N2 | 162.23 | Rivanicline; Metanicotine; RJR 2403 |
RJR 2429 dihydrochloride | 1021418-53-0 | C12H16N2.2HCl | 261.19 | (±)-2-(3-Pyridinyl)-1-azabicyclo[2.2.2]octane dihydrochloride; RJR-2429 2HCL; RJR-2429 dihydrochloride |
Rizatriptan-d6 Benzoate | 1216984-85-8 | C15H13N5D6.C7H6O2 | 397.51 | N,N-(Dimethyl-d6)-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine Benzoate; MK-0462-d6; MK-462-d6; Maxalt-d6 |
Rizatriptan Trimethylammonium Chloride | 1030849-63-8 | C16H22N5.Cl | 319.84 | Rizatriptan N,N,N-Trimethylethanammonium Chloride |
Rizatriptan N-oxide | 260435-42-5 | C15H19N5O | 285.35 | N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine N-Oxide |
Rizatriptan Impurity G | 1000673-59-5 | C13H13ClN4 | 260.73 | 3-(2-Chloroethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole |
RHODAMINE S | 67226-84-0 | C22H27N2O3Cl | 402.93 | |
RHODAMINE S | 72968-14-0 | 0 | RHODAMINE S; C.I.45050 | |
Rhodamine B amine | 100992-88-9 | C28H31N3O3 | 457.56 | [9-(4-amino-2-carboxyphenyl)-6-(diethylamino)xanthen-3-ylidene]-diethylazanium; chloride; RHODAMINEBAMINE; PL009836; 100992-88-9; 9-(4-AMINO-2-CARBOXYPHENYL)-6-(DIETHYLAMINO)-N,N-DIETHYL-3H-XANTHEN-3-IMINIUMCHLORIDE |
Rhodamine phalloidin | 219920-04-4 | C60H70N12O13S2 | 1231.40 | |
Rhodamine DHPE | 126111-99-7 | C70H11N4O14PS2 | 1333.81 | N-(Lissamine rhodamine B sulfonyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt |
Rhodamine B Isothiocyanate | 36877-69-7 | C29H30ClN3O3S | 500.63 | 9-[2-carboxy-5(or 6)-isothiocyanatophenyl]-3,6-bis(diethylamino)xanthylium chloride |
Rhodamine B isothiocyanate | 944130-99-8 | C29H30ClN3O3S | 536.1 | RBITC; RITC; Isothiocyanatorhodamine B; 9-[2-carboxy-4(or 5)-isothiocyanatophenyl]-3,6-bis(diethylamino)-xanthylium, monochloride |
Rhodamine B | 81-88-9 | C28H31ClN2O3 | 479.017 | Basic Violet 10; Brilliant Pink B; Tetraethylrhodamine; Rhodamine O; Rhodamine 610 |
RETINYL PROPIONATE | 7069-42-3 | C23H34O2 | 342.51 | ALL TRANS-RETINOL PROPIONATE; RETINYL PROPIONATE; VITAMIN A PROPIONATE; Retinol,propanoate; VITAMIN-A-PROPIONATE, ~2500 U/MG*; VITAMIN-A-PROPIONATE 2500 U MG 98+%; Retinylpropionat; Propanoic acid (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexene-1 |
RETINYL LINOLEATE | 631-89-0 | C38H60O2 | 548.8818 | |
Retinyl acetate | 127-47-9 | C22H32O2 | 328.496 | Vitamin A acetate; Retinol Acetate; Retinol acetate; All-trans-Retinyl acetate; Retinol, acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate |
Retinyl (Vitamin A) Palmitate | 79-81-2 | C36H60O2 | 524.86 | Pantothenate, Vitamin B5 |
Retinoic Acid 3,3-Dimethyl-2-oxobutyl Ester | 893412-73-2 | C26H38O3 | 398.58 | |
Retinamide | 20638-84-0 | C20H29NO | 299.45 | all-trans- |
RAGE antagonist peptide | 1092460-91-7 | C57H101N13O17S | 1272.56 | Ac-Glu-Leu-Lys-Val-Leu-Met-Glu-Lys-Glu-Leu-NH2 |
Rafoxanide-13C6 | 1353867-98-7 | N-[3-Chloro-4-(4-chloro- phenoxy)-phenyl]-2- hydroxy-3,5-diiodo-benzamide-13C6 | ||
Rafoxanide | 22662-39-1 | C19H11Cl2I2NO3 | 626.01 | Disalan; NSC 355278; BRN 2228187; Ranide; NSC355278; BRN2228187; NSC-355278; BRN-2228187; |
Rafigrelide | 1029711-88-3 | C12H11Cl2N3O | 284.14 | 6,7-Dichloro-3,3-dimethyl-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one;6,7-Dichloro-3,3-dimethyl-5,10-dihydroimidazo[2,1-b]quinazolin-2-one |
Quizartinib | 950769-58-1 | C29H32N6O4S | 560.67 | 1-(5-(tert-butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea; AC220; AC 220; AC-220; AC010220; AC-010220; AC 010220; AC010220; Quizartinib |
Quizalofop-p-tefuryl | 119738-06-6 | C22H21ClN2O5 | 428.88 | Quizalofop-p-tefuryl |
Quizalofop-p-ethyl | 100646-51-3 | C19H17ClN2O4 | 372.80 | 2-(4-((6-chloro-2-quinoxalinyl)oxy)phenoxy)-,ethylester,(r)-propanoicaci;assureii;ethyl(r)-2-(4-((6-chloro-2-quinoxalinyl)oxy)phenoxy)propanoate;nci-861094;QUIZALOFOP-P-ETHYL;QUINOFOP-P-ETHYL;DPX-Y6202-31;ETHYL (R)-2-[4-(6-CHLORO-2-QUINOXALYLOXY)PHENOXY] |
QUIZALOFOP METHYL | 76578-13-7 | C18H15ClN2O4 | 358.7757 | METHYL-2-[4-[(6-CHLORO-2-QUINOXALINYL)OXY]PHENOXY]PROPANOATE; QUIZALOFOP METHYL |
Quizalofop | 76578-12-6 | C17H13ClN2O4 | 344.76 | |
PUMICE STONE | 1332-09-8 | Pumicestonepowder; PUMICE; PUMICE F; PUMICE FFF; PUMICE O; PUMICE OO; PUMICE STONE; FFFF | ||
Pullulanase | 9075-68-7 | 0 | PULLULANASE; EC 3.2.1.41; LIMIT DEXTRINASE; AMYLOPECTIN 6-GLUCONOHYDROLASE; pullulanase from bacillus sp.; pullulanase from klebsiella pneumoniae; PULLULANASE FROM BACILLUS SP., POWDER, ~ 1 U/MG; PULLULANASE FROM BACILLUS*ACIDOPULLULYTI | |
Pullulan | 9057-02-7 | (C6H12O5)n | E1204; Polymaltotriose | |
Pulegone | 89-82-7 | C10H16O | 152.23 | (+)-Pulegone; (R)-(+)-Pulegone |
Pulchinenoside B | 135247-95-9 | C53H86O22 | Anemoside B | |
Puerol A | 152784-32-2 | C17H14O5 | 298.30 | 3-(2,4-dihydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-2H-furan-5-one |
Rizatriptan Impurity C | 208941-96-2 | C15H19N5 | 269.35 | |
Rizatriptan Dimer Impurity 3 | 1016900-25-6 | C28H35N7.C7H6O2 | 591.76 | 2-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine Benzoate; Rizatriptan Dimer Benzoate; |
Rizatriptan Benzoate | 145202-66-0 | C22H25N5O2 | 391.47 | Rizatriptan Benzoate; MK-462; MK-0462; 2-(5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-1H-INDOL-3-YL)-N,N-DIMETHYLETHANAMINE BENZOATE; MK 462; rizatriptan benzoate; Maxalt; MK 0462; MK 462; |
Rizatriptan | 144034-80-0 | C15H19N5 | 269.34 | |
Rivulobirin E | 237407-59-9 | C32H30O11 | 590.6 | 9-{[(2R)-2-Hydroxy-3-({(2R)-3-hydroxy-3-methyl-1-[(7-oxo-7H-furo[ 3,2-g]chromen-9-yl)oxy]-2-butanyl}oxy)-3-methylbutyl]oxy}-7H-furo [3,2-g]chromen-7-one |
Rivulobirin B | 194145-29-4 | C23H12O9 | ||
Riviciclib HCl | 920113-03-7 | C21H21Cl2NO5 | 438.3 | 2-(2-chlorophenyl)-5,7-dihydroxy-8-((2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4H-chromen-4-one hydrochloride; P276-00; P-276-00; P 276-00; P-27600; P 27600; P 27600; Riviciclib, Riviciclib HCl |
Riviciclib | 920113-02-6 | C21H21Cl2NO5 | 401.840 | P276, P276-00; P 276-00; P-276-00; |
Rivenprost | 256382-08-8 | C24H34O6S | 450.6 | ONO-4819; Methyl 4-[2-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxy-4-[3-(methoxymethyl)phenyl]but-1-enyl]-5-oxocyclopentyl]ethylsulfanyl]butanoate |
Rivastigmine-d3 | 1133229-21-6 | C14H19N2O2D3 | 253.36 | (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl-d3)carbamate |
Rivastigmine USP Related Compound F | 1346602-84-3 | C12H15NO2 | 205.26 | 3-Vinylphenyl ethyl(methyl)carbamate; 3-Ethenylphenyl ethyl(methyl)carbamate; N-Ethyl-N-methyl-3-vinylphenyl Carbamate |
Rivastigmine tartrate | 129101-54-8 | C14H22N2O2.C4H6O6 | 400.42 | ENA 713 |
Rivastigmine D6 Tartrate | 194930-00-2 | C18H22D6N2O8 | 406.42 | 3-[(1S)-1-[bis(D3)methylamino]ethyl]phenyl N-ethyl-N-methylcarbamate |
Rivastigmine Carbamate Impurity | 1346242-31-6 | C10H12N2O4 | 224.22 | 3-Nitrophenyl Ester N-Ethyl-N-methylcarbamic Acid |
Rivastigmine | 123441-03-2 | C14H22N2O2 | 250.34 | [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate; (S)-N-ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate; 713, ENA; 713, SDZ ENA; ENA 713; ENA 713, SDZ; ENA-713; ENA713; Exelon; Hydrogen Tartrate, Rivastigmine; rivastigmine; Riva |
Rivaroxaban-d4 | 1132681-38-9 | C19H14ClN3O5SD4 | 439.91 | 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl-d4]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide; BAY 59-7939-d4; |
Rivaroxaban Related Impurity 1 | 31166-29-7 | C5H2Cl2O2S | 197.04 | 4,5-Dichlorothiophene-2-carboxylic Acid |
Rivaroxaban Related Compound (Ethyl 4-(3-Oxomorpholino)-Phenylcarbamate) | 1327778-39-1 | C13H16N2O4 | 264.28 | N-[4-(3-Oxo-4-morpholinyl)phenyl]carbamic acid ethyl ester |
Ritanserin | 87051-43-2 | C27H25F2N3OS | 477.57 | 6-[2-[4-[Bis(4-fluorophenyl)methylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one; Ritanserin; R-55667; R 55667; R55667 |
RITA (NSC 652287) | 213261-59-7 | C14H12O3S2 | 292.367 | |
Ristocetin A sulfate | 11140-99-1 | C95H112N8O48S | 2166.0 | |
Ristocetin A sulfate | 11021-66-2 | C95H112N8O48S | 2166.0 | Ristocetin, Ristomycin III, Spontin, Riston |
Ristocetin A sulfate | 90831-71-3 | C95H112N8O44·SO4 | 2166 | Ristomycin III |
Ristocetin A | 1404-55-3 | C95H110N8O44 | 2166 | Ristocetin A; Ristocetin sulfate salt |
Risperidone Related Impurity 1 (6-Fluoro-3-(1,2,3,6-Tetrahydro-4-Pyridinyl)-1,2-Benzisoxazole) | 439082-09-4 | C12H11FN2O | 218.23 | 6-Fluoro-3-(1,2,3,6-tetrahydropyridin-4-yl)benzo[d]isoxazole |
Risperidone Related Compound HCl (3-(4-Piperidyl)-1,2-Benzisoxazole HCl) | 84163-68-8 | C12H14N2O. HCl | 238.72 | 3-(piperidin-4-yl)benzo[d]isoxazole |
Risperidone Pyrimidinone N-Oxide | 1301724-91-3 | C23H27FN4O3 | 426.5 | 3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine 1-oxide |
Risperidone N-Oxide | 832747-55-4 | C23H27FN4O3 | 426.5 | 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-oxido-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; |
Risperidone Metabolite | 152542-00-2 | C23H28FN3O3 | 413.5 | 3-[2-[4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one |
Risperidone mesylate | 666179-96-0 | C24H31FN4O5S | 506.59 | R 64 766 mesylate; 3-{2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one methanesulfonate; |
Risperidone impurity J | 1346606-24-3 | C35H40F2N6O3 | 630.73 | 3-{2-[4-({4-Fluoro-2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-phenyl}-hydroxyimino-methyl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one; |
Risperidone Impurity H | 158697-67-7 | C23H27F2N3O2 | 415.49 | 3-[2-[4-(2,4-Difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(2,4-Difluorobenzoyl)piperidino]ethyl]-6,7,8,9- tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; |
Risperidone Impurity F | 1346603-86-8 | C24H27FN4O4 | 454.51 | 2-[2-Methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl]ethyl-4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-carboxylate; |
Risperidone Impurity E | 1346602-28-5 | C24H29FN4O2 | 424.52 | 3-[2-4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl-6,7,8,9-tetrahydro-2,6-dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one; |
Risperidone Impurity D | 1199589-74-6 | C23H27FN4O2 | 410.5 | 3-[2-[4-(5-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; |
Risperidone Impurity B (Z-Isomer) | 132961-05-8 | C23H28F2N4O2 | 430.5 | 3-[2-[4-[(Z)-(2,4-Difluorophenyl)(hydroxyimino)methyl]-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; |
Risperidone Impurity B (Mixture of E/Z Isomers) | 158697-66-6 | C23H28F2N4O2 | 430.5 | 3-(2-(4-((2,4-difluorophenyl)(hydroxyimino)methyl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
Risperidone Impurity B (E-Isomer) | 691007-09-7 | C23H28F2N4O2 | 430.5 | 3-[2-[4-[(E)-(2,4-Difluorophenyl)(hydroxyimino)methyl]-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
Risperidone Impurity (3-Vinyl-6,7,8,9-Tetrahydro-2-Methyl-4H-Pyrido[1,2-a]pyrimidin-4-one) | 832747-59-8 | C11H14N2O | 190.25 | 3-Vinyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one3-Ethenyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; |
Risperidone hydrochloride | 666179-74-4 | C23H28ClFN4O2 | 446.94 | R 64 766 hydrochloride; 3-{2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride |
Risperidone EP Impurity I | 1329796-66-8 | C35H39F2N5O3 | 615.73 | 3-[2-[4-[4-Fluoro-2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]benzolyl]piperidin-1-yl]ethyl-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (Risperidone Impurity)3-[2-[4-{4-Fluoro-2-[4-(6-fluorobenzo[d]soxazol-3-yl)piperidin-1-yl]benzo |
Risperidone | 106266-06-2 | C23H27FN4O2 | 410.48 | R-64766 |
Riluzole-13C-15N2 | 1215552-03-6 | C7H5F3[13C]15N2OS | 237.18 | 6-(Trifluoromethoxy)-2-benzothiazolamine-13C,15N2; 6-(Trifluoromethoxy)-2-amino- benzothiazole-13C,15N2; 2-Amino-6-(trifluoromethoxy)benzothiazole-13C,15N2; PK-26124-13C,15N2; RP-54274-13C,15N2; Rilutek-13C,15N2 |
Risedronic acid D4 | 1035438-80-2 | C7H7D4NO7P2 | 287.14 | [1-Hydroxy-2-(3-pyridinyl)ethylidene]bis phosphonic Acid-d4; Actonel-d4; NE 58095-d4; |
Risedronate Sodium | 115436-72-1 | C7H10NNaO7P2 | 305.09 | NE 58095 Sodium |
Risedronate acid | 105462-24-6 | C7H11NO7P2 | 283.113 | Risedronate; (1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid |
Risedremate Sodium | 329003-65-8 | 0 | disodium; hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate; pentahydrate; UNII-HU2YAQ274O; Actonel(TN); RISEDREMATESODIUM | |
Ripretinib | 1442472-39-0 | C24H21BrFN5O2 | 510.36 | DCC-2618; 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea |
Ripasudil (K-115) | 887375-67-9 | C15H23ClFN3O4S | 395.88 | K-115; 4-fluoro-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline dihydrate hydrochloride |
RIPA-56 | 1956370-21-0 | C13H19NO2 | 221.3 | N-benzyl-N-hydroxy-2,2-dimethylbutanamide; |
Rioprostil | 77287-05-9 | C21H38O4 | 354.527 | RIOPROSTIL |
Riodoxol (2,4,6-Triiodoresorcinol) | 19403-92-0 | C6H3I3O2 | 487.8 | 2,4,6-Triiodoresorcinol |
Riociguat Impurity 6 | 1702271-98-4 | C18H17FN8 | 364.39 | 2-[1-[(2-Fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-N5-methyl-4,5,6-pyrimidinetriamine |
Riociguat Impurity 2 | 304874-06-4 | C15H13FN4O | 284.3 | 1-[(2-Fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridine-3-carboximidic acid methyl ester |
Riociguat | 625115-55-1 | C20H19FN8O2 | 422.424 | Riociguat. BAY 63-2521; Brand name: Adempas. |
Rink amide-MBHA PS resin, 1% DVB (200-400 mesh | 56603-28-2 | |||
Rimonabant-d10 | 929221-88-5 | C22H11Cl3N4OD10 | 473.95 | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-[(2,2,3,3,4,4,5,5,6,6-D10)piperidin-1-yl]-1H-pyrazole-3-carboxamide |
Rimonabant Hydrochloride | 158681-13-1 | C22H21Cl3N4O.HCl | 500.25 | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide; Rimonabant free base, SR141716; SR 141716; SR-141716; A 281; A-281; A281; Rimonabant, Acomplia, Zimulti |
Rimonabant | 168273-06-1 | C22H21Cl3N4O | 463.79 | SR141716; SR 141716; SR-141716 |
Rimiterol | 32953-89-2 | C12H17NO3 | 223.27 | Rimiterol; 4-Hydroxyl-2-Piperidinylmethyl)-1,2-benzenediol |
Rimeporide | 187870-78-6 | C11H15N3O5S2 | 0 | Rimeporide |
Rimegepant | 1289023-67-1 | C28H28F2N6O3 | 534.56 | Rimegepant; BMS-927711; UNII-997WVV895X; CHEMBL2178422; 997WVV895X |
Rimcazole dihydrochloride | 75859-03-9 | C21H27N3.2HCl | 394.39 | 9-[3-(cis-3,5-Dimethyl-1-piperazinyl)propyl]-9H-carbazole dihydrochloride; cis-9-[3-(3,5-Dimethyl-1-piperazinyl)propyl]-9H-carbazole Dihydrochloride; rel-9-[3-[(3R,5S)-3,5-Dimethyl-1-piperazinyl]propyl]-9H-carbazole Dihydrochloride (9CI); BW 234U; Rimcazo |
Rimantadine | 13392-28-4 | C12H21N | 179.30 | 1-(1-Adamantyl)ethanamine;1-Adamantanemethylamine, alpha-methyl-;alpha-Methyl-1-adamantanemethylamine;alpha-Methyladamantanemethylamine;Tricyclo(3.3.1.13,7)decane-1-methanamine, alpha-methyl-;Tricyclo[3,3,1,1(3,7)]decane-1-methanamine, alpha-m |
Riluzole Impurity B | 144631-82-3 | C8H4BrF3N2OS | 313.1 | 4-Bromo-6-(trifluoromethoxy-2-benzothiazolamine |
Riluzole Impurity A | 1391054-04-8 | C8H5F3N2OS | 234.2 | 2-Amino-5-(trifluoromethoxy)phenyl Thiocyanate |
Riluzole hydrochloride | 850608-87-6 | C8H5F3N2OS.HCl | 270.66 | 2-Amino-6-trifluoromethoxybenzothiazole hydrochloride; PK 26124 |
Riluzole 4-Trifluoromethoxyl Impurity | 235101-36-7 | C8H5F3N2OS | 234.2 | 4-(Trifluoromethoxy)-2-benzothiazolamine; 2-Amino-4-trifluoromethoxybenzothiazole; 4-(Trifluoromethoxy)benzo[d]thiazol-2-amine |
Riluzole | 1744-22-5 | C8H5F3N2OS | 234.2 | RP-54274, PK 26124 |
Riluzolamide | 1456696-94-8 | C9H6F3N3O2S | 277.23 | 1-(6-(Trifluoromethoxy)benzo[d]thiazol-2-yl)urea; Riluzolamide |
Rifampicin-d3 | 1262052-36-7 | C43H55D3N4O12 | 825.96 | Rifampin-d3 |
Rilpivirine Z-Isomer HCl | 500287-94-5 | C22H18N6. HCl | 402.89 | 4-[[4-[[4-[(1Z)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]-benzonitrile |
Rilpivirine N-Glucuronide | 143779-52-0 | C28H26N6O6 | 542.56 | 4-[[4-[[4-[(1E)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile N-Glucuronide; R 278474 N-Glucuronide; TMC 278 N-Glucuronide; |
Rilpivirine HCl | 700361-47-3 | C22H19ClN6 | 402.88 | (E)-4-((4-((4-(2-cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile hydrochloride; Rilpivirine; Rilpivirine hydrochloride; TMC278; TMC-278; TMC 278. trade name Edurant |
Rilpivirine | 500287-72-9 | C22H18N6 | 366.428 | R 278474; TMC 278; R-278474; R278474; TMC278; TMC-278 |
Rilonacept | 501081-76-1 | C9030H13932N2400O2670S74 | 0 | RILONACEPT |
Rilmenidine Phosphate | 85409-38-7 | C10H19N2O5P | 278.24 | |
Rilmenidine Impurity A | 54187-44-9 | C10H18N2O2 | 198.27 | |
Rilmenidine hemifumarate | 207572-68-7 | C10H16N2O.1/2C4H4O4 | 238.29 | 2-[N-(Dicyclopropylmethyl)amino]oxazoline hemifumarate; Oxaminozoline; S 3341 |
Rilmenidine | 54187-04-1 | C10H16N2O | 180.25 | |
Rilmazafone HCl | 85815-37-8 | C21H20Cl2N6O3 HCl | 475.34 36.46 | 1-(2-(2-chlorobenzoyl)-4-chlorophenyl)-5-glycylaminomethyl-3-dimethylaminocarbonyl-1H-1,2,4-triazole hydrochloride;S 450191S-450191 |
Rilmazafone | 99593-25-6 | C21H20Cl2N6O3 | 475.334 | |
Riligustilide | 89354-45-0 | C24H28O4 | 380.48 | (Z)-6,8',7,3'-Diligustilide; (3Z,3'Z)-6.8',7.3'-Diligustilide |
Rilapladib | 412950-08-4 | C40H38F5N3O3S | 735.8 | GSK 659032; 2-[2-[(2,3-difluorophenyl)methylsulfanyl]-4-oxoquinolin-1-yl]-N-[1-(2-methoxyethyl)piperidin-4-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide; |
Rigosertib sodium | 592542-60-4 | C21H24NNaO8S | 473.47 | sodium;2-[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetate; |
Rigosertib sodium | 1225497-78-8 | C21H24NNaO8S | 473.47 | Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, monosodium salt (9CI); (E)-2,4,6-Trimethoxystyryl 3-[(carboxymethyl)amino]-4-methoxybenzyl sulfone sodium salt; Novonex; ON 01910 sodium; ON 01 |
Rigosertib | 592542-59-1 | C21H25NO8S | 451.49 | UNII-67DOW7F9GL; 2-[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetic acid; ON-01910 |
RIG-1 modulator 1 | 1428729-63-8 | C14H17N5OS2 | 335.45 | CS-8144; HY-107902; 1-[2-(dimethylamino)ethyl]-3-(7-methyl-[1,3]thiazolo[5,4-e][1,3]benzothiazol-2-yl)urea |
Rifamycin SV | 6998-60-3 | C37H47NO12 | 697.77 | Rifogal; NSC133100; [2S-(2R*,12Z,14E,16R*,17R*,18S*,19S*,20S*,21R*,22S*,23R*,24E)]-21-(Acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione; (2S,12Z,14E,16S |
Rifaximin-d6 | 1262992-43-7 | C43H45N3O11D6 | 791.94 | 4-Deoxy-4'-methylpyridol[1',2'-1,2]imidazo[5,4-c]rifamycin SV-d6; Rifamycin L 105-d6; Rifaxidin-d6; L-105-d6; Fatroximin-d6; Normix-d6; Rifacol-d6; Xifaxan-d6 |
Rifaximin Impurity 2 | 1351775-03-5 | C43H49N3O11 | 783.88 | |
Rifaximin Impurity 1 | 1351775-04-6 | C43H49N3O11 | 783.88 | |
Rifaximin | 80621-81-4 | C43H51N3O11 | 785.88 | 4-Deoxy-4'-methylpyridol[1',2'-1,2]imidazo[5,4-c]rifamycin SV; Rifamycin L 105; Rifaxidin; L-105; Fatroximin; Normix; Rifacol; Xifaxan |
Rifapentine | 61379-65-5 | C47H64N4O12 | 877.03 | MDL473; MDL 473; MDL-473; Rifapentine; DL 473; DL-473; DL473; R 773; R-773; R773; |
Rifandin | 89499-17-2 | C46H64N4O12 | 865.028 | Rifandin |
Rifamycin Y | 15271-73-5 | C39H47NO15 | 769.81 | Aceticacid,[(1,2-dihydro-5,6,16,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11,17-trioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-9-yl)oxy]-,21-acetate (8CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, |
Rifamycin S | 13553-79-2 | C37H45NO12 | 695.75 | 5,17,19,21-Tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone 21-Acetate; 1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin; Rifaximin EP Impurity E; NSC 144130; BRN 0604802 |
Rifamycin B | 13929-35-6 | C39H49NO14 | 755.80 | 4-O-(Carboxymethyl)rifamycin; [(1,2-Dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-9-yl)oxy]acetic Acid 21-Acetate; Rifaximin EP Impurity B; NSC 145604 |
Rifampicin | 13292-46-1 | C43H58N4O12 | 822.94 | Rimactane |
Riboflavin, 2',3',4',5'-tetraacetate | 752-13-6 | C25H28N4O10 | 544.5 | Riboflavin tetraacetate |
Riboflavin Impurity 2 (Lumichrome) | 1086-80-2 | C12H10N4O2 | 242.24 | 7,8-Dimethylbenzo[g]pteridine-2,4(1H,3H)-dione;7,8-Dimethylalloxazine; 7,8-Dimethylisoalloxazine; NSC 96911; Riboflavin lumichrome |
Riboflavin | 83-88-5 | C17H20N4O6 | 376.36 | CP-62993; XZ-450; Lactoflavin; AK-77706 AC1Q2QPS; Spectrum2_000660 |
Ribocil-C | 1825355-56-3 | C21H21N7OS | 419.50 | 2-[(3S)-1-[(1-pyrimidin-2-ylimidazol-4-yl)methyl]piperidin-3-yl]-6-thiophen-2-yl-1H-pyrimidin-4-one Ribocil-C |
Ribocil | 1381289-58-2 | C19H22N6OS | 382.48 | Ribocil; CS-5272 |
Ribociclib | 1211441-98-3 | C23H30N8O | 434.55 | LEE011; LEE 011; LEE-011; Kisqali |
RIBITYL-3,4-XYLIDINE* | 3051-94-3 | C13H21NO4 | 255.31014 | RIBITYL-3,4-XYLIDINE*; 1-(D-Ribosylamino)-3,4-dimethylbenzene; 3,4-xylidino-D-ribitol; Deoxy-1-((3,4-dimethylphenyl)amino)-Dribitol; 1-(3,4-dimethylanilino)-1-deoxyribitol; (2R,3S,4S)-5-[(3,4-Dimethylphenyl)amino]-1,2,3,4-pentanetetrol |
Ribitol | 488-81-3 | C5H12O5 | 152.15 | Adonitol |
Ribavirin 5'-triphosphate tetrasodium salt | 63142-71-2 | C8H15N4O14P3·Na4 | 576.10 | 1-b-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide-5'-triphosphate; 1-[5-O-[Hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-b-D-ribofuranosyl]-1H-1,2,4-triazole-3-carboxamide tetrasodium; Hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-b-D |
Ribavirin Monophosphate | 40925-28-8 | C8H13N4O8P (free acid) | 324.18 (free acid) | Sodium salt |
R-Hydroxy topiramate | 198215-60-0 | C12H21NO9S | 355.36 | 4,5-O-[(1R)-2-Hydroxy-1-methylethylidene]-2,3-O-(1-methylethylidene)-b-D-fructopyranose 1-sulfamate; 10-Hydroxy topiramate |
Rhuscholide A | 944804-58-4 | C31H42O3 | 462.7 | |
r-HuGM-CSF | 123774-72-1 | C639H1002N168O196S8 | ||
RHPS 4 methosulfate | 390362-78-4 | C22H17F2N2.CH3O4S | 458.48 | 3,11-Difluoro-6,8,13-trimethylquino[4,3,2-kl]acridinium methylsulfate; RHPS 4 methosulfate; RHPS-4; RHPS 4; RHPS4 |
Rhosin hydrochloride | 1281870-42-5 | C20H19ClN6O | 394.86 | Rhosin hydrochloride |